data_2m3u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3u _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.653 ' CG2' ' NE1' ' A' ' 47' ' ' TRP . 2.7 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.796 0.332 . . . . 253.78999999999999 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 376.25 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 HG21 ' CE3' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 100.09999999999999 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 242.31999999999999 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 22.579999999999998 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 66.540000000000006 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.552 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.960000000000001 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.969999999999999 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 304.75999999999999 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 22.02 110.895 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 18.219999999999999 110.71 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.713 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.920000000000002 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.741 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 354.75 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.741 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 386.43000000000001 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HG2' HH11 ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 156.77000000000001 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 597.33000000000004 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 290.30000000000001 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 157.43000000000001 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54000000000002 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 222.68000000000001 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 116.14 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86000000000001 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 55.140000000000001 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.447 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 91.620000000000005 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.411 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 359.23000000000002 110.645 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 583.80999999999995 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 105.43000000000001 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 354.83999999999997 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.469 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 746.04999999999995 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 366.42000000000002 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 305.02999999999997 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 248.05000000000001 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 102.28 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 177.71000000000001 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 100.09999999999999 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41000000000003 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.564 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.80000000000001 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 104.84 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 288.31999999999999 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.653 ' NE1' ' CG2' ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 57.049999999999997 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 103.44 109.879 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 211.36000000000001 110.208 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 113.93000000000001 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.719 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.14999999999998 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99000000000001 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 96.319999999999993 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.969999999999999 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 58.649999999999999 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 120.95999999999999 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21000000000001 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.54 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 239.03 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 282.70999999999998 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.502 ' HH ' ' HB2' ' A' ' 76' ' ' LEU . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 142.75 110.859 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 96.620000000000005 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 46' ' ' THR . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 119.51000000000001 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 67.870000000000005 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.564 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 207.75999999999999 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 17.84 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 76.170000000000002 110.422 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 43.350000000000001 112.157 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.980000000000004 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 162.46000000000001 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 280.10000000000002 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 801.89999999999998 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.668 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 679.40999999999997 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 153.90000000000001 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.668 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.779999999999999 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 ' HB2' ' HH ' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 398.54000000000002 111.344 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 817.98000000000002 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.949999999999999 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.719 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 990.59000000000003 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HG ' ' C ' ' A' ' 79' ' ' ARG . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 101.09999999999999 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.53999999999999 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 307.13999999999999 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 75.549999999999997 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 999.99000000000001 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.574 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 99.379999999999995 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 46' ' ' THR . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 132.63999999999999 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 9.8 m-70 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 214.78 110.379 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 293.24000000000001 110.522 -179.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.403 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.69 0.281 . . . . 236.94999999999999 110.929 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.537 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 348.85000000000002 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.528 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 98.480000000000004 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 287.57999999999998 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 93.180000000000007 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 249.66999999999999 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 266.19 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.329999999999998 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.78999999999999 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 41.539999999999999 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 86.75 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 32.810000000000002 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 341.61000000000001 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 80.579999999999998 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 100.0 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 134.38 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.030000000000001 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 63.07 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.483 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 31.280000000000001 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 91.920000000000002 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.699 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 90.590000000000003 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.413 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 413.49000000000001 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.699 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36000000000001 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.425 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.449999999999999 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 8.8599999999999994 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 24.82 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.533 ' HG3' ' HB ' ' A' ' 118' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 106.2 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 864.77999999999997 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.590000000000003 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 92.719999999999999 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 32.840000000000003 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 277.07999999999998 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.507 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 183.72999999999999 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 530.38 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.641 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 563.59000000000003 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 409.16000000000003 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.83999999999997 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.009999999999998 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 388.56999999999999 110.611 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.688 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 18.449999999999999 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.555 HG22 ' CE1' ' A' ' 140' ' ' TYR . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 102.43000000000001 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 205.22999999999999 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.676 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 96.620000000000005 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.95999999999999 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.554 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 127.36 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.525 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 16.690000000000001 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.969999999999999 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 70.620000000000005 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 379.11000000000001 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 147' ' ' GLY . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 882.58000000000004 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.676 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 506.92000000000002 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 71.909999999999997 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 249.05000000000001 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 166.83000000000001 110.081 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.895 0.379 . . . . 145.78 109.981 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 479.0 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 598.73000000000002 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.695 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 45.490000000000002 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 162.31 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.27999999999997 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.695 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.27 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 22.370000000000001 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 101.95999999999999 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 128.53 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 94.430000000000007 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 63.289999999999999 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 104.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.488 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 93.329999999999998 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 102.39 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 290.07999999999998 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.1799999999999997 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.688 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 22.890000000000001 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.558 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 731.72000000000003 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 176' ' ' ILE . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 99.620000000000005 110.214 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 460.27999999999997 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99000000000001 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 3.2 m-80 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.671 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.671 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.635 ' HG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' N ' ' OG1' ' A' ' 46' ' ' THR . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.414 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.545 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.635 ' N ' ' HG ' ' A' ' 39' ' ' SER . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 3.8 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.412 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.729 0.3 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.736 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.472 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.736 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.657 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.491 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.714 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.714 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.99 0.424 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.415 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.601 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.432 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.551 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.657 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.744 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.548 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.529 ' HG1' ' CB ' ' A' ' 22' ' ' ASP . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.68 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.68 ' NE2' HD21 ' A' ' 15' ' ' ASN . 6.8 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.629 ' CG2' ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.611 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' CB ' ' HG1' ' A' ' 9' ' ' THR . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.426 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.546 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.548 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.3 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 14.8 m-70 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' H ' HD11 ' A' ' 88' ' ' LEU . 3.4 mp . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 7.8 m-85 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' GLY . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.508 ' HG ' ' NE2' ' A' ' 121' ' ' GLN . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.731 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.443 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.731 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.508 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 49.2 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.674 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.407 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.435 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.487 ' N ' ' OG ' ' A' ' 172' ' ' SER . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.674 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.63 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.649 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.649 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.2 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.622 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HG ' ' H ' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' H ' ' HG ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.3 m120 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.548 ' H ' ' CG2' ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HH ' ' NH1' ' A' ' 148' ' ' ARG . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' C ' ' HG ' ' A' ' 39' ' ' SER . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 39' ' ' SER . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.8 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.458 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.747 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 38' ' ' ASN . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.199 0.523 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 26.1 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.492 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.484 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.55 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.463 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.454 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.687 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE1' ' NE2' ' A' ' 149' ' ' GLN . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.8 m-80 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.538 ' NH1' ' HH ' ' A' ' 58' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.474 ' NE2' ' CE1' ' A' ' 140' ' ' TYR . 82.9 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.55 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.419 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.687 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.638 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.589 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.695 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.695 ' NE2' HD21 ' A' ' 15' ' ' ASN . 9.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.69 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.497 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.5 t-20 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.706 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.407 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.407 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.755 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.41 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.706 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.3 mp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.724 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.573 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.655 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 8.6 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.67 HD21 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.67 ' NE2' HD21 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.66 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.528 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.514 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' VAL . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.655 ' HE1' ' HG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.498 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.498 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' ARG . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 102' ' ' GLY . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.756 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.482 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.756 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.452 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 99' ' ' PHE . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.737 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 138' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.557 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.557 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 152' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 130' ' ' CYS . 23.3 m-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.725 0.297 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.458 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.458 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.737 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.708 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.586 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.634 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.634 ' NE2' HD21 ' A' ' 15' ' ' ASN . 21.5 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.65 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.65 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.503 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.699 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.537 ' CA ' ' HH ' ' A' ' 11' ' ' TYR . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.464 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.484 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.464 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 9.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.737 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.487 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.402 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.428 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.418 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.413 ' OH ' ' NE2' ' A' ' 149' ' ' GLN . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.675 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.675 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 59.7 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.714 0.293 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.437 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.437 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.586 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.671 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 6.7 t . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.66 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.66 ' NE2' HD21 ' A' ' 15' ' ' ASN . 20.6 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.603 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.472 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' C ' HD21 ' A' ' 38' ' ' ASN . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.6 m120 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' N ' ' HH ' ' A' ' 11' ' ' TYR . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.707 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 4.3 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.707 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.751 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.592 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.556 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.716 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.415 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 152' ' ' LEU . 10.5 mp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.556 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.592 HE22 ' CE ' ' A' ' 119' ' ' MET . 78.4 mm-40 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.716 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.588 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.575 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.665 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.665 ' NE2' HD21 ' A' ' 15' ' ' ASN . 17.5 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.655 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.655 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.407 ' C ' HD21 ' A' ' 38' ' ' ASN . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.67 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.661 ' N ' ' HH ' ' A' ' 11' ' ' TYR . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.575 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.3 t-20 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.658 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.9 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.658 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.757 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 112' ' ' THR . 3.2 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.516 ' OE2' ' NE2' ' A' ' 121' ' ' GLN . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.544 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.699 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.417 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.699 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.544 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 47.0 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.628 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.681 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.628 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 173' ' ' PHE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.695 ' H ' ' HG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.681 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.537 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.488 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.659 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.659 ' NE2' HD21 ' A' ' 15' ' ' ASN . 12.7 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.655 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.655 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.55 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.409 ' C ' HD21 ' A' ' 38' ' ' ASN . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.645 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.7 OUTLIER -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.538 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.538 ' H ' ' CG2' ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.1 t-20 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.841 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.432 ' N ' ' CG2' ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 121' ' ' GLN . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.715 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.456 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.715 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.9 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.544 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.453 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.447 ' CA ' ' OH ' ' A' ' 157' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.89 0.376 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.453 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.404 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.62 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.62 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.3 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.613 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.571 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 78' ' ' ASP . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 86' ' ' VAL . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.453 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.757 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' OG1' ' A' ' 46' ' ' THR . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 87' ' ' HIS . 3.4 m-70 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.721 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.502 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.497 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.665 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.457 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.571 ' CD2' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.438 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.438 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.621 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.689 HD21 ' NE2' ' A' ' 17' ' ' GLN . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.689 ' NE2' HD21 ' A' ' 15' ' ' ASN . 9.5 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.713 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.443 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 6.1 m120 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HZ1' ' CG ' ' A' ' 66' ' ' GLU . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.497 ' HG1' ' CG2' ' A' ' 61' ' ' ILE . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' CG ' ' HZ1' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 6.6 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.862 ' HG ' ' H ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 9.4 mp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.477 ' OH ' ' CG2' ' A' ' 177' ' ' VAL . 47.5 m-85 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.8 tm0? -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.746 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.465 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.759 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.496 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.496 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.41 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.412 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' A' ' 115' ' ' CYS . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.671 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.759 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.64 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.641 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.641 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.9 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.641 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.5 m120 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.444 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.64 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.451 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.672 0.272 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.72 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.483 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.695 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 148' ' ' ARG . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.531 HH21 ' HH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HH ' HH21 ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.414 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.414 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.695 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.562 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.444 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.664 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.664 ' NE2' HD21 ' A' ' 15' ' ' ASN . 21.3 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.621 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.621 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.635 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 6.4 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.416 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 4.3 m-30 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.691 0.282 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.503 HE21 ' CD ' ' A' ' 110' ' ' GLU . 96.0 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 113' ' ' GLU . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.577 ' N ' ' HG1' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 129' ' ' SER . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.775 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.446 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.4 m-80 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.538 HH21 ' HH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.538 ' HH ' HH21 ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.454 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.454 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.404 ' HA ' HE21 ' A' ' 171' ' ' GLN . 1.0 OUTLIER -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.775 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.559 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.634 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.634 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.7 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.652 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.652 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.53 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.2 t-20 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 39.0 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.693 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.851 0.357 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' GLY . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.7 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.554 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.7 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.477 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.476 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.732 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.473 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.413 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.738 0.304 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 161' ' ' ILE . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.554 HE22 ' CE ' ' A' ' 119' ' ' MET . 76.2 mm-40 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.732 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.451 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.636 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.636 ' NE2' HD21 ' A' ' 15' ' ' ASN . 15.1 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.596 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.596 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CE1' ' A' ' 33' ' ' TYR . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE1' ' OH ' ' A' ' 21' ' ' TYR . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' H ' ' CG2' ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.498 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.5 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' CD2' ' NH2' ' A' ' 148' ' ' ARG . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' O ' ' OG ' ' A' ' 39' ' ' SER . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' A' ' 39' ' ' SER . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.736 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.445 ' HG ' ' CD ' ' A' ' 53' ' ' PRO . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.688 0.28 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.506 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.707 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 138' ' ' ILE . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.734 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.734 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 10.6 mp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.403 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 170' ' ' VAL . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 168' ' ' PRO . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.707 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.625 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' NZ ' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.515 ' CG2' ' NZ ' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.659 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.659 ' NE2' HD21 ' A' ' 15' ' ' ASN . 12.9 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.679 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.679 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.813 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.408 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 7.5 mp . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.58 0.229 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 102' ' ' GLY . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.744 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.449 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.744 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.7 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.612 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.771 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.71 HD21 HH21 ' A' ' 146' ' ' ARG . 6.6 m-80 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.71 HH21 HD21 ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.813 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.612 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.512 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.771 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.508 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.64 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 15' ' ' ASN . 20.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.599 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.513 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 36' ' ' ARG . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.519 ' H ' ' HG ' ' A' ' 35' ' ' SER . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.2 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.76 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 7.1 mp . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.632 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 5.6 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.632 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.708 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.428 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.708 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.603 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.604 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.591 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.616 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.54 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.54 ' NE2' HD21 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.619 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.616 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 3.1 t30 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 46' ' ' THR . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.576 0.227 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.472 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.652 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.6 mp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.432 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.652 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.514 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.503 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' A' ' 7' ' ' LYS . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.555 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.566 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 9.9 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.66 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.498 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.495 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.5 m120 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.426 ' C ' ' HG ' ' A' ' 39' ' ' SER . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 69' ' ' GLU . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 51' ' ' GLU . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.3 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.705 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.705 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.635 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.75 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.475 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.71 0.29 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.41 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.635 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.75 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.613 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.617 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 8.9 t . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.563 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.563 ' NE2' HD21 ' A' ' 15' ' ' ASN . 8.6 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.583 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' HIS . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.678 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.485 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.485 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 44.6 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 172' ' ' SER . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.41 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 127' ' ' ILE . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.705 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.404 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.525 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.705 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.605 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.152 -1.579 . . . . 999.99000000000001 109.152 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.511 ' C ' ' O ' ' A' ' 1' ' ' GLY . 23.2 t 6.16 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.466 0.745 . . . . 999.99000000000001 111.852 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.644 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -171.2 177.87 3.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.032 -0.531 . . . . 999.99000000000001 110.353 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.614 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -137.83 138.94 39.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.621 . . . . 999.99000000000001 110.682 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.68 -82.85 0.95 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.835 -1.306 . . . . 263.51999999999998 109.835 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.653 ' CG2' ' NE1' ' A' ' 47' ' ' TRP . 2.7 t -153.38 143.19 22.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 253.78999999999999 110.613 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 376.25 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG21 ' CE3' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 100.09999999999999 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 242.31999999999999 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 22.579999999999998 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 66.540000000000006 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.552 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.960000000000001 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.969999999999999 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 304.75999999999999 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 22.02 110.895 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 18.219999999999999 110.71 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.713 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.920000000000002 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.741 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 354.75 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.741 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 386.43000000000001 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HG2' HH11 ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 156.77000000000001 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 597.33000000000004 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 290.30000000000001 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 157.43000000000001 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54000000000002 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 222.68000000000001 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 116.14 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86000000000001 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 55.140000000000001 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.447 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 91.620000000000005 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.411 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 359.23000000000002 110.645 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 583.80999999999995 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 105.43000000000001 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 354.83999999999997 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.469 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 746.04999999999995 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 366.42000000000002 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 305.02999999999997 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 248.05000000000001 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 102.28 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 177.71000000000001 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 100.09999999999999 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41000000000003 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.564 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.80000000000001 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 104.84 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 288.31999999999999 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.653 ' NE1' ' CG2' ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 57.049999999999997 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 103.44 109.879 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 211.36000000000001 110.208 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 113.93000000000001 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.14999999999998 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99000000000001 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 96.319999999999993 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.969999999999999 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 58.649999999999999 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 120.95999999999999 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21000000000001 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.54 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 239.03 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 282.70999999999998 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.502 ' HH ' ' HB2' ' A' ' 76' ' ' LEU . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 142.75 110.859 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 96.620000000000005 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 46' ' ' THR . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 119.51000000000001 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 67.870000000000005 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.564 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 207.75999999999999 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 17.84 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 76.170000000000002 110.422 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 43.350000000000001 112.157 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.980000000000004 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 162.46000000000001 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 280.10000000000002 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 801.89999999999998 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.668 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 679.40999999999997 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 153.90000000000001 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.668 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.779999999999999 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 ' HB2' ' HH ' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 398.54000000000002 111.344 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 817.98000000000002 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.949999999999999 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.719 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 990.59000000000003 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HG ' ' C ' ' A' ' 79' ' ' ARG . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 101.09999999999999 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.53999999999999 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 307.13999999999999 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 75.549999999999997 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 999.99000000000001 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.574 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 99.379999999999995 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 46' ' ' THR . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 132.63999999999999 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 9.8 m-70 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 214.78 110.379 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.3 mp -82.94 127.4 69.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 293.24000000000001 110.522 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.77 149.22 53.91 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.902 2.401 . . . . 136.33000000000001 112.122 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.13 155.06 32.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.919 -0.582 . . . . 852.86000000000001 110.293 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.33 -159.26 27.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.807 -0.917 . . . . 522.44000000000005 110.807 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.85 24.02 0.02 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 620.59000000000003 111.183 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -118.62 -39.35 3.0 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.269 -0.172 . . . . 387.79000000000002 110.662 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.403 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 43.31 86.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.389 0.431 . . . . 236.94999999999999 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.537 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 348.85000000000002 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.528 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 98.480000000000004 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 287.57999999999998 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 93.180000000000007 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 249.66999999999999 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 266.19 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.329999999999998 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.78999999999999 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 41.539999999999999 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 86.75 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 32.810000000000002 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 341.61000000000001 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 80.579999999999998 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 100.0 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 134.38 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.030000000000001 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 63.07 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 31.280000000000001 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 91.920000000000002 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.699 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 90.590000000000003 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.413 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 413.49000000000001 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.699 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36000000000001 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.425 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.449999999999999 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 8.8599999999999994 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 24.82 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.533 ' HG3' ' HB ' ' A' ' 118' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 106.2 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 864.77999999999997 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.590000000000003 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 92.719999999999999 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 32.840000000000003 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 277.07999999999998 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.507 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 183.72999999999999 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 530.38 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.641 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 563.59000000000003 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 409.16000000000003 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.83999999999997 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.009999999999998 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 388.56999999999999 110.611 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.688 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 18.449999999999999 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.555 HG22 ' CE1' ' A' ' 140' ' ' TYR . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 102.43000000000001 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 205.22999999999999 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.676 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 96.620000000000005 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.95999999999999 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 127.36 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.525 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 16.690000000000001 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.969999999999999 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 70.620000000000005 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 379.11000000000001 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 147' ' ' GLY . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 882.58000000000004 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.676 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 506.92000000000002 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 71.909999999999997 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 249.05000000000001 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.74 82.81 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 166.83000000000001 110.081 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.504 ' C ' ' HG2' ' A' ' 154' ' ' LYS . 40.1 t0 -52.01 -96.01 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.941 -0.572 . . . . 452.54000000000002 110.461 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.504 ' HG2' ' C ' ' A' ' 153' ' ' ASP . 1.2 mtmt -147.7 -138.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.527 -0.306 . . . . 999.99000000000001 110.198 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.7 -162.88 0.27 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.404 -0.362 . . . . 999.99000000000001 110.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.64 114.6 21.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 504.88 110.464 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -74.51 80.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 145.78 109.981 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 479.0 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 598.73000000000002 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.695 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 45.490000000000002 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 162.31 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.27999999999997 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.695 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.27 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 22.370000000000001 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 101.95999999999999 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 128.53 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 94.430000000000007 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 63.289999999999999 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 104.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.488 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 93.329999999999998 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 102.39 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 290.07999999999998 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.1799999999999997 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.688 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 22.890000000000001 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.558 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 731.72000000000003 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 176' ' ' ILE . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 99.620000000000005 110.214 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 460.27999999999997 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99000000000001 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m 57.44 67.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.777 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 67.27 169.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.521 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -45.16 144.4 1.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.298 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.4 -40.17 0.26 Allowed Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t -82.48 136.1 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 3.2 m-80 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.671 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.671 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.635 ' HG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' N ' ' OG1' ' A' ' 46' ' ' THR . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.414 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.545 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.635 ' N ' ' HG ' ' A' ' 39' ' ' SER . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 3.8 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.412 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.13 129.98 58.92 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.23 157.27 29.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.618 2.212 . . . . 0.0 112.203 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.3 t -64.94 139.97 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.098 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . -138.98 -70.56 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.64 -14.12 2.05 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 91' ' ' GLY . 58.4 tt0 -113.34 -47.94 2.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.599 0.238 . . . . 0.0 110.527 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' GLN . 91.8 m-85 39.12 93.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.185 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.736 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.472 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.736 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.657 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.491 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.714 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.714 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.47 46.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.72 -41.37 96.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.573 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' O ' ' OH ' ' A' ' 157' ' ' TYR . 99.0 mttt -58.13 159.81 5.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.468 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 156' ' ' GLU . 63.4 pttt -100.48 141.69 32.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.388 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 155' ' ' LYS . 80.0 tt0 57.83 151.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.478 ' OH ' ' O ' ' A' ' 154' ' ' LYS . 44.2 m-85 -145.56 83.37 1.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.415 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.601 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.432 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.551 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.657 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.744 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' LYS . 17.0 t 46.48 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 5' ' ' GLY . 17.4 ptmt 31.17 57.67 0.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.39 0.431 . . . . 0.0 110.994 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.5 m 40.69 -90.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.559 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 120.1 -55.48 0.62 Allowed Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.548 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t -150.53 143.04 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.529 ' HG1' ' CB ' ' A' ' 22' ' ' ASP . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.68 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.68 ' NE2' HD21 ' A' ' 15' ' ' ASN . 6.8 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.629 ' CG2' ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.611 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' CB ' ' HG1' ' A' ' 9' ' ' THR . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.426 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.546 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.548 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.3 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 14.8 m-70 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' H ' HD11 ' A' ' 88' ' ' LEU . 3.4 mp -96.42 131.25 28.82 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.23 141.88 20.97 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 122.093 1.862 . . . . 0.0 112.237 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.8 p -63.38 161.29 14.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.817 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.37 -59.2 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.91 15.49 81.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 50.4 tt0 -140.29 -94.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 7.8 m-85 93.57 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' GLY . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.508 ' HG ' ' NE2' ' A' ' 121' ' ' GLN . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.731 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.443 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.731 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.508 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 49.2 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.546 ' H ' ' HZ2' ' A' ' 154' ' ' LYS . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.674 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.407 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.6 mp -94.06 120.03 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 155' ' ' LYS . 59.2 t0 -86.72 23.09 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HZ2' ' H ' ' A' ' 135' ' ' GLY . 55.4 tttp 64.56 -5.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.613 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 153' ' ' ASP . 88.3 tttt -67.62 138.04 56.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -49.48 142.43 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.179 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 155' ' ' LYS . 42.0 m-85 -119.12 90.96 3.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.435 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.487 ' N ' ' OG ' ' A' ' 172' ' ' SER . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.674 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.63 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 p -155.37 161.88 40.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.825 0.345 . . . . 0.0 110.489 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 4' ' ' THR . 23.5 tptt -148.45 170.99 16.79 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.24 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.434 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 1.7 t -161.12 49.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.28 -76.45 1.23 Allowed Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t -150.1 141.18 23.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.649 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.649 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.2 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.622 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HG ' ' H ' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' H ' ' HG ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.3 m120 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.548 ' H ' ' CG2' ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HH ' ' NH1' ' A' ' 148' ' ' ARG . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' C ' ' HG ' ' A' ' 39' ' ' SER . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 39' ' ' SER . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.8 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.458 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.747 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 38' ' ' ASN . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.88 149.25 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.19 173.22 8.85 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.529 2.153 . . . . 0.0 111.992 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -57.36 162.77 2.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.939 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.35 96.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.77 149.41 17.34 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.503 ' O ' ' CB ' ' A' ' 94' ' ' TYR . 31.3 tt0 -61.38 -73.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.503 ' CB ' ' O ' ' A' ' 93' ' ' GLN . 5.6 m-30 118.49 147.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.157 1.536 . . . . 0.0 110.717 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 26.1 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.492 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.484 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.55 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.463 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.454 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.687 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE1' ' NE2' ' A' ' 149' ' ' GLN . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.8 m-80 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.538 ' NH1' ' HH ' ' A' ' 58' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.474 ' NE2' ' CE1' ' A' ' 140' ' ' TYR . 82.9 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.35 129.87 34.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -125.88 73.65 1.36 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.219 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 155' ' ' LYS . 63.3 mttp 46.9 -151.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 154' ' ' LYS . 20.6 tptp 60.02 131.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.561 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.74 141.33 57.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -97.54 85.77 3.69 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.015 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.55 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.419 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.687 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.638 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.0 t 51.52 172.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.391 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 5' ' ' GLY . 68.5 mttm -112.33 15.73 20.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m 40.02 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 153.44 -39.17 0.71 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.589 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t -150.6 142.02 23.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.695 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.695 ' NE2' HD21 ' A' ' 15' ' ' ASN . 9.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.69 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.5 t-20 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.706 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.407 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.755 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.64 141.52 56.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.43 162.36 41.69 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.519 2.146 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -74.57 156.12 37.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.309 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 139.4 -147.47 19.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.14 -41.89 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.57 -174.86 2.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.629 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 -141.87 96.56 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.93 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.41 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.706 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.3 mp -89.85 128.86 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 44.3 t0 -55.32 -109.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.639 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 153' ' ' ASP . 6.1 tmtt? -177.79 -3.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.08 -73.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.47 156.28 4.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.484 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.469 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 11.8 m-85 -135.24 96.44 3.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.276 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.724 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.573 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -75.48 169.17 18.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.629 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.58 -51.86 37.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m 39.08 -101.68 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.44 -45.62 2.89 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.655 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 8.6 t -152.08 143.78 23.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.67 HD21 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.67 ' NE2' HD21 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.66 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.528 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.514 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' VAL . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.655 ' HE1' ' HG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.498 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.498 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' ARG . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -90.54 144.94 31.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.68 136.74 21.52 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.46 2.107 . . . . 0.0 111.977 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -67.14 116.85 8.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.95 -145.21 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.92 14.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 55.4 tt0 -131.86 -107.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 11.6 m-85 92.08 113.98 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 123.801 0.688 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 102' ' ' GLY . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.756 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.482 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.756 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.452 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 99' ' ' PHE . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.737 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 138' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.557 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.557 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 152' ' ' LEU . 8.9 mp -86.24 127.9 34.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.676 ' H ' ' HH ' ' A' ' 157' ' ' TYR . 33.0 t0 -96.07 -168.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.086 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 24.9 pttm -78.08 -5.45 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.537 ' O ' ' CE1' ' A' ' 157' ' ' TYR . 69.9 mmtt -70.14 161.58 29.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.391 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -87.28 153.23 21.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.676 ' HH ' ' H ' ' A' ' 153' ' ' ASP . 23.3 m-85 -124.66 92.04 3.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.485 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.448 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.458 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.458 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.737 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.708 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.7 p -77.82 9.86 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.614 0.245 . . . . 0.0 110.765 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp 57.74 -111.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.803 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 m -56.65 -71.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.361 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.15 156.95 1.23 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.586 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -86.83 136.93 32.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.634 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.634 ' NE2' HD21 ' A' ' 15' ' ' ASN . 21.5 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.65 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.65 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.503 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.699 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.537 ' CA ' ' HH ' ' A' ' 11' ' ' TYR . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.464 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.484 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.464 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 9.8 mp -90.22 143.76 30.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.87 167.32 27.52 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.534 2.156 . . . . 0.0 112.036 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 m -57.21 147.28 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.64 -123.44 0.26 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.77 -70.64 1.35 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 52.1 tt0 -178.7 117.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.785 0.326 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.02 168.25 20.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.737 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.487 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.402 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.566 ' CG1' ' HZ2' ' A' ' 154' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.418 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' OH ' ' NE2' ' A' ' 149' ' ' GLN . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.675 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.675 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 59.7 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.06 128.41 42.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.29 18.69 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HZ2' ' CG1' ' A' ' 132' ' ' VAL . 65.9 tttp 57.42 104.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.516 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -151.07 -79.42 0.12 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.449 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -164.28 -38.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.49 ' OH ' ' N ' ' A' ' 154' ' ' LYS . 20.6 m-85 46.62 78.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.437 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.437 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.586 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.671 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -74.32 144.15 44.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.604 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -47.49 -65.12 0.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -120.8 80.37 1.62 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.392 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 131.25 10.61 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 6.7 t -94.76 151.11 19.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.66 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.66 ' NE2' HD21 ' A' ' 15' ' ' ASN . 20.6 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.603 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.472 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' C ' HD21 ' A' ' 38' ' ' ASN . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.6 m120 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' N ' ' HH ' ' A' ' 11' ' ' TYR . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.707 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 4.3 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.707 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.751 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.38 148.96 45.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.36 158.31 57.94 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.603 2.202 . . . . 0.0 112.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.2 t -65.84 166.46 11.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.49 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.76 -168.26 0.06 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . -133.28 -97.64 0.64 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' O ' ' O ' ' A' ' 94' ' ' TYR . 36.0 tt0 62.94 -56.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.945 0.438 . . . . 0.0 111.379 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 93' ' ' GLN . 70.1 m-85 55.71 139.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.592 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.556 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.716 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.415 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.467 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 152' ' ' LEU . 10.5 mp -76.38 131.66 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.519 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 25.7 t0 -103.52 -174.21 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.517 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 65.6 tttm -64.0 -33.25 75.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -54.69 133.45 46.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.748 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.23 -175.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 55.4 m-85 -142.74 83.43 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.358 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.556 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.592 HE22 ' CE ' ' A' ' 119' ' ' MET . 78.4 mm-40 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.716 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.588 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -63.17 -66.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.666 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' ' OG1' ' A' ' 4' ' ' THR . 8.7 ptmm? -142.36 36.91 1.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.354 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 3' ' ' LYS . 65.9 p 50.26 -136.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -114.29 4.97 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.575 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p -84.71 134.2 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.665 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.665 ' NE2' HD21 ' A' ' 15' ' ' ASN . 17.5 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.655 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.655 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.407 ' C ' HD21 ' A' ' 38' ' ' ASN . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.67 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.661 ' N ' ' HH ' ' A' ' 11' ' ' TYR . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.575 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.3 t-20 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.658 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.9 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.658 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.757 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp -80.69 131.94 59.38 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.52 147.46 40.95 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.076 1.851 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -63.94 151.61 42.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.979 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 152.35 26.43 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 94' ' ' TYR . . . -122.81 -127.79 3.32 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 67.62 -41.66 0.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.948 0.44 . . . . 0.0 110.751 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 92' ' ' GLY . 3.2 m-85 37.38 77.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' OE2' ' NE2' ' A' ' 121' ' ' GLN . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.544 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.699 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.417 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.699 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.544 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 47.0 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.628 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.681 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.74 141.91 28.65 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.521 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 53.0 t0 -134.28 -125.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 68.0 mmtt -77.85 -147.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.64 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 58.75 156.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.115 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -94.67 1.03 55.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.208 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 54.9 m-85 55.59 71.89 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.419 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.628 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 173' ' ' PHE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.695 ' H ' ' HG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.681 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.537 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.429 ' HG ' ' N ' ' A' ' 3' ' ' LYS . 41.7 t -124.01 -98.37 0.43 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 2' ' ' SER . 43.4 mmtm -79.06 -74.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.669 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 84.5 m -136.75 145.71 44.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.568 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -48.57 155.85 1.4 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.488 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -87.62 135.82 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.659 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.659 ' NE2' HD21 ' A' ' 15' ' ' ASN . 12.7 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.655 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.655 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.55 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.409 ' C ' HD21 ' A' ' 38' ' ' ASN . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.645 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.7 OUTLIER -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.538 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.538 ' H ' ' CG2' ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.1 t-20 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.841 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.85 138.68 27.72 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.38 172.08 16.82 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.686 2.258 . . . . 0.0 111.697 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -45.35 132.93 7.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.99 -149.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.49 -133.69 11.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -105.77 178.69 4.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 -134.26 95.36 3.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.975 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.432 ' N ' ' CG2' ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 121' ' ' GLN . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.715 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.456 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.715 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.9 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.544 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.453 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.447 ' CA ' ' OH ' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -105.06 78.76 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 66.4 t0 -66.02 -37.37 85.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.186 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.98 155.8 37.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -96.38 6.48 48.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.79 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -149.43 152.25 35.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 -150.95 99.94 2.75 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.275 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.453 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.404 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 t -67.74 -40.52 84.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.69 94.53 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -136.16 -101.0 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.12 -15.91 30.94 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.79 123.09 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.62 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.62 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.3 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.613 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.571 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 78' ' ' ASP . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 86' ' ' VAL . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.453 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.757 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' OG1' ' A' ' 46' ' ' THR . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 87' ' ' HIS . 3.4 m-70 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -77.75 142.88 66.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.94 149.76 10.92 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.875 1.717 . . . . 0.0 111.915 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -70.46 157.54 37.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.273 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.9 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.74 0.39 18.45 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' O ' ' OG1' ' A' ' 112' ' ' THR . 58.2 tt0 -116.78 -44.72 2.81 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.742 0.306 . . . . 0.0 110.277 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 39.99 90.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.253 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 93' ' ' GLN . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.721 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.502 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.497 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.665 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.457 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.05 137.14 32.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 155' ' ' LYS . 48.3 t0 -111.55 35.26 3.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 54.69 6.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.733 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 153' ' ' ASP . 62.5 tttp -74.34 138.02 43.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 156' ' ' GLU . 57.0 mp0 -47.42 138.57 7.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.319 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.571 ' CD2' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 -116.81 77.29 1.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.438 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.438 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.621 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 4' ' ' THR . 37.8 m -59.98 -44.17 94.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.643 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 51.08 -81.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 2' ' ' SER . 14.7 t -136.26 166.99 22.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.84 50.29 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t -93.4 143.03 26.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.689 HD21 ' NE2' ' A' ' 17' ' ' GLN . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.689 ' NE2' HD21 ' A' ' 15' ' ' ASN . 9.5 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.713 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.443 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 6.1 m120 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HZ1' ' CG ' ' A' ' 66' ' ' GLU . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.497 ' HG1' ' CG2' ' A' ' 61' ' ' ILE . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' CG ' ' HZ1' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 6.6 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.862 ' HG ' ' H ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 9.4 mp -92.88 116.3 66.28 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.86 163.1 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.204 1.936 . . . . 0.0 112.484 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLY . 25.8 t -71.2 164.97 24.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.49 63.35 0.11 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' SER . . . -62.58 -107.08 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.58 ' O ' ' O ' ' A' ' 94' ' ' TYR . 34.8 tp60 -143.29 -21.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.58 ' O ' ' O ' ' A' ' 93' ' ' GLN . 47.5 m-85 52.7 133.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.8 tm0? -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.746 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.465 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.759 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.75 97.11 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.66 -104.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -159.93 77.11 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 156' ' ' GLU . 98.8 mttt -140.72 13.94 2.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 155' ' ' LYS . 42.1 tp10 60.39 148.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.118 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -126.84 147.25 50.04 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.496 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.496 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.41 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.412 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' A' ' 115' ' ' CYS . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.671 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.759 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' H3 ' ' HG1' ' A' ' 4' ' ' THR . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -89.3 10.97 20.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -154.11 -65.26 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.689 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' GLY . 1.4 m 61.89 16.15 7.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' THR . . . -51.2 -175.44 0.02 OUTLIER Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.64 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -141.51 128.3 20.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.641 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.641 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.9 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.641 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.5 m120 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.444 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.64 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.451 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.677 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.64 153.33 47.83 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.96 129.78 11.78 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.323 2.015 . . . . 0.0 111.801 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.4 t -69.48 125.23 26.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.295 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.39 169.19 41.43 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.01 8.2 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.89 152.11 34.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -141.13 176.93 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.391 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.72 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.483 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.695 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 148' ' ' ARG . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.531 HH21 ' HH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HH ' HH21 ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.75 -161.92 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.523 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 6.1 t70 71.13 81.53 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 110.813 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -156.83 -64.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.149 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -160.75 154.88 22.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.504 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -42.26 117.09 0.93 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.405 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.523 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 60.9 m-85 -74.91 83.37 2.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.414 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.414 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.695 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.562 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.444 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m 55.83 -117.61 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.737 0.304 . . . . 0.0 110.511 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -158.87 52.71 0.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.423 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 -40.16 7.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.5 176.86 28.02 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -79.4 123.23 27.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.664 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.664 ' NE2' HD21 ' A' ' 15' ' ' ASN . 21.3 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.621 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.621 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.635 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 6.4 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.34 126.61 78.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.79 144.69 22.11 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.254 1.969 . . . . 0.0 112.341 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.4 t -63.22 137.0 58.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.89 -76.35 0.03 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.86 -83.23 0.32 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 49.4 tt0 -66.67 -70.06 0.27 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.612 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 4.3 m-30 99.97 80.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.147 1.529 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.503 HE21 ' CD ' ' A' ' 110' ' ' GLU . 96.0 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 113' ' ' GLU . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.577 ' N ' ' HG1' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 129' ' ' SER . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.775 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.446 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.4 m-80 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.538 HH21 ' HH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.538 ' HH ' HH21 ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.83 129.31 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 38.5 p30 -106.0 138.51 42.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -47.54 99.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.556 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -149.14 -94.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.485 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -173.55 -28.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 153' ' ' ASP . 3.3 m-85 54.95 68.84 0.8 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.454 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.454 ' CH2' ' HA ' ' A' ' 160' ' ' PRO . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.404 ' HA ' HE21 ' A' ' 171' ' ' GLN . 1.0 OUTLIER -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.775 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.559 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 76.58 21.21 1.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.27 . . . . 0.0 110.476 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' A' ' 4' ' ' THR . 30.2 tptt -88.76 -137.73 0.11 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.501 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 82.7 p -64.0 163.5 12.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.13 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.86 112.74 1.9 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p -146.05 136.67 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.634 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.634 ' NE2' HD21 ' A' ' 15' ' ' ASN . 11.7 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.652 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.652 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.53 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.2 t-20 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 39.0 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.693 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.6 151.77 68.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 128.33 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.351 1.367 . . . . 0.0 111.351 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.2 m -75.09 143.28 43.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.612 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 38.39 41.06 1.03 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.93 -134.16 1.45 Allowed Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 52.1 tt0 -148.1 151.06 34.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 0.0 110.362 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -121.75 145.49 47.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.254 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' GLY . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.7 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.554 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.7 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.477 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.476 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.732 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.473 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.413 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.71 117.93 29.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.671 ' N ' ' HH ' ' A' ' 157' ' ' TYR . 18.7 t70 -81.65 -155.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.111 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.549 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 72.3 mmtt -96.58 78.21 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 157' ' ' TYR . 43.2 tttm -151.97 158.41 43.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 110.253 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -81.81 -12.76 58.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.671 ' HH ' ' N ' ' A' ' 153' ' ' ASP . 51.7 m-85 57.09 88.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.666 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 161' ' ' ILE . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.554 HE22 ' CE ' ' A' ' 119' ' ' MET . 76.2 mm-40 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.732 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.451 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -85.85 164.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.82 0.343 . . . . 0.0 110.405 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -71.27 -75.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -45.03 7.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 29.82 4.04 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t -147.98 140.19 24.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.636 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.636 ' NE2' HD21 ' A' ' 15' ' ' ASN . 15.1 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.596 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.596 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CE1' ' A' ' 33' ' ' TYR . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE1' ' OH ' ' A' ' 21' ' ' TYR . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' H ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' H ' ' CG2' ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.498 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' CD2' ' NH2' ' A' ' 148' ' ' ARG . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' O ' ' OG ' ' A' ' 39' ' ' SER . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' A' ' 39' ' ' SER . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.736 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.445 ' HG ' ' CD ' ' A' ' 53' ' ' PRO . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.31 128.32 53.74 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.51 173.38 14.6 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.304 2.003 . . . . 0.0 112.027 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.8 p -50.61 128.97 21.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.04 -130.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.25 -138.06 13.68 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 HE21 ' CG2' ' A' ' 112' ' ' THR . 56.7 tt0 -111.1 121.06 44.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.357 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -80.09 111.33 16.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.506 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.707 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 138' ' ' ILE . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.734 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.734 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 10.6 mp -89.37 131.38 35.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 56.4 t0 -144.35 -17.91 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.198 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -69.66 142.65 53.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.364 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -39.57 92.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.428 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -137.8 151.58 48.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 -121.64 87.05 2.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.083 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.403 ' NE1' ' CB ' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 170' ' ' VAL . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 168' ' ' PRO . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.707 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.625 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -61.36 -67.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.717 0.294 . . . . 0.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.29 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.159 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 m -47.16 141.68 4.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.414 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.62 62.33 0.39 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t -87.12 138.0 31.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' NZ ' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.515 ' CG2' ' NZ ' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.659 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.659 ' NE2' HD21 ' A' ' 15' ' ' ASN . 12.9 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.679 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.679 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.813 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.408 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 7.5 mp -87.65 132.0 41.94 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.37 146.83 36.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.1 1.867 . . . . 0.0 112.304 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.7 m -63.24 155.47 28.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.13 -152.32 21.8 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.6 23.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.92 -45.75 5.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 40.97 78.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.16 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.744 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.449 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.744 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.7 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.612 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.771 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.71 HD21 HH21 ' A' ' 146' ' ' ARG . 6.6 m-80 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.71 HH21 HD21 ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.813 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' CD ' ' N ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.06 99.22 9.63 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -68.99 -92.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -157.06 -158.33 0.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.51 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 62.64 159.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.546 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 31.8 tp10 -69.16 146.96 52.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.331 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.0 -49.0 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.612 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.512 ' HG ' ' N ' ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.771 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.508 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.6 p -78.04 -148.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -118.6 -59.32 1.89 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.061 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -68.28 172.49 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.1 -103.91 0.21 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t -79.06 129.62 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.64 HD21 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 15' ' ' ASN . 20.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.599 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.513 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 36' ' ' ARG . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.519 ' H ' ' HG ' ' A' ' 35' ' ' SER . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.2 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.76 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 7.1 mp -85.4 133.58 42.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 151.36 26.06 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.034 1.823 . . . . 0.0 112.355 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.8 p -66.61 152.91 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.95 -165.47 0.05 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.95 75.5 0.98 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' LYS . 59.3 tt0 -46.76 120.4 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 -66.53 69.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' GLN . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.632 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 5.6 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.632 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.708 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.428 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.708 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.77 127.98 44.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.5 ' H ' ' HH ' ' A' ' 157' ' ' TYR . 16.6 m-20 -97.21 -124.34 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.166 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.62 24.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -93.4 34.35 1.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.583 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 97.4 mt-10 53.09 176.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.459 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' A' ' 153' ' ' ASP . 73.6 m-85 -153.01 85.26 1.22 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.603 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.604 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.591 ' H ' ' CD ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 4' ' ' THR . 8.7 t -170.75 16.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.609 0.242 . . . . 0.0 110.602 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.18 -77.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.949 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -78.26 1.97 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.255 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.82 -150.52 42.99 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.616 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p -143.54 133.15 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.54 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.54 ' NE2' HD21 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.619 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.616 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 3.1 t30 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 46' ' ' THR . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.48 136.53 26.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 130.59 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.063 1.842 . . . . 0.0 112.06 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -75.5 148.25 39.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.384 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 137.79 -42.43 1.29 Allowed Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . 72.7 -138.83 26.53 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.452 HE21 ' CE ' ' A' ' 95' ' ' LYS . 56.8 tt0 65.3 -49.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.822 0.366 . . . . 0.0 110.952 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 92' ' ' GLY . 78.7 m-85 37.4 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' CE ' HE21 ' A' ' 93' ' ' GLN . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.472 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.652 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.6 mp -90.1 118.39 29.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.546 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 48.9 t0 -170.47 26.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' LYS . 45.9 mmtm -125.35 84.34 2.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 154' ' ' LYS . 67.5 mttm 40.87 -165.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.856 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.64 151.16 47.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.546 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 42.4 m-85 -108.27 84.63 1.97 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.432 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.652 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.514 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.8 m -138.08 145.7 42.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.276 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -173.86 86.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.253 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 p 49.33 -139.14 0.84 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.305 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.78 49.73 0.06 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.503 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -84.19 135.71 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' A' ' 7' ' ' LYS . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.555 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.566 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 9.9 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' CG2' ' H ' ' A' ' 19' ' ' ARG . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.66 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.498 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.495 ' C ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.5 m120 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 45' ' ' GLY . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.426 ' C ' ' HG ' ' A' ' 39' ' ' SER . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 69' ' ' GLU . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 51' ' ' GLU . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.35 147.81 57.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.05 159.28 48.08 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.703 2.269 . . . . 0.0 112.477 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -78.8 166.76 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.517 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.8 -134.77 11.29 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.95 52.13 0.03 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 94' ' ' TYR . 42.6 tp60 -140.93 -34.33 0.51 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.371 0.129 . . . . 0.0 110.675 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 93' ' ' GLN . 58.7 m-85 56.26 145.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.3 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.705 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.705 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' NE2' ' HG ' ' A' ' 115' ' ' CYS . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.635 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.75 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.475 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.91 136.09 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.49 156.03 36.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -71.23 66.82 0.44 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.66 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -139.64 24.41 2.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 55.04 176.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -147.92 84.42 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.41 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.635 ' CZ3' ' SG ' ' A' ' 130' ' ' CYS . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' CB ' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.75 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.613 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.7 p -157.35 -15.61 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.336 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' GLY . 13.3 tptp 71.12 -32.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 31.74 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.349 0.406 . . . . 0.0 111.318 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 138.44 44.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.617 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 8.9 t -80.79 135.48 35.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.563 HD21 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.563 ' NE2' HD21 ' A' ' 15' ' ' ASN . 8.6 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.583 ' CG1' ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' H ' ' CG1' ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' A' ' 82' ' ' SER . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' HIS . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.678 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 6' ' ' THR . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.485 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.485 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 44.6 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.7 132.66 32.6 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.47 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.395 2.063 . . . . 0.0 111.697 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.0 p -65.64 146.11 55.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.477 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.46 -97.85 0.16 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.75 -69.49 3.2 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -172.67 106.41 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.721 0.296 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 -73.23 90.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 172' ' ' SER . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.41 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 127' ' ' ILE . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.705 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.404 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HE ' ' HH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.525 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 3.6 mp -84.44 111.47 19.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.27 -37.32 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.689 ' N ' ' HH ' ' A' ' 157' ' ' TYR . 69.2 mmtt -65.8 141.56 58.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.056 0.455 . . . . 0.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.5 -40.25 96.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.407 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.02 160.12 26.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.698 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.689 ' HH ' ' N ' ' A' ' 154' ' ' LYS . 76.4 m-85 -138.93 93.07 2.66 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.705 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.605 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.741 HG23 ' NE1' ' A' ' 47' ' ' TRP . 2.7 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.796 0.332 . . . . 129.8 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 199.79 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 9.02 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 108.38 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 16.01 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 8.22 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HB2' HG21 ' A' ' 18' ' ' VAL . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.96 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.97 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 148.27 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m120 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 20.47 110.895 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 17.57 110.71 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.943 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.92 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 181.28 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.968 ' H ' HG13 ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 213.85 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 104.2 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 409.66 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 191.9 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.42 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 68.05 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 135.72 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 21.25 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 36.83 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 65.11 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 183.12 110.645 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 446.29 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 19.97 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 239.39 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 564.4 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 223.41 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 108.56 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 131.54 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 8.32 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.681 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 65.38 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 45' ' ' GLY . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 14.81 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.8 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 25.7 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.677 HG21 HG23 ' A' ' 61' ' ' ILE . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 174.48 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.741 ' NE1' HG23 ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 17.04 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 14.03 109.879 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.74 110.208 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 37.37 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.765 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.15 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 44.98 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.97 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 43.93 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 51.03 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 137.33 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 166.9 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 66.05 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 15.15 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 61' ' ' ILE . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 23.69 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 32.25 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.66 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 199.43 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 15.69 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 10.27 110.422 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 26.52 112.157 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.98 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 62.43 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 231.83 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 550.39 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.835 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 351.03 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 76.84 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.69 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.78 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 199.52 111.344 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 454.41 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.95 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 628.23 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.835 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 14.38 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.54 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 173.09 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 28.95 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.584 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 700.8 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.584 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 15.11 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 48' ' ' ALA . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 30.12 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 95.66 110.379 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 88' ' ' LEU . 5.3 mp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 139.16 110.522 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.415 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.69 0.281 . . . . 124.95 110.929 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.606 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 226.38 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 13.39 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 148.11 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.731 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 7.27 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 162.91 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 113.54 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.33 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.79 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 34.18 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 23.87 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 17.98 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 323.67 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 12.97 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 17.27 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' THR . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 27.98 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.03 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 11.48 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 22.16 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 16.8 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 172' ' ' SER . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 7.88 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.429 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 225.51 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.45 111.119 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.441 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 7.59 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 19.62 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.731 ' SD ' HD12 ' A' ' 98' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 18.09 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 626.95 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.59 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 7.57 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 24.0 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 150.56 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' GLN . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 114.1 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.668 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 340.15 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 367.36 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 235.19 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.84 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.01 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 203.93 110.611 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.736 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 14.22 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.488 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 8.38 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HD2' HG21 ' A' ' 170' ' ' VAL . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 88.53 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.696 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 33.84 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.96 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.565 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 26.84 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.531 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 15.01 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.62 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 14.57 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 223.34 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 58' ' ' TYR . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 587.44 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.696 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 309.46 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 29.64 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 116.16 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 59.45 110.081 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.895 0.379 . . . . 91.81 109.981 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 356.15 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 412.73 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.733 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 24.57 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 43.57 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.28 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.24 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 19.49 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.792 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 18.17 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 25.38 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 26.27 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 30.49 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 83.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.788 HG21 ' HD2' ' A' ' 139' ' ' PHE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 10.44 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 72.16 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 118' ' ' ILE . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 145.02 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.18 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.736 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 19.73 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.643 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 428.71 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 66.03 110.214 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 274.9 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.45 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 3.0 m120 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' C ' HG23 ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.84 ' H ' HG12 ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.3 p-80 -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' C ' HD12 ' A' ' 61' ' ' ILE . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.437 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.633 ' O ' HD23 ' A' ' 80' ' ' LEU . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' ALA . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.587 HD11 ' OE1' ' A' ' 178' ' ' GLU . 2.6 pp . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.729 0.3 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.704 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.704 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.432 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.676 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 59' ' ' MET . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.99 0.424 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.926 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.926 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.701 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.813 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.543 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 11' ' ' TYR . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 18' ' ' VAL . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.985 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.5 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.858 ' N ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.484 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.499 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' LEU . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' HG22 ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.467 ' C ' HD12 ' A' ' 61' ' ' ILE . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.797 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.1 p30 -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 49' ' ' VAL . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 88' ' ' LEU . 3.4 mp . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 7.8 m-85 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 172' ' ' SER . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.706 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.48 ' SD ' HD12 ' A' ' 98' ' ' ILE . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 129' ' ' SER . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.722 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.415 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.474 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.897 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.897 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 172' ' ' SER . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.58 ' HA ' HG23 ' A' ' 118' ' ' ILE . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.722 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.695 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 21' ' ' TYR . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.454 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.9 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.764 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 9' ' ' THR . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.499 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 32' ' ' THR . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 27.7 m-20 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.58 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.666 ' N ' HG22 ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 69' ' ' GLU . 8.4 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.543 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 76' ' ' LEU . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' ARG . 8.0 p30 -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD11 ' CH2' ' A' ' 73' ' ' TRP . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.199 0.523 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 95.8 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' HD12 ' A' ' 118' ' ' ILE . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.725 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.6 m120 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.496 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' MET . 34.8 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.929 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.929 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.572 ' HA ' HG23 ' A' ' 118' ' ' ILE . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.725 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.66 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.576 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' OE2' ' NH1' ' A' ' 19' ' ' ARG . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.49 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.621 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.922 HG22 ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.922 ' H ' HG22 ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m120 -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.576 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 80' ' ' LEU . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.778 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.541 ' C ' HD12 ' A' ' 61' ' ' ILE . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.499 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.4 p30 -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp . . . . . 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.4 ' N ' ' HA ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 130' ' ' CYS . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.77 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 142' ' ' LEU . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.778 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.3 mp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 161' ' ' ILE . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.9 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.9 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.551 ' HA ' HG23 ' A' ' 118' ' ' ILE . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.77 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.599 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.579 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.6 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 21' ' ' TYR . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 18' ' ' VAL . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.643 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.789 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 9' ' ' THR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.579 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 80' ' ' LEU . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.717 ' OH ' HD22 ' A' ' 76' ' ' LEU . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.007 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 38.3 p30 -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.459 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.671 ' H ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 133' ' ' LEU . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.726 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.481 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.566 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 176' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.591 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 147' ' ' GLY . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.545 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.625 ' N ' HD13 ' A' ' 151' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 130' ' ' CYS . 23.3 m-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.725 0.297 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.965 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.965 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 118' ' ' ILE . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.785 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.741 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.448 HD11 HG13 ' A' ' 138' ' ' ILE . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.608 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.576 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 5.6 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.819 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' TYR . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 32' ' ' THR . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' LYS . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' H ' HG22 ' A' ' 6' ' ' THR . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.498 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.794 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.514 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.794 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.533 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.401 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.479 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.9 m80 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.623 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.422 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.66 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.66 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 33.2 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 133' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.714 0.293 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 165' ' ' ALA . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.956 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.956 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.546 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.623 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.73 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.7 t . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.45 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.589 ' O ' HG12 ' A' ' 18' ' ' VAL . 5.0 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.753 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.753 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 18.6 m-20 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.613 HD12 HD21 ' A' ' 62' ' ' LEU . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 62' ' ' LEU . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.549 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 61' ' ' ILE . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 11.5 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.752 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 79' ' ' ARG . 11.7 p30 -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' CG1' ' A' ' 49' ' ' VAL . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.0 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 98' ' ' ILE . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 124' ' ' MET . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 129' ' ' SER . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 129' ' ' SER . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.403 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.431 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 142' ' ' LEU . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 151' ' ' LEU . 10.5 mp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.447 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.911 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.911 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 172' ' ' SER . 17.5 mm100 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.597 ' HA ' HG23 ' A' ' 118' ' ' ILE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.619 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 4.3 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.832 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.832 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 62' ' ' LEU . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.706 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 69' ' ' GLU . 12.0 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.706 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p30 -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.481 ' OD2' ' ND2' ' A' ' 38' ' ' ASN . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CG1' ' A' ' 49' ' ' VAL . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 111' ' ' THR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 112' ' ' THR . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' OG ' ' A' ' 172' ' ' SER . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' HD12 ' A' ' 98' ' ' ILE . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.719 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.609 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 61' ' ' ILE . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.45 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.833 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.833 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.609 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 118' ' ' ILE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.526 ' N ' ' OG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.719 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.581 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.419 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.3 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.825 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.3 m120 -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' HG22 ' A' ' 6' ' ' THR . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.673 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.789 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 61' ' ' ILE . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.402 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' ARG . 5.7 p30 -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.671 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.688 ' NE2' HG11 ' A' ' 132' ' ' VAL . 74.2 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.421 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 112' ' ' THR . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.46 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.442 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 8.1 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.431 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HZ2' ' HD1' ' A' ' 104' ' ' PHE . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.688 HG11 ' NE2' ' A' ' 97' ' ' GLN . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.519 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 20.8 mp0 -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.89 0.376 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 165' ' ' ALA . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.836 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.836 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.576 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.581 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.78 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 18' ' ' VAL . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' H ' HG21 ' A' ' 18' ' ' VAL . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.9 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.779 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' LEU . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' HG22 ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.596 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 61' ' ' ILE . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.533 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.482 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.1 p30 -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 48' ' ' ALA . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.493 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.702 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 132' ' ' VAL . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.703 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.475 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.927 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.927 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.435 ' HB3' ' H ' ' A' ' 172' ' ' SER . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.579 ' HA ' HG23 ' A' ' 118' ' ' ILE . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.703 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.701 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 177' ' ' VAL . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.453 HG21 ' CE3' ' A' ' 47' ' ' TRP . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.633 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.2 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 16' ' ' PHE . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 45.0 m-20 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.641 ' N ' HG22 ' A' ' 40' ' ' ILE . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.813 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 16.9 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 49' ' ' VAL . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.4 mp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.477 ' OH ' ' CG2' ' A' ' 177' ' ' VAL . 47.5 m-85 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.685 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.6 OUTLIER -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.685 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 129' ' ' SER . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.443 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.907 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.8 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.555 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.852 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.852 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.54 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.433 ' HA ' HD11 ' A' ' 118' ' ' ILE . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.712 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.785 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.658 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.0 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.7 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 32.7 m-20 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.432 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.658 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.497 ' C ' HD12 ' A' ' 61' ' ' ILE . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 73' ' ' TRP . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.672 0.272 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.445 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 ' SG ' ' A' ' 130' ' ' CYS . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 136' ' ' VAL . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.421 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.599 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.534 HD12 ' CA ' ' A' ' 147' ' ' GLY . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.534 ' CA ' HD12 ' A' ' 142' ' ' LEU . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.526 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 151' ' ' LEU . 5.4 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 165' ' ' ALA . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.876 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.876 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.563 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.572 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 176' ' ' ILE . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 6.1 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.631 HD12 HD21 ' A' ' 62' ' ' LEU . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.622 ' N ' HG22 ' A' ' 46' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.716 HD11 ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 13.9 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' HE1' HD11 ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.416 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 4.3 m-30 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.691 0.282 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' H ' HD22 ' A' ' 133' ' ' LEU . 27.9 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' SD ' ' A' ' 124' ' ' MET . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' THR . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.462 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.701 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 129' ' ' SER . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.77 ' O ' HD21 ' A' ' 133' ' ' LEU . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' O ' HD23 ' A' ' 133' ' ' LEU . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 130' ' ' CYS . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.82 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.7 m120 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 118' ' ' ILE . 32.5 mm-40 -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.635 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.82 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.581 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.59 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.952 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.8 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG23 ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' N ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.664 ' N ' HG22 ' A' ' 46' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.403 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' C ' HD12 ' A' ' 61' ' ' ILE . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD21 ' NE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.535 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' C ' ' OG ' ' A' ' 39' ' ' SER . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.765 ' NE1' HD21 ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 ' CG1' ' A' ' 49' ' ' VAL . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 48' ' ' ALA . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.851 0.357 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 124' ' ' MET . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 136' ' ' VAL . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.779 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.553 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 61' ' ' ILE . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.0 mp . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.738 0.304 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.863 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.863 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.779 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.423 ' H ' HG21 ' A' ' 18' ' ' VAL . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.418 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.4 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.787 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CB ' HD23 ' A' ' 34' ' ' LEU . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.651 ' N ' HG22 ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 82' ' ' SER . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.501 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.486 ' C ' HD12 ' A' ' 61' ' ' ILE . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.54 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 79' ' ' ARG . 9.9 p30 -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.525 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 82' ' ' SER . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.688 0.28 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 111' ' ' THR . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.426 ' HA ' ' N ' ' A' ' 124' ' ' MET . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.426 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.419 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.569 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.752 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.811 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.811 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.6 mp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.895 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.895 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' HD11 ' A' ' 118' ' ' ILE . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.752 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.658 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HZ1' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.518 ' CG2' ' HZ1' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.674 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.989 ' O ' HG22 ' A' ' 18' ' ' VAL . 2.1 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.869 ' H ' HG23 ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' N ' HG22 ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.639 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.684 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.889 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 69' ' ' GLU . 6.0 pt20 -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.498 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD22 HG12 ' A' ' 49' ' ' VAL . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.5 mp . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.58 0.229 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 111' ' ' THR . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.424 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.424 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 11.9 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.444 ' O ' HD12 ' A' ' 118' ' ' ILE . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 129' ' ' SER . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.542 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.809 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.65 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.6 m120 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.435 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.889 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.5 mp0 -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.479 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.83 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.83 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.531 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.809 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.603 ' O ' HG12 ' A' ' 18' ' ' VAL . 4.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.776 ' H ' HG22 ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD22 ' A' ' 80' ' ' LEU . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.616 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' C ' HD12 ' A' ' 61' ' ' ILE . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.411 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 7.8 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 79' ' ' ARG . 13.3 p30 -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 ' CH2' ' A' ' 73' ' ' TRP . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.689 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.1 mp . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 109' ' ' TYR . 4.3 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.482 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.552 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.421 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' O ' ' A' ' 131' ' ' LYS . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 135' ' ' GLY . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.632 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.492 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.632 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.438 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.7 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.751 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.4 p-80 -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.764 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 13.2 t-20 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.764 HD11 ' CH2' ' A' ' 73' ' ' TRP . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.476 ' N ' ' OG ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.576 0.227 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 98' ' ' ILE . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.459 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.679 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.6 m80 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 13.0 m80 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 133' ' ' LEU . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.6 mp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.432 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.877 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.505 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.693 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 45' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.58 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.92 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.8 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.823 ' H ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 32.8 m-20 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.528 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.796 ' CH2' HD11 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.796 HD11 ' CH2' ' A' ' 73' ' ' TRP . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.2 mp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 96.1 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.455 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.634 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.797 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.656 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.71 0.29 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.906 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.906 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.797 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.637 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.48 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.9 t . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.461 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.7 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.6 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.48 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.585 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.585 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 69' ' ' GLU . 48.1 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 79' ' ' ARG . 10.4 p30 -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 73' ' ' TRP . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.702 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 48' ' ' ALA . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 98' ' ' ILE . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.402 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.403 HG21 ' SG ' ' A' ' 130' ' ' CYS . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.446 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.603 ' C ' HD23 ' A' ' 151' ' ' LEU . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 152' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.47 ' O ' HD11 ' A' ' 118' ' ' ILE . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 118' ' ' ILE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.64 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.152 -1.579 . . . . 999.99 109.152 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.511 ' C ' ' O ' ' A' ' 1' ' ' GLY . 23.2 t 6.16 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.466 0.745 . . . . 999.99 111.852 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.657 ' HG2' ' N ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -171.2 177.87 3.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.032 -0.531 . . . . 999.99 110.353 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.657 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -137.83 138.94 39.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.621 . . . . 999.99 110.682 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.68 -82.85 0.95 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.835 -1.306 . . . . 130.31 109.835 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.741 HG23 ' NE1' ' A' ' 47' ' ' TRP . 2.7 t -153.38 143.19 22.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 129.8 110.613 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 199.79 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 9.02 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 108.38 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 16.01 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 8.22 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HB2' HG21 ' A' ' 18' ' ' VAL . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.96 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.97 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 148.27 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m120 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 20.47 110.895 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 17.57 110.71 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.943 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.92 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 181.28 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.968 ' H ' HG13 ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 213.85 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 104.2 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 409.66 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 191.9 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.42 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 68.05 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 135.72 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 21.25 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 36.83 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.5 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 65.11 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 183.12 110.645 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 446.29 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 19.97 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 239.39 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 564.4 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 223.41 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 108.56 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 131.54 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 8.32 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.681 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 65.38 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 45' ' ' GLY . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 14.81 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.8 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 25.7 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.677 HG21 HG23 ' A' ' 61' ' ' ILE . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 174.48 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.741 ' NE1' HG23 ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 17.04 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 14.03 109.879 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.74 110.208 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 37.37 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.765 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.15 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 44.98 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.97 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 43.93 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 51.03 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 137.33 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 166.9 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 66.05 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 15.15 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 61' ' ' ILE . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 23.69 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 32.25 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.66 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 199.43 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 15.69 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 10.27 110.422 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 26.52 112.157 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.98 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 62.43 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 231.83 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 550.39 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.835 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 351.03 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 76.84 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.69 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.78 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 199.52 111.344 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 454.41 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.95 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 628.23 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.835 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 14.38 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.54 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 173.09 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 28.95 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.584 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 700.8 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.584 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 15.11 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 48' ' ' ALA . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 30.12 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 95.66 110.379 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 88' ' ' LEU . 5.3 mp -82.94 127.4 69.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 139.16 110.522 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' CG ' HG12 ' A' ' 136' ' ' VAL . 55.7 Cg_endo -71.77 149.22 53.91 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.902 2.401 . . . . 96.6 112.122 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.13 155.06 32.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.919 -0.582 . . . . 693.88 110.293 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.33 -159.26 27.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.807 -0.917 . . . . 371.01 110.807 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.85 24.02 0.02 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 458.5 111.183 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -118.62 -39.35 3.0 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.269 -0.172 . . . . 326.48 110.662 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 43.31 86.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.389 0.431 . . . . 124.95 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.606 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 226.38 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 13.39 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 148.11 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.731 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 7.27 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 162.91 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 113.54 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.33 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.79 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 34.18 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 23.87 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 17.98 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 323.67 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 12.97 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 17.27 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' THR . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 27.98 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.03 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 11.48 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 22.16 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 16.8 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 172' ' ' SER . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 7.88 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.429 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 225.51 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.45 111.119 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.441 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 7.59 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 19.62 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.731 ' SD ' HD12 ' A' ' 98' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 18.09 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 626.95 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.59 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 7.57 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 24.0 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 150.56 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' GLN . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 114.1 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.668 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 340.15 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 367.36 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 235.19 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.84 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.01 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG12 ' CG ' ' A' ' 89' ' ' PRO . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 203.93 110.611 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.736 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 14.22 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.488 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 8.38 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HD2' HG21 ' A' ' 170' ' ' VAL . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 88.53 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.696 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 33.84 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.96 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.565 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 26.84 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.531 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 15.01 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.62 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 14.57 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 223.34 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 58' ' ' TYR . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 587.44 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.696 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 309.46 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 29.64 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 116.16 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.74 82.81 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 59.45 110.081 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.525 ' C ' ' HG2' ' A' ' 154' ' ' LYS . 40.1 t0 -52.01 -96.01 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.941 -0.572 . . . . 452.54 110.461 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 153' ' ' ASP . 1.2 mtmt -147.7 -138.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.527 -0.306 . . . . 999.99 110.198 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.7 -162.88 0.27 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.404 -0.362 . . . . 999.99 110.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.64 114.6 21.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 504.88 110.464 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -74.51 80.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 91.81 109.981 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 356.15 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 412.73 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.733 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 24.57 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 43.57 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.28 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.24 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 19.49 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.792 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 18.17 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 25.38 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 26.27 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 30.49 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 83.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.788 HG21 ' HD2' ' A' ' 139' ' ' PHE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 10.44 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 72.16 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 118' ' ' ILE . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 145.02 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.18 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.736 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 19.73 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.643 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 428.71 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 66.03 110.214 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 274.9 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m 57.44 67.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.777 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 67.27 169.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.521 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -45.16 144.4 1.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.298 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.4 -40.17 0.26 Allowed Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t -82.48 136.1 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.45 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 3.0 m120 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' C ' HG23 ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.84 ' H ' HG12 ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.3 p-80 -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.426 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' C ' HD12 ' A' ' 61' ' ' ILE . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.437 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.633 ' O ' HD23 ' A' ' 80' ' ' LEU . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' ALA . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.587 HD11 ' OE1' ' A' ' 178' ' ' GLU . 2.6 pp -83.13 129.98 58.92 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.23 157.27 29.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.618 2.212 . . . . 0.0 112.203 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.3 t -64.94 139.97 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.098 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . -138.98 -70.56 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.64 -14.12 2.05 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' GLY . 58.4 tt0 -113.34 -47.94 2.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.599 0.238 . . . . 0.0 110.527 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' GLN . 91.8 m-85 39.12 93.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.185 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.704 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.704 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.466 HG22 ' H ' ' A' ' 156' ' ' GLU . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.676 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 59' ' ' MET . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.8 mp -86.47 46.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.72 -41.37 96.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.573 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -58.13 159.81 5.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 156' ' ' GLU . 63.4 pttt -100.48 141.69 32.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.388 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' H ' HG22 ' A' ' 132' ' ' VAL . 80.0 tt0 57.83 151.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -145.56 83.37 1.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.926 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.926 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.701 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.813 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' LYS . 17.0 t 46.48 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 5' ' ' GLY . 17.4 ptmt 31.17 57.67 0.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.39 0.431 . . . . 0.0 110.994 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.5 m 40.69 -90.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.559 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 120.1 -55.48 0.62 Allowed Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.543 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t -150.53 143.04 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 11' ' ' TYR . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 18' ' ' VAL . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.985 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.5 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.858 ' N ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.484 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.499 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' LEU . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' HG22 ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.415 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.467 ' C ' HD12 ' A' ' 61' ' ' ILE . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.797 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.1 p30 -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 49' ' ' VAL . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 88' ' ' LEU . 3.4 mp -96.42 131.25 28.82 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.23 141.88 20.97 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 122.093 1.862 . . . . 0.0 112.237 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.8 p -63.38 161.29 14.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.817 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.37 -59.2 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.91 15.49 81.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 50.4 tt0 -140.29 -94.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 7.8 m-85 93.57 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 172' ' ' SER . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.706 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.48 ' SD ' HD12 ' A' ' 98' ' ' ILE . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 129' ' ' SER . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.722 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.415 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.6 mp -94.06 120.03 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 155' ' ' LYS . 59.2 t0 -86.72 23.09 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 tttp 64.56 -5.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.613 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 153' ' ' ASP . 88.3 tttt -67.62 138.04 56.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -49.48 142.43 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.179 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 155' ' ' LYS . 42.0 m-85 -119.12 90.96 3.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.474 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.897 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.897 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 172' ' ' SER . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.58 ' HA ' HG23 ' A' ' 118' ' ' ILE . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.722 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.695 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 p -155.37 161.88 40.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.825 0.345 . . . . 0.0 110.489 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 4' ' ' THR . 23.5 tptt -148.45 170.99 16.79 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.24 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.441 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 1.7 t -161.12 49.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.28 -76.45 1.23 Allowed Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t -150.1 141.18 23.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 21' ' ' TYR . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.454 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.9 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.764 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 9' ' ' THR . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.499 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 32' ' ' THR . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 27.7 m-20 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.58 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.666 ' N ' HG22 ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 69' ' ' GLU . 8.4 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.543 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 76' ' ' LEU . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' ARG . 8.0 p30 -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD11 ' CH2' ' A' ' 73' ' ' TRP . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.88 149.25 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.19 173.22 8.85 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.529 2.153 . . . . 0.0 111.992 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -57.36 162.77 2.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.939 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.35 96.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.77 149.41 17.34 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 31.3 tt0 -61.38 -73.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 5.6 m-30 118.49 147.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.157 1.536 . . . . 0.0 110.717 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 95.8 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' HD12 ' A' ' 118' ' ' ILE . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.725 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.6 m120 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.496 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' MET . 34.8 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -86.35 129.87 34.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -125.88 73.65 1.36 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.219 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 155' ' ' LYS . 63.3 mttp 46.9 -151.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 154' ' ' LYS . 20.6 tptp 60.02 131.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.561 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.74 141.33 57.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -97.54 85.77 3.69 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.015 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.929 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.929 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.572 ' HA ' HG23 ' A' ' 118' ' ' ILE . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.725 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.66 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.0 t 51.52 172.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.391 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 5' ' ' GLY . 68.5 mttm -112.33 15.73 20.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m 40.02 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 153.44 -39.17 0.71 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.576 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t -150.6 142.02 23.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' OE2' ' NH1' ' A' ' 19' ' ' ARG . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.49 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.621 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.922 HG22 ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.922 ' H ' HG22 ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m120 -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 80' ' ' LEU . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.778 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.541 ' C ' HD12 ' A' ' 61' ' ' ILE . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.499 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.4 p30 -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp -79.64 141.52 56.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.43 162.36 41.69 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.519 2.146 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -74.57 156.12 37.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.309 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 139.4 -147.47 19.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.14 -41.89 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.57 -174.86 2.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.629 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 -141.87 96.56 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.93 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.4 ' N ' ' HA ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 130' ' ' CYS . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.77 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 142' ' ' LEU . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.778 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.3 mp -89.85 128.86 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 44.3 t0 -55.32 -109.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.639 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 153' ' ' ASP . 6.1 tmtt? -177.79 -3.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.425 ' H ' ' H ' ' A' ' 154' ' ' LYS . 86.2 tttt -79.08 -73.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.465 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.47 156.28 4.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.484 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.469 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 11.8 m-85 -135.24 96.44 3.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.276 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 161' ' ' ILE . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.9 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.9 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.551 ' HA ' HG23 ' A' ' 118' ' ' ILE . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.77 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.599 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -75.48 169.17 18.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.629 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.58 -51.86 37.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m 39.08 -101.68 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.44 -45.62 2.89 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.579 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.6 t -152.08 143.78 23.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 21' ' ' TYR . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 18' ' ' VAL . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.643 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 1.7 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.789 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 9' ' ' THR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.579 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 80' ' ' LEU . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.717 ' OH ' HD22 ' A' ' 76' ' ' LEU . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.007 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 38.3 p30 -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.459 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.671 ' H ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -90.54 144.94 31.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.68 136.74 21.52 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.46 2.107 . . . . 0.0 111.977 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -67.14 116.85 8.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.95 -145.21 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.92 14.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 55.4 tt0 -131.86 -107.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 11.6 m-85 92.08 113.98 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 123.801 0.688 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 133' ' ' LEU . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.726 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.481 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.566 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 176' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.591 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 147' ' ' GLY . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.545 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.625 ' N ' HD13 ' A' ' 151' ' ' LEU . 8.9 mp -86.24 127.9 34.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.583 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 33.0 t0 -96.07 -168.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.086 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 24.9 pttm -78.08 -5.45 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.537 ' O ' ' CE1' ' A' ' 157' ' ' TYR . 69.9 mmtt -70.14 161.58 29.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.391 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -87.28 153.23 21.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 23.3 m-85 -124.66 92.04 3.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.485 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.965 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.965 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 118' ' ' ILE . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.785 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.741 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.448 HD11 HG13 ' A' ' 138' ' ' ILE . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.7 p -77.82 9.86 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.614 0.245 . . . . 0.0 110.765 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp 57.74 -111.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.803 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 m -56.65 -71.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.361 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.15 156.95 1.23 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.608 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -86.83 136.93 32.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.576 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 5.6 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.819 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' TYR . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 32' ' ' THR . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' LYS . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' H ' HG22 ' A' ' 6' ' ' THR . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.498 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.794 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.794 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.533 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.8 mp -90.22 143.76 30.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.87 167.32 27.52 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.534 2.156 . . . . 0.0 112.036 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 m -57.21 147.28 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.64 -123.44 0.26 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.77 -70.64 1.35 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 52.1 tt0 -178.7 117.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.785 0.326 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.02 168.25 20.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.401 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.479 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.9 m80 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.623 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.422 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.66 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.66 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 33.2 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 133' ' ' LEU . 11.0 mp -96.06 128.41 42.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.29 18.69 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.49 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 65.9 tttp 57.42 104.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.516 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -151.07 -79.42 0.12 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.449 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -164.28 -38.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.49 ' OH ' ' N ' ' A' ' 154' ' ' LYS . 20.6 m-85 46.62 78.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 165' ' ' ALA . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.956 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.956 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.546 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.623 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.73 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -74.32 144.15 44.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.604 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -47.49 -65.12 0.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -120.8 80.37 1.62 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.392 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 131.25 10.61 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.7 t -94.76 151.11 19.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.45 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.589 ' O ' HG12 ' A' ' 18' ' ' VAL . 5.0 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.753 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.753 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 18.6 m-20 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.613 HD12 HD21 ' A' ' 62' ' ' LEU . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 62' ' ' LEU . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.549 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 61' ' ' ILE . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 11.5 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.752 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 79' ' ' ARG . 11.7 p30 -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' CG1' ' A' ' 49' ' ' VAL . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.0 mp -87.38 148.96 45.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.36 158.31 57.94 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.603 2.202 . . . . 0.0 112.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.2 t -65.84 166.46 11.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.49 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.76 -168.26 0.06 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . -133.28 -97.64 0.64 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' O ' ' O ' ' A' ' 94' ' ' TYR . 36.0 tt0 62.94 -56.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.945 0.438 . . . . 0.0 111.379 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 93' ' ' GLN . 70.1 m-85 55.71 139.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 98' ' ' ILE . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 124' ' ' MET . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 129' ' ' SER . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 129' ' ' SER . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.403 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.431 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 142' ' ' LEU . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 151' ' ' LEU . 10.5 mp -76.38 131.66 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.519 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 25.7 t0 -103.52 -174.21 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 65.6 tttm -64.0 -33.25 75.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -54.69 133.45 46.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.748 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.23 -175.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 55.4 m-85 -142.74 83.43 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.358 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.447 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.911 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.911 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 172' ' ' SER . 17.5 mm100 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.597 ' HA ' HG23 ' A' ' 118' ' ' ILE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.619 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -63.17 -66.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.666 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 4' ' ' THR . 8.7 ptmm? -142.36 36.91 1.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.354 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 3' ' ' LYS . 65.9 p 50.26 -136.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -114.29 4.97 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p -84.71 134.2 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 4.3 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.832 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.832 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 62' ' ' LEU . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.706 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 69' ' ' GLU . 12.0 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.706 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p30 -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.481 ' OD2' ' ND2' ' A' ' 38' ' ' ASN . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CG1' ' A' ' 49' ' ' VAL . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp -80.69 131.94 59.38 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.52 147.46 40.95 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.076 1.851 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -63.94 151.61 42.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.979 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 152.35 26.43 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 94' ' ' TYR . . . -122.81 -127.79 3.32 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 67.62 -41.66 0.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.948 0.44 . . . . 0.0 110.751 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 92' ' ' GLY . 3.2 m-85 37.38 77.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 111' ' ' THR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 112' ' ' THR . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' OG ' ' A' ' 172' ' ' SER . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' HD12 ' A' ' 98' ' ' ILE . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.609 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 61' ' ' ILE . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.74 141.91 28.65 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.521 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 53.0 t0 -134.28 -125.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -77.85 -147.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.64 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 58.75 156.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.115 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -94.67 1.03 55.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.208 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 54.9 m-85 55.59 71.89 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.419 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.45 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.833 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.833 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.609 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 118' ' ' ILE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.526 ' N ' ' OG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.719 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.581 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -124.01 -98.37 0.43 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -79.06 -74.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.669 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 84.5 m -136.75 145.71 44.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.568 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -48.57 155.85 1.4 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -87.62 135.82 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.419 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.3 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.825 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.3 m120 -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' HG22 ' A' ' 6' ' ' THR . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.673 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.789 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 61' ' ' ILE . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' ARG . 5.7 p30 -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.671 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.85 138.68 27.72 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.38 172.08 16.82 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.686 2.258 . . . . 0.0 111.697 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -45.35 132.93 7.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.99 -149.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.49 -133.69 11.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.77 178.69 4.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 -134.26 95.36 3.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.975 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.688 ' NE2' HG11 ' A' ' 132' ' ' VAL . 74.2 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.421 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 112' ' ' THR . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.46 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.442 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 8.1 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.431 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HZ2' ' HD1' ' A' ' 104' ' ' PHE . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.688 HG11 ' NE2' ' A' ' 97' ' ' GLN . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.519 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 20.8 mp0 -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -105.06 78.76 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 66.4 t0 -66.02 -37.37 85.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.186 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.98 155.8 37.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -96.38 6.48 48.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.79 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -149.43 152.25 35.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 -150.95 99.94 2.75 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.275 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 165' ' ' ALA . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.836 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.836 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.576 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.581 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.78 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 t -67.74 -40.52 84.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.69 94.53 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -136.16 -101.0 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.12 -15.91 30.94 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 6' ' ' THR . 1.0 OUTLIER -79.79 123.09 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 18' ' ' VAL . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' H ' HG21 ' A' ' 18' ' ' VAL . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.9 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.779 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' LEU . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' HG22 ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.596 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 61' ' ' ILE . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.533 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.482 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' ARG . 6.1 p30 -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 48' ' ' ALA . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -77.75 142.88 66.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.94 149.76 10.92 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.875 1.717 . . . . 0.0 111.915 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -70.46 157.54 37.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.273 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.9 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.74 0.39 18.45 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 112' ' ' THR . 58.2 tt0 -116.78 -44.72 2.81 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.742 0.306 . . . . 0.0 110.277 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 39.99 90.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.253 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.493 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.702 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 132' ' ' VAL . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.703 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.475 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.5 mp -91.05 137.14 32.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 155' ' ' LYS . 48.3 t0 -111.55 35.26 3.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 54.69 6.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.733 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 153' ' ' ASP . 62.5 tttp -74.34 138.02 43.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 57.0 mp0 -47.42 138.57 7.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.319 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 -116.81 77.29 1.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.927 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.927 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.435 ' HB3' ' H ' ' A' ' 172' ' ' SER . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.579 ' HA ' HG23 ' A' ' 118' ' ' ILE . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.703 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.701 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 177' ' ' VAL . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 4' ' ' THR . 37.8 m -59.98 -44.17 94.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.643 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 51.08 -81.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 2' ' ' SER . 14.7 t -136.26 166.99 22.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.84 50.29 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t -93.4 143.03 26.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.453 HG21 ' CE3' ' A' ' 47' ' ' TRP . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.633 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 2.2 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 16' ' ' PHE . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 45.0 m-20 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.641 ' N ' HG22 ' A' ' 40' ' ' ILE . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.813 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 16.9 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 49' ' ' VAL . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.4 mp -92.88 116.3 66.28 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.86 163.1 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.204 1.936 . . . . 0.0 112.484 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' GLY . 25.8 t -71.2 164.97 24.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.49 63.35 0.11 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' SER . . . -62.58 -107.08 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.58 ' O ' ' O ' ' A' ' 94' ' ' TYR . 5.7 tp-100 -143.29 -21.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.58 ' O ' ' O ' ' A' ' 93' ' ' GLN . 47.5 m-85 52.7 133.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.685 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.6 OUTLIER -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.685 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 129' ' ' SER . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.443 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.907 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.8 mp -91.75 97.11 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.66 -104.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -159.93 77.11 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 156' ' ' GLU . 98.8 mttt -140.72 13.94 2.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 155' ' ' LYS . 42.1 tp10 60.39 148.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.118 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -126.84 147.25 50.04 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.555 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.852 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.852 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.54 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.433 ' HA ' HD11 ' A' ' 118' ' ' ILE . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.712 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.785 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -89.3 10.97 20.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 5' ' ' GLY . 35.5 ttpt -154.11 -65.26 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.689 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' GLY . 1.4 m 61.89 16.15 7.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 3' ' ' LYS . . . -51.2 -175.44 0.02 OUTLIER Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.658 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -141.51 128.3 20.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.0 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.7 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 32.7 m-20 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.432 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.658 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.497 ' C ' HD12 ' A' ' 61' ' ' ILE . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 73' ' ' TRP . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.64 153.33 47.83 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.96 129.78 11.78 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.323 2.015 . . . . 0.0 111.801 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.4 t -69.48 125.23 26.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.295 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.39 169.19 41.43 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.01 8.2 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.89 152.11 34.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -141.13 176.93 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.391 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.445 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 ' SG ' ' A' ' 130' ' ' CYS . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 136' ' ' VAL . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.421 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.599 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.534 HD12 ' CA ' ' A' ' 147' ' ' GLY . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.534 ' CA ' HD12 ' A' ' 142' ' ' LEU . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.526 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 151' ' ' LEU . 5.4 mp -104.75 -161.92 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.529 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 6.1 t70 71.13 81.53 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 110.813 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -156.83 -64.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.149 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -160.75 154.88 22.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.504 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -42.26 117.09 0.93 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.405 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 60.9 m-85 -74.91 83.37 2.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 165' ' ' ALA . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.876 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.876 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.563 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.572 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 176' ' ' ILE . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m 55.83 -117.61 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.737 0.304 . . . . 0.0 110.511 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -158.87 52.71 0.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.423 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 -40.16 7.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.5 176.86 28.02 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -79.4 123.23 27.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' C ' ' CD2' ' A' ' 16' ' ' PHE . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 6.1 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.631 HD12 HD21 ' A' ' 62' ' ' LEU . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.622 ' N ' HG22 ' A' ' 46' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.716 HD11 ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 13.9 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' HE1' HD11 ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.34 126.61 78.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' CG ' HG12 ' A' ' 136' ' ' VAL . 81.5 Cg_endo -77.79 144.69 22.11 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.254 1.969 . . . . 0.0 112.341 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.4 t -63.22 137.0 58.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.89 -76.35 0.03 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.86 -83.23 0.32 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.647 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 49.4 tt0 -66.67 -70.06 0.27 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.612 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 4.3 m-30 99.97 80.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.147 1.529 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' H ' HD22 ' A' ' 133' ' ' LEU . 27.9 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' SD ' ' A' ' 124' ' ' MET . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' THR . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.462 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.701 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 129' ' ' SER . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.77 ' O ' HD21 ' A' ' 133' ' ' LEU . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' O ' HD23 ' A' ' 133' ' ' LEU . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 130' ' ' CYS . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.401 HG12 ' CG ' ' A' ' 89' ' ' PRO . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.82 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.7 m120 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.9 mp -84.83 129.31 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 38.5 p30 -106.0 138.51 42.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -47.54 99.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.556 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -149.14 -94.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.485 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -173.55 -28.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 153' ' ' ASP . 3.3 m-85 54.95 68.84 0.8 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 118' ' ' ILE . 32.5 mm-40 -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.635 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.82 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.581 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 76.58 21.21 1.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.27 . . . . 0.0 110.476 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' A' ' 4' ' ' THR . 30.2 tptt -88.76 -137.73 0.11 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 82.7 p -64.0 163.5 12.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.13 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.86 112.74 1.9 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.59 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p -146.05 136.67 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.952 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.8 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG23 ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' N ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.664 ' N ' HG22 ' A' ' 46' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.403 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' C ' HD12 ' A' ' 61' ' ' ILE . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD21 ' NE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.535 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' C ' ' OG ' ' A' ' 39' ' ' SER . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.765 ' NE1' HD21 ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 ' CG1' ' A' ' 49' ' ' VAL . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 48' ' ' ALA . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.6 151.77 68.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 128.33 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.351 1.367 . . . . 0.0 111.351 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.2 m -75.09 143.28 43.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.612 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 38.39 41.06 1.03 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.93 -134.16 1.45 Allowed Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 52.1 tt0 -148.1 151.06 34.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 0.0 110.362 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -121.75 145.49 47.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.254 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 124' ' ' MET . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 136' ' ' VAL . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.779 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.553 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 61' ' ' ILE . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.0 mp -90.71 117.93 29.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 18.7 t70 -81.65 -155.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.111 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 72.3 mmtt -96.58 78.21 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 157' ' ' TYR . 43.2 tttm -151.97 158.41 43.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 110.253 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -81.81 -12.76 58.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 155' ' ' LYS . 51.7 m-85 57.09 88.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.666 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.863 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.863 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.779 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -85.85 164.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.82 0.343 . . . . 0.0 110.405 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -71.27 -75.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -45.03 7.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 29.82 4.04 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t -147.98 140.19 24.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.423 ' H ' HG21 ' A' ' 18' ' ' VAL . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.418 ' C ' HG23 ' A' ' 18' ' ' VAL . 2.4 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.787 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CB ' HD23 ' A' ' 34' ' ' LEU . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.651 ' N ' HG22 ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 82' ' ' SER . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.501 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.486 ' C ' HD12 ' A' ' 61' ' ' ILE . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.54 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 79' ' ' ARG . 9.9 p30 -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.525 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 82' ' ' SER . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp -88.31 128.32 53.74 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.51 173.38 14.6 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.304 2.003 . . . . 0.0 112.027 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.8 p -50.61 128.97 21.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.04 -130.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.25 -138.06 13.68 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.41 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 7.1 tt0 -111.1 121.06 44.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.357 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -80.09 111.33 16.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 111' ' ' THR . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.426 ' HA ' ' N ' ' A' ' 124' ' ' MET . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.426 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.419 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.569 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.752 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.811 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.811 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.6 mp -89.37 131.38 35.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 56.4 t0 -144.35 -17.91 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.198 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -69.66 142.65 53.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.364 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -39.57 92.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.428 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -137.8 151.58 48.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 -121.64 87.05 2.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.083 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.895 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.895 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' HD11 ' A' ' 118' ' ' ILE . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.752 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.658 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -61.36 -67.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.717 0.294 . . . . 0.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.29 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.159 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 m -47.16 141.68 4.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.414 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.62 62.33 0.39 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t -87.12 138.0 31.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HZ1' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.518 ' CG2' ' HZ1' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.674 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.989 ' O ' HG22 ' A' ' 18' ' ' VAL . 2.1 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.869 ' H ' HG23 ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' N ' HG22 ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.639 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.684 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.889 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 69' ' ' GLU . 6.0 pt20 -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.498 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD22 HG12 ' A' ' 49' ' ' VAL . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.5 mp -87.65 132.0 41.94 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.37 146.83 36.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.1 1.867 . . . . 0.0 112.304 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.7 m -63.24 155.47 28.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.13 -152.32 21.8 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.6 23.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.92 -45.75 5.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 40.97 78.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.16 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 111' ' ' THR . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.424 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 11.9 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.444 ' O ' HD12 ' A' ' 118' ' ' ILE . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 129' ' ' SER . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.542 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.809 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.65 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.6 m120 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.435 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.889 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.5 mp0 -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.06 99.22 9.63 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -68.99 -92.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -157.06 -158.33 0.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.51 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 62.64 159.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.546 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 31.8 tp10 -69.16 146.96 52.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.331 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.0 -49.0 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.479 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.83 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.83 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.531 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.809 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.6 p -78.04 -148.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -118.6 -59.32 1.89 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.061 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -68.28 172.49 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.1 -103.91 0.21 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t -79.06 129.62 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.603 ' O ' HG12 ' A' ' 18' ' ' VAL . 4.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.776 ' H ' HG22 ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD22 ' A' ' 80' ' ' LEU . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.616 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' C ' HD12 ' A' ' 61' ' ' ILE . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.411 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 7.8 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 79' ' ' ARG . 13.3 p30 -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 ' CH2' ' A' ' 73' ' ' TRP . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.689 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.1 mp -85.4 133.58 42.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 151.36 26.06 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.034 1.823 . . . . 0.0 112.355 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.8 p -66.61 152.91 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.95 -165.47 0.05 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.95 75.5 0.98 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' LYS . 59.3 tt0 -46.76 120.4 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 -66.53 69.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 93' ' ' GLN . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 109' ' ' TYR . 4.3 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.482 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.552 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.421 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' O ' ' A' ' 131' ' ' LYS . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 135' ' ' GLY . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.632 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.492 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.2 mp -98.77 127.98 44.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.465 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 16.6 m-20 -97.21 -124.34 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.166 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.62 24.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -93.4 34.35 1.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.583 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 97.4 mt-10 53.09 176.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.459 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.465 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 73.6 m-85 -153.01 85.26 1.22 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.632 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 4' ' ' THR . 8.7 t -170.75 16.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.609 0.242 . . . . 0.0 110.602 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.18 -77.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.949 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -78.26 1.97 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.255 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.82 -150.52 42.99 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p -143.54 133.15 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.438 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.7 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.751 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' ASP . 2.4 p-80 -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.764 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 13.2 t-20 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.764 HD11 ' CH2' ' A' ' 73' ' ' TRP . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.476 ' N ' ' OG ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.48 136.53 26.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 130.59 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.063 1.842 . . . . 0.0 112.06 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -75.5 148.25 39.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.384 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 137.79 -42.43 1.29 Allowed Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . 72.7 -138.83 26.53 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' TYR . 7.1 tt0 65.3 -49.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.822 0.366 . . . . 0.0 110.952 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 92' ' ' GLY . 78.7 m-85 37.4 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 98' ' ' ILE . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.459 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.679 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.6 m80 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 13.0 m80 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 133' ' ' LEU . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.6 mp -90.1 118.39 29.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.546 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 48.9 t0 -170.47 26.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' LYS . 45.9 mmtm -125.35 84.34 2.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 154' ' ' LYS . 67.5 mttm 40.87 -165.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.856 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.64 151.16 47.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.546 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 42.4 m-85 -108.27 84.63 1.97 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.432 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.877 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.505 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.693 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.8 m -138.08 145.7 42.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.276 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -173.86 86.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.253 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 p 49.33 -139.14 0.84 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.305 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.78 49.73 0.06 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -84.19 135.71 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 14' ' ' LYS . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.92 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.8 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.823 ' H ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 32.8 m-20 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.528 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.796 ' CH2' HD11 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.796 HD11 ' CH2' ' A' ' 73' ' ' TRP . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.2 mp -82.35 147.81 57.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.05 159.28 48.08 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.703 2.269 . . . . 0.0 112.477 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -78.8 166.76 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.517 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.8 -134.77 11.29 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.95 52.13 0.03 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 94' ' ' TYR . 6.6 tp-100 -140.93 -34.33 0.51 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.371 0.129 . . . . 0.0 110.675 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 93' ' ' GLN . 58.7 m-85 56.26 145.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 96.1 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.455 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.634 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.797 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.656 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 11.0 mp -90.91 136.09 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.49 156.03 36.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -71.23 66.82 0.44 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.66 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -139.64 24.41 2.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 55.04 176.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -147.92 84.42 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.906 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.906 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.797 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.637 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.7 p -157.35 -15.61 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.336 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' GLY . 13.3 tptp 71.12 -32.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 31.74 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.349 0.406 . . . . 0.0 111.318 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 138.44 44.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.48 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.9 t -80.79 135.48 35.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.461 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.7 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.6 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.0 m120 -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.48 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.585 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 69' ' ' GLU . 48.1 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 79' ' ' ARG . 10.4 p30 -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 73' ' ' TRP . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.702 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 48' ' ' ALA . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.7 132.66 32.6 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' CG ' HG12 ' A' ' 136' ' ' VAL . 92.6 Cg_endo -76.47 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.395 2.063 . . . . 0.0 111.697 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.0 p -65.64 146.11 55.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.477 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.46 -97.85 0.16 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.75 -69.49 3.2 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -172.67 106.41 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.721 0.296 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 -73.23 90.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 98' ' ' ILE . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.402 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.403 HG21 ' SG ' ' A' ' 130' ' ' CYS . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG12 ' CG ' ' A' ' 89' ' ' PRO . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.446 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.603 ' C ' HD23 ' A' ' 151' ' ' LEU . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 152' ' ' LEU . 3.6 mp -84.44 111.47 19.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.27 -37.32 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' CE1' ' A' ' 157' ' ' TYR . 69.2 mmtt -65.8 141.56 58.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.056 0.455 . . . . 0.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.5 -40.25 96.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.407 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.02 160.12 26.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.698 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CE1' ' O ' ' A' ' 154' ' ' LYS . 76.4 m-85 -138.93 93.07 2.66 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.47 ' O ' HD11 ' A' ' 118' ' ' ILE . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 118' ' ' ILE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.64 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.741 HG23 ' NE1' ' A' ' 47' ' ' TRP . 2.7 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.796 0.332 . . . . 129.8 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 199.79 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 9.02 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 108.38 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 16.01 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 8.22 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HB2' HG21 ' A' ' 18' ' ' VAL . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.96 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.97 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 148.27 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.413 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 20.47 110.895 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 17.57 110.71 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.943 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.92 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 181.28 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.968 ' H ' HG13 ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 213.85 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 104.2 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 409.66 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 191.9 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.42 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 68.05 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 135.72 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 21.25 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 36.83 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 65.11 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 183.12 110.645 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 446.29 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 19.97 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 239.39 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 564.4 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 223.41 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 108.56 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 131.54 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 8.32 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.681 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 65.38 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 45' ' ' GLY . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 14.81 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.8 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 25.7 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.677 HG21 HG23 ' A' ' 61' ' ' ILE . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 174.48 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.741 ' NE1' HG23 ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 17.04 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 14.03 109.879 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.74 110.208 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 37.37 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.765 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.15 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 44.98 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.97 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 43.93 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 51.03 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 137.33 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 166.9 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 66.05 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 15.15 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 61' ' ' ILE . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 23.69 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 32.25 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.66 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 199.43 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 15.69 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 10.27 110.422 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 26.52 112.157 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.98 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 62.43 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 231.83 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 550.39 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.835 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 351.03 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 76.84 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.69 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.78 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 199.52 111.344 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 454.41 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.95 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 628.23 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.835 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 14.38 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.54 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 173.09 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 28.95 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.584 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 700.8 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.584 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 15.11 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 48' ' ' ALA . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 30.12 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 9.8 m-70 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 95.66 110.379 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 88' ' ' LEU . 5.3 mp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 139.16 110.522 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.415 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.69 0.281 . . . . 124.95 110.929 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.606 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 226.38 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 13.39 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 148.11 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.731 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 7.27 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 162.91 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 113.54 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.33 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.79 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 34.18 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 23.87 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 17.98 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 323.67 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 12.97 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 17.27 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' THR . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 27.98 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.03 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 11.48 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 22.16 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 16.8 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 172' ' ' SER . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 7.88 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.429 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 225.51 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.45 111.119 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.441 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 7.59 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 19.62 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.731 ' SD ' HD12 ' A' ' 98' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 18.09 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 626.95 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.59 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 7.57 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 24.0 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 150.56 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' GLN . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 114.1 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.668 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 340.15 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 367.36 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 235.19 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.84 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.01 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 203.93 110.611 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.736 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 14.22 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.488 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 8.38 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HD2' HG21 ' A' ' 170' ' ' VAL . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 88.53 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.696 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 33.84 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.96 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.565 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 26.84 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.531 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 15.01 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.62 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 14.57 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 223.34 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 58' ' ' TYR . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 587.44 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.696 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 309.46 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 29.64 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 116.16 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 59.45 110.081 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.895 0.379 . . . . 91.81 109.981 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 356.15 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 412.73 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.733 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 24.57 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 43.57 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.28 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.24 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 19.49 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.792 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 18.17 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 25.38 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 26.27 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 30.49 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 83.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.788 HG21 ' HD2' ' A' ' 139' ' ' PHE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 10.44 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 72.16 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 118' ' ' ILE . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 145.02 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.18 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.736 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 19.73 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.643 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 428.71 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 66.03 110.214 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 274.9 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 3.2 m-80 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' C ' HG23 ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.84 ' H ' HG12 ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' C ' HD12 ' A' ' 61' ' ' ILE . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 3.8 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.437 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.633 ' O ' HD23 ' A' ' 80' ' ' LEU . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' ALA . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.587 HD11 ' OE1' ' A' ' 178' ' ' GLU . 2.6 pp . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.729 0.3 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.704 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.704 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.432 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.676 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 59' ' ' MET . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.99 0.424 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.926 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.926 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.701 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.813 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.543 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 11' ' ' TYR . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 18' ' ' VAL . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.712 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.985 ' O ' HG22 ' A' ' 18' ' ' VAL . 6.8 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.858 ' N ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.484 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.499 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' LEU . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' HG22 ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.467 ' C ' HD12 ' A' ' 61' ' ' ILE . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.797 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.3 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.807 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 49' ' ' VAL . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 14.8 m-70 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 88' ' ' LEU . 3.4 mp . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 7.8 m-85 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 172' ' ' SER . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.706 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.419 HE22 ' CG ' ' A' ' 113' ' ' GLU . 49.2 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.48 ' SD ' HD12 ' A' ' 98' ' ' ILE . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 129' ' ' SER . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.722 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.415 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.474 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.897 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.897 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 172' ' ' SER . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.58 ' HA ' HG23 ' A' ' 118' ' ' ILE . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.722 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.695 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 21' ' ' TYR . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.683 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.683 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.2 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.764 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 9' ' ' THR . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.499 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 32' ' ' THR . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.3 m120 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.58 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.666 ' N ' HG22 ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.8 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.543 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 76' ' ' LEU . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.847 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 38' ' ' ASN . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD11 ' CH2' ' A' ' 73' ' ' TRP . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.199 0.523 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 26.1 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' HD12 ' A' ' 118' ' ' ILE . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.725 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE1' ' NE2' ' A' ' 149' ' ' GLN . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.8 m-80 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.496 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.474 ' NE2' ' CE1' ' A' ' 140' ' ' TYR . 82.9 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.929 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.929 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.572 ' HA ' HG23 ' A' ' 118' ' ' ILE . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.725 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.66 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.576 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.727 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.727 ' NE2' HD22 ' A' ' 15' ' ' ASN . 9.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.922 HG22 ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.922 ' H ' HG22 ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.732 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.576 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 80' ' ' LEU . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.5 t-20 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.778 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.541 ' C ' HD12 ' A' ' 61' ' ' ILE . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.499 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.862 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp . . . . . 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.4 ' N ' ' HA ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 130' ' ' CYS . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.77 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 142' ' ' LEU . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.778 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.3 mp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 161' ' ' ILE . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.9 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.9 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.551 ' HA ' HG23 ' A' ' 118' ' ' ILE . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.77 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.599 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.579 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.6 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 21' ' ' TYR . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 18' ' ' VAL . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.704 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.704 ' NE2' HD22 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.789 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 9' ' ' THR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.514 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.579 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 80' ' ' LEU . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.717 ' OH ' HD22 ' A' ' 76' ' ' LEU . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.007 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.459 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.671 ' H ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 133' ' ' LEU . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.726 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.481 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.566 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 176' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.591 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 147' ' ' GLY . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.545 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.625 ' N ' HD13 ' A' ' 151' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 130' ' ' CYS . 23.3 m-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.725 0.297 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.965 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.965 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 118' ' ' ILE . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.785 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.741 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.448 HD11 HG13 ' A' ' 138' ' ' ILE . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.608 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.668 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.668 ' NE2' HD22 ' A' ' 15' ' ' ASN . 21.5 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.819 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.503 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 32' ' ' THR . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' LYS . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' H ' HG22 ' A' ' 6' ' ' THR . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.498 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.794 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.514 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.794 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.533 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.401 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.479 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.623 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.422 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.413 ' OH ' ' NE2' ' A' ' 149' ' ' GLN . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.66 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.66 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 59.7 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 133' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.714 0.293 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 165' ' ' ALA . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.956 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.956 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.546 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.623 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.73 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.7 t . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' H ' HG11 ' A' ' 18' ' ' VAL . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.69 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.69 ' NE2' HD22 ' A' ' 15' ' ' ASN . 20.6 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.753 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.753 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.472 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' C ' HD22 ' A' ' 38' ' ' ASN . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.6 m120 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.613 HD12 HD21 ' A' ' 62' ' ' LEU . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 62' ' ' LEU . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.549 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 61' ' ' ILE . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 4.3 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.752 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.851 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' CG1' ' A' ' 49' ' ' VAL . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.0 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 98' ' ' ILE . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.631 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 129' ' ' SER . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 129' ' ' SER . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.403 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.431 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 142' ' ' LEU . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 151' ' ' LEU . 10.5 mp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.671 0.272 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.447 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.911 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.911 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.631 HE22 ' CE ' ' A' ' 119' ' ' MET . 78.4 mm-40 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.597 ' HA ' HG23 ' A' ' 118' ' ' ILE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.619 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.7 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.7 ' NE2' HD22 ' A' ' 15' ' ' ASN . 17.5 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.832 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.832 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' C ' HD22 ' A' ' 38' ' ' ASN . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.702 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 62' ' ' LEU . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.3 t-20 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.706 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.9 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.706 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.853 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CG1' ' A' ' 49' ' ' VAL . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 111' ' ' THR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.516 ' OE2' ' NE2' ' A' ' 121' ' ' GLN . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.544 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.544 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 47.0 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' HD12 ' A' ' 98' ' ' ILE . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.719 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.609 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 61' ' ' ILE . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.45 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.833 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.833 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.609 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 118' ' ' ILE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.526 ' N ' ' OG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.719 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.581 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.692 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.692 ' NE2' HD22 ' A' ' 15' ' ' ASN . 12.7 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.825 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.55 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' C ' HD22 ' A' ' 38' ' ' ASN . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' HG22 ' A' ' 6' ' ' THR . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.673 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.1 t-20 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.789 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 61' ' ' ILE . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.402 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.943 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.671 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' OE1' HG11 ' A' ' 132' ' ' VAL . 34.5 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.421 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 121' ' ' GLN . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.46 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.9 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.431 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HZ2' ' HD1' ' A' ' 104' ' ' PHE . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 HG11 ' OE1' ' A' ' 97' ' ' GLN . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.519 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.89 0.376 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 165' ' ' ALA . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.836 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.836 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.576 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.581 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.78 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 18' ' ' VAL . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' H ' HG21 ' A' ' 18' ' ' VAL . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.653 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.653 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.3 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.779 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' LEU . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' HG22 ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.596 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 61' ' ' ILE . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.533 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.482 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.852 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 48' ' ' ALA . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 87' ' ' HIS . 3.4 m-70 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.493 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.702 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 132' ' ' VAL . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.703 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.475 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.927 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.927 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.435 ' HB3' ' H ' ' A' ' 172' ' ' SER . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.579 ' HA ' HG23 ' A' ' 118' ' ' ILE . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.703 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.701 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 177' ' ' VAL . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.453 HG21 ' CE3' ' A' ' 47' ' ' TRP . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' H ' HG11 ' A' ' 18' ' ' VAL . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.726 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.726 ' NE2' HD22 ' A' ' 15' ' ' ASN . 9.5 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 16' ' ' PHE . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.443 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 6.1 m120 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.641 ' N ' HG22 ' A' ' 40' ' ' ILE . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.813 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 6.6 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 49' ' ' VAL . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.4 mp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.477 ' OH ' ' CG2' ' A' ' 177' ' ' VAL . 47.5 m-85 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.8 tm0? -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 129' ' ' SER . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.443 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.907 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.8 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.555 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.852 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.852 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.54 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.433 ' HA ' HD11 ' A' ' 118' ' ' ILE . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.712 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.785 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.658 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.676 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.676 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.9 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.5 m120 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.432 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.658 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.497 ' C ' HD12 ' A' ' 61' ' ' ILE . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 73' ' ' TRP . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.672 0.272 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.445 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 ' SG ' ' A' ' 130' ' ' CYS . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 136' ' ' VAL . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.421 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.599 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.534 HD12 ' CA ' ' A' ' 147' ' ' GLY . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.534 ' CA ' HD12 ' A' ' 142' ' ' LEU . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.526 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 151' ' ' LEU . 5.4 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 165' ' ' ALA . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.876 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.876 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.563 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.572 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 176' ' ' ILE . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.698 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.698 ' NE2' HD22 ' A' ' 15' ' ' ASN . 21.3 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.631 HD12 HD21 ' A' ' 62' ' ' LEU . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.622 ' N ' HG22 ' A' ' 46' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.716 HD11 ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 6.4 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' HE1' HD11 ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.416 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 4.3 m-30 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.691 0.282 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.532 HE21 ' CD ' ' A' ' 110' ' ' GLU . 96.0 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' SD ' ' A' ' 124' ' ' MET . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' THR . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.462 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.701 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 129' ' ' SER . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.77 ' O ' HD21 ' A' ' 133' ' ' LEU . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' O ' HD23 ' A' ' 133' ' ' LEU . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 130' ' ' CYS . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.82 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.4 m-80 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.635 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.82 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.581 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.59 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.665 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.952 ' O ' HG22 ' A' ' 18' ' ' VAL . 11.7 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG23 ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' N ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.664 ' N ' HG22 ' A' ' 46' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.2 t-20 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.403 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' C ' HD12 ' A' ' 61' ' ' ILE . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD21 ' NE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.535 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 39.0 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.765 ' NE1' HD21 ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 ' CG1' ' A' ' 49' ' ' VAL . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 48' ' ' ALA . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.851 0.357 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.587 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 136' ' ' VAL . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.779 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.553 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 61' ' ' ILE . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.0 mp . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.738 0.304 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.863 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.863 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.587 HE22 ' CE ' ' A' ' 119' ' ' MET . 76.2 mm-40 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.779 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.423 ' H ' HG21 ' A' ' 18' ' ' VAL . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.669 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.669 ' NE2' HD22 ' A' ' 15' ' ' ASN . 15.1 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.787 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CB ' HD23 ' A' ' 34' ' ' LEU . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.651 ' N ' HG22 ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 82' ' ' SER . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.501 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.486 ' C ' HD12 ' A' ' 61' ' ' ILE . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.54 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.836 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.525 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 82' ' ' SER . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.688 0.28 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 111' ' ' THR . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.426 ' HA ' ' N ' ' A' ' 124' ' ' MET . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.426 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.419 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.569 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.752 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.811 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.811 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.6 mp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.895 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.895 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' HD11 ' A' ' 118' ' ' ILE . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.752 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.658 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HZ1' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.518 ' CG2' ' HZ1' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.674 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.692 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.989 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.9 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.869 ' H ' HG23 ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' N ' HG22 ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.639 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.684 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.889 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.498 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD22 HG12 ' A' ' 49' ' ' VAL . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.5 mp . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.58 0.229 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 111' ' ' THR . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.7 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.444 ' O ' HD12 ' A' ' 118' ' ' ILE . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 129' ' ' SER . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.542 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.809 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.65 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.74 HD22 HH21 ' A' ' 146' ' ' ARG . 6.6 m-80 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.74 HH21 HD22 ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.889 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.479 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.83 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.83 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.531 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.809 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.672 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.672 ' NE2' HD22 ' A' ' 15' ' ' ASN . 20.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.776 ' H ' HG22 ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD22 ' A' ' 80' ' ' LEU . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.616 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' C ' HD12 ' A' ' 61' ' ' ILE . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.2 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.845 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 ' CH2' ' A' ' 73' ' ' TRP . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.689 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.1 mp . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.632 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 5.6 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.632 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.552 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.421 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' O ' ' A' ' 131' ' ' LYS . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 135' ' ' GLY . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.632 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.492 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.632 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.751 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.764 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 3.1 t30 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.764 HD11 ' CH2' ' A' ' 73' ' ' TRP . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.476 ' N ' ' OG ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 120.576 0.227 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 98' ' ' ILE . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.459 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.679 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.2 m-70 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 133' ' ' LEU . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.6 mp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.432 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.877 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.505 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.693 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 45' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.534 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.588 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.92 ' O ' HG22 ' A' ' 18' ' ' VAL . 9.9 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.823 ' H ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.498 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.5 m120 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.528 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.796 ' CH2' HD11 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.796 HD11 ' CH2' ' A' ' 73' ' ' TRP . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.2 mp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.3 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.455 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.634 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.797 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.656 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.71 0.29 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.906 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.906 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.797 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.637 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.48 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.9 t . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.595 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 15' ' ' ASN . 8.6 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.48 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.585 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.585 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.485 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.485 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 44.6 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.85 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 73' ' ' TRP . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.702 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 48' ' ' ALA . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.423 HE22 HG21 ' A' ' 132' ' ' VAL . 26.0 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 98' ' ' ILE . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.402 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.403 HG21 ' SG ' ' A' ' 130' ' ' CYS . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.423 HG21 HE22 ' A' ' 97' ' ' GLN . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.446 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.603 ' C ' HD23 ' A' ' 151' ' ' LEU . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 152' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.47 ' O ' HD11 ' A' ' 118' ' ' ILE . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 118' ' ' ILE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.64 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.152 -1.579 . . . . 999.99 109.152 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.511 ' C ' ' O ' ' A' ' 1' ' ' GLY . 23.2 t 6.16 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.466 0.745 . . . . 999.99 111.852 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.657 ' HG2' ' N ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -171.2 177.87 3.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.032 -0.531 . . . . 999.99 110.353 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.657 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -137.83 138.94 39.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.621 . . . . 999.99 110.682 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.68 -82.85 0.95 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.835 -1.306 . . . . 130.31 109.835 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.741 HG23 ' NE1' ' A' ' 47' ' ' TRP . 2.7 t -153.38 143.19 22.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 129.8 110.613 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 9.3 ttpt -116.38 120.78 39.95 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.223 -0.444 . . . . 199.79 110.912 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 47' ' ' TRP . 19.2 tt -109.85 141.0 26.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 9.02 110.512 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -135.14 122.52 21.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 108.38 110.372 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -115.52 127.35 55.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.815 0.34 . . . . 16.01 110.674 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.14 148.7 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 8.22 110.326 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HB2' HG21 ' A' ' 18' ' ' VAL . 96.8 mt-10 -65.26 -21.61 66.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.303 -0.408 . . . . 39.96 110.78 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 85.7 m-20 -125.92 -161.65 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.361 -0.607 . . . . 92.97 109.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -109.69 -178.51 3.56 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.365 0.416 . . . . 148.27 109.948 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.413 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 71.37 15.93 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 20.47 110.895 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.97 50.21 14.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.366 -0.379 . . . . 17.57 110.71 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.943 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.6 pt20 -123.15 -177.56 3.72 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.823 -0.608 . . . . 56.92 109.67 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 ' H ' ' A' ' 19' ' ' ARG . 2.7 p 102.9 -133.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.705 1.253 . . . . 181.28 110.881 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.968 ' H ' HG13 ' A' ' 18' ' ' VAL . 15.5 ptp180 -121.42 34.34 5.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.84 0.352 . . . . 213.85 110.489 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 20' ' ' ARG . 2.6 ptt-85 -70.16 -173.23 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 104.2 110.588 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 70.4 m-85 -128.72 -164.93 1.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 409.66 110.285 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -161.48 44.58 0.16 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.001 0.429 . . . . 246.69 110.613 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.84 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.931 -0.577 . . . . 191.9 110.246 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -89.72 140.19 29.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 51.42 110.29 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -178.05 -174.24 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 68.05 110.484 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -138.22 128.33 25.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 475.54 110.258 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.87 166.84 23.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.408 . . . . 135.72 110.432 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.56 81.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 21.25 110.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 31' ' ' HIS . 20.8 p-10 -167.43 123.36 1.1 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.058 0.456 . . . . 300.86 110.064 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -67.48 2.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 36.83 110.731 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -58.64 -12.39 4.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 65.11 110.659 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 2.4 m -70.43 -30.25 67.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 183.12 110.645 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 72.4 m-85 -93.11 -31.59 14.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.556 . . . . 446.29 110.647 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.26 124.58 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.512 . . . . 19.97 110.492 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 81.5 p -58.76 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.275 -0.639 . . . . 239.39 109.275 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HH22 ' A' ' 79' ' ' ARG . 19.1 mtt180 -76.52 156.19 33.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 564.4 110.172 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 13.0 t -144.31 146.92 32.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.993 0.425 . . . . 223.41 110.587 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 39.0 m-80 -119.81 -141.83 0.35 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.608 -0.886 . . . . 108.56 108.608 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -26.45 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.593 1.183 . . . . 131.54 112.689 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 ' N ' ' A' ' 41' ' ' LYS . 84.1 mt -147.55 173.16 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.028 -0.533 . . . . 8.32 111.044 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.681 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.4 tttt -137.98 113.7 9.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.156 -0.475 . . . . 65.38 109.804 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 45' ' ' GLY . 97.5 t -112.37 131.84 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.174 -0.466 . . . . 14.81 110.364 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -121.28 88.11 2.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 258.41 110.503 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 77.09 107.66 0.15 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 111.072 -0.811 . . . . 136.8 111.072 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 6' ' ' THR . . . 109.7 162.54 19.37 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.23 -0.748 . . . . 25.7 111.23 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.677 HG21 HG23 ' A' ' 61' ' ' ILE . 5.8 m -114.14 119.89 38.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.176 . . . . 174.48 111.069 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.741 ' NE1' HG23 ' A' ' 6' ' ' THR . 15.2 m95 -93.73 141.92 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.72 -0.392 . . . . 17.04 110.147 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -104.32 122.4 45.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 14.03 109.879 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -112.33 132.17 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.74 110.208 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' PHE . 62.8 m-85 -106.51 148.72 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 37.37 110.229 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.765 ' CG ' ' HG2' ' A' ' 79' ' ' ARG . 3.9 tt0 -67.69 -37.22 82.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.834 0.349 . . . . 392.15 111.104 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -116.86 154.19 49.49 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.862 -0.608 . . . . 999.99 110.456 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 33.8 Cg_exo -57.55 157.69 22.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.021 2.481 . . . . 44.98 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 t-20 80.27 24.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.439 -0.801 . . . . 75.97 110.658 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 13.5 m-85 59.51 43.54 16.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.304 0.574 . . . . 43.93 110.25 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' ARG . . . -133.51 125.34 28.71 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.538 -0.755 . . . . 51.03 110.705 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 123.62 116.47 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.809 -0.916 . . . . 237.21 110.809 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 3.4 m-30 44.39 -178.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.075 0.464 . . . . 137.33 111.023 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.3 mtt -153.56 99.17 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 166.9 110.463 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -105.74 126.4 52.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 66.05 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 46' ' ' THR . 3.1 mp -100.99 134.12 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 15.15 110.118 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 61' ' ' ILE . 5.7 mp -127.93 90.02 48.88 Favored Pre-proline 0 N--CA 1.456 -0.166 0 CA-C-O 120.699 0.285 . . . . 23.69 110.429 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 57.0 Cg_endo -73.12 166.35 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.031 2.487 . . . . 32.25 112.405 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.66 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -42.86 99.95 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.026 -0.534 . . . . 199.43 110.412 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.54 155.6 20.29 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.013 -0.835 . . . . 15.69 111.013 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.33 135.09 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.726 0.298 . . . . 35.68 110.739 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.6 m-85 -128.72 89.35 49.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 10.27 110.422 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.74 -24.07 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.632 2.221 . . . . 26.52 112.157 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 57.8 mt-10 -134.79 158.33 44.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.985 0.422 . . . . 67.98 110.785 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 54.0 p90 -67.62 -3.93 10.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.725 -0.67 . . . . 62.43 110.831 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 pt20 -91.43 -19.58 22.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.239 -0.437 . . . . 231.83 110.44 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -16.81 32.02 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.146 -0.479 . . . . 550.39 111.528 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.835 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -107.02 14.61 26.21 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 351.03 110.526 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 45.8 mtm 43.93 58.9 3.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.57 -0.286 . . . . 76.84 111.573 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.69 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -84.28 -169.27 45.28 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 111.173 -0.771 . . . . 15.78 111.173 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.86 -67.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.03 -0.268 . . . . 199.52 111.344 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.674 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -141.94 49.39 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.935 0.874 . . . . 454.41 110.426 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 35.26 53.97 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.645 -1.284 . . . . 28.95 111.108 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.765 ' HG2' ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.81 112.72 22.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.996 -0.547 . . . . 628.23 111.151 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.835 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.97 120.31 4.56 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.552 -0.459 . . . . 14.38 110.182 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -123.82 4.28 8.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 194.54 110.905 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 5.2 t -152.14 149.63 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.671 -0.24 . . . . 173.09 110.589 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.8 p -149.2 144.52 26.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.494 . . . . 28.95 110.425 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.584 ' HG2' ' N ' ' A' ' 85' ' ' ALA . 21.3 ttm-85 -147.8 155.03 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 700.8 110.432 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.584 ' N ' ' HG2' ' A' ' 84' ' ' ARG . . . -88.03 141.85 28.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 15.11 110.467 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 48' ' ' ALA . 25.9 t -133.75 137.72 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.024 -0.535 . . . . 30.12 110.354 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 9.8 m-70 -113.36 147.77 37.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.497 . . . . 95.66 110.379 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 88' ' ' LEU . 5.3 mp -82.94 127.4 69.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.281 -0.418 . . . . 139.16 110.522 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' CG ' HG12 ' A' ' 136' ' ' VAL . 55.7 Cg_endo -71.77 149.22 53.91 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.902 2.401 . . . . 96.6 112.122 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.13 155.06 32.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.919 -0.582 . . . . 693.88 110.293 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.33 -159.26 27.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.807 -0.917 . . . . 371.01 110.807 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.85 24.02 0.02 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 458.5 111.183 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -118.62 -39.35 3.0 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.269 -0.172 . . . . 326.48 110.662 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' O ' ' HB ' ' A' ' 112' ' ' THR . 47.1 m-85 43.31 86.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.389 0.431 . . . . 124.95 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.606 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 16.8 ttmt -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.453 -0.34 . . . . 226.38 110.293 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 18.1 tt -125.59 140.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 13.39 110.961 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 130' ' ' CYS . 30.0 mt-30 -125.61 111.3 14.83 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.072 -0.513 . . . . 148.11 110.25 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.731 HD12 ' SD ' ' A' ' 124' ' ' MET . 12.5 pt -104.93 142.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.691 0.281 . . . . 7.27 110.761 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.806 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 19.1 m-85 -113.91 137.83 51.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 162.91 110.675 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.87 -30.74 71.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.652 . . . . 251.75 110.367 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -109.49 158.97 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 113.54 110.594 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -73.15 -38.33 54.69 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.35 -0.7 . . . . 34.33 111.35 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -78.72 33.24 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.289 . . . . 201.79 111.175 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 70.9 m-85 50.52 66.7 1.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 34.18 110.674 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 m -155.97 162.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 23.87 110.827 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.86 -152.81 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.028 -0.829 . . . . 17.98 111.028 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -81.46 110.22 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 323.67 110.64 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.806 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 29.5 ttp -104.14 141.38 36.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 144.53 110.418 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -115.93 133.71 55.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 12.97 110.182 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.635 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.4 tt0 -130.97 149.6 52.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.817 -0.629 . . . . 280.37 109.542 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.635 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.6 m 132.98 154.16 0.0 OUTLIER 'General case' 0 C--N 1.343 0.314 0 O-C-N 125.142 1.526 . . . . 17.27 110.368 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' THR . 4.4 t -90.69 161.75 15.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.389 -0.967 . . . . 27.98 108.389 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER 150.09 162.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.923 -0.399 . . . . 708.12 109.923 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.34 126.17 32.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.544 -0.539 . . . . 55.03 109.544 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 19.7 m -122.93 114.88 29.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 11.48 110.402 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.471 ' O ' ' OG ' ' A' ' 172' ' ' SER . 71.2 Cg_endo -81.92 -61.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.095 2.53 . . . . 22.16 112.046 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 112.71 18.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 16.8 110.028 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 172' ' ' SER . 1.2 pt -54.2 -47.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.583 -0.281 . . . . 7.88 110.496 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.429 ' HA ' ' N ' ' A' ' 124' ' ' MET . 8.5 ptt? -63.21 20.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.196 -0.456 . . . . 225.51 110.686 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 118' ' ' ILE . 1.8 tt0 -131.47 -61.11 0.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 290.36 110.42 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -72.97 -38.65 66.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.223 -0.898 . . . . 16.45 111.119 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.441 ' CB ' ' HG2' ' A' ' 124' ' ' MET . 52.3 m-85 -111.2 -4.24 15.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.152 -0.476 . . . . 7.59 111.094 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 60.44 33.18 20.68 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.322 -0.399 . . . . 19.62 110.787 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.731 ' SD ' HD12 ' A' ' 98' ' ' ILE . 3.0 ptp -130.28 129.15 42.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 18.09 110.211 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.08 -6.31 48.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 626.95 111.141 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -153.52 162.11 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.422 . . . . 81.59 110.826 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.07 129.2 27.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 7.57 109.912 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -95.74 -15.97 22.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.733 0.302 . . . . 24.0 110.94 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 7.3 t -151.68 139.33 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 150.56 110.708 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' GLN . 85.7 m -116.78 -14.96 10.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.524 . . . . 114.1 110.883 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.668 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 13.7 tttt 48.88 -179.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.023 0.44 . . . . 340.15 110.946 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 47.8 t -66.55 141.14 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.261 -0.427 . . . . 367.36 110.329 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -119.4 -109.6 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.948 -0.569 . . . . 235.19 110.426 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 3.0 tt0 -165.84 136.17 3.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.375 -0.375 . . . . 420.84 110.379 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.07 -102.79 0.2 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.536 -1.026 . . . . 32.01 110.536 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG12 ' CG ' ' A' ' 89' ' ' PRO . 1.3 p -162.03 130.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 203.93 110.611 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.736 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.42 158.71 29.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 14.22 110.334 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.488 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 68.9 mt -109.19 135.67 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 8.38 110.263 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HD2' HG21 ' A' ' 170' ' ' VAL . 3.2 m-85 -107.5 134.5 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 88.53 110.173 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.696 ' CE2' ' HG2' ' A' ' 149' ' ' GLN . 67.5 m-85 -115.92 134.52 54.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 33.84 110.721 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.73 -34.69 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 113.96 110.373 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.565 ' C ' ' HG3' ' A' ' 171' ' ' GLN . 56.6 mt -109.28 156.58 39.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 26.84 110.095 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.531 ' N ' ' HG3' ' A' ' 171' ' ' GLN . 55.7 Cg_endo -69.88 171.65 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.699 2.266 . . . . 15.01 111.736 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.403 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.4 m-80 64.96 17.56 11.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 21.62 110.515 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 69.87 59.32 0.28 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.052 0.453 . . . . 14.57 110.605 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -141.68 173.39 11.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.722 -0.672 . . . . 223.34 111.114 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 74.24 123.21 0.1 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.73 -0.948 . . . . 178.22 110.73 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 58' ' ' TYR . 34.2 ttp180 -6.74 118.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.195 0.585 . . . . 587.44 111.805 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.696 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -88.84 167.45 13.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.913 -0.585 . . . . 309.46 110.632 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -132.64 136.5 46.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 29.64 110.021 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 tp -94.52 113.89 25.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 116.16 110.246 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.74 82.81 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 59.45 110.081 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.525 ' C ' ' HG2' ' A' ' 154' ' ' LYS . 40.1 t0 -52.01 -96.01 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.941 -0.572 . . . . 452.54 110.461 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 153' ' ' ASP . 1.2 mtmt -147.7 -138.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.527 -0.306 . . . . 999.99 110.198 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.7 -162.88 0.27 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.404 -0.362 . . . . 999.99 110.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.64 114.6 21.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 504.88 110.464 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -74.51 80.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 91.81 109.981 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -67.18 -23.12 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 356.15 110.76 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 160' ' ' PRO . 14.6 mtpt -136.36 166.22 29.52 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 412.73 110.545 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.733 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 27.6 Cg_endo -65.23 -31.18 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.512 2.141 . . . . 24.57 112.202 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 165' ' ' ALA . 44.8 pt -82.22 -11.48 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.053 -0.521 . . . . 43.57 111.244 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.38 -32.77 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 299.28 111.59 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.2 p90 -93.99 32.17 1.52 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 17.24 111.238 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.85 23.66 77.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.939 -0.464 . . . . 19.49 111.939 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.792 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.54 123.62 35.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.943 0.372 . . . . 18.17 110.868 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.79 69.63 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.777 -0.369 . . . . 25.38 110.306 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.3 18.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 26.27 110.304 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 160' ' ' PRO . 40.1 Cg_endo -70.72 5.96 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.966 2.444 . . . . 30.49 112.043 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.22 105.21 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 83.45 110.823 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.788 HG21 ' HD2' ' A' ' 139' ' ' PHE . 3.2 p -148.32 138.51 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.741 -0.466 . . . . 10.44 109.741 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' A' ' 142' ' ' LEU . 80.3 mm-40 -91.69 -145.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.273 0.358 . . . . 72.16 110.665 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 118' ' ' ILE . 24.2 p -76.79 -140.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.152 -0.477 . . . . 145.02 111.454 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.448 ' N ' ' OG ' ' A' ' 172' ' ' SER . 17.3 p90 178.32 178.29 0.39 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.94 -0.573 . . . . 8.18 109.812 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.736 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.1 ptt180 -162.62 141.85 9.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.302 -0.408 . . . . 19.73 110.241 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.643 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.27 147.07 26.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 428.71 110.673 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -81.33 132.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.644 . . . . 66.03 110.214 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.41 129.3 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 274.9 110.449 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.101 -0.952 . . . . 999.99 110.707 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m 57.44 67.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.777 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 67.27 169.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.521 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -45.16 144.4 1.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.298 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.4 -40.17 0.26 Allowed Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.0 t -82.48 136.1 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -134.99 133.05 39.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -117.49 139.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 p -135.04 125.74 27.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.158 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -119.01 125.39 49.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.11 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -122.9 140.42 53.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -58.46 -20.97 49.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -123.15 -159.09 0.82 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 3.6 pttt -114.32 -179.81 3.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 14' ' ' LYS . 3.2 m-80 75.26 8.94 3.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m-85 60.92 45.96 9.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.077 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' C ' HG23 ' A' ' 18' ' ' VAL . 9.5 pt20 -113.96 -162.3 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.1 t 85.13 -139.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.598 0.561 . . . . 0.0 110.62 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.84 ' H ' HG12 ' A' ' 18' ' ' VAL . 16.1 ptp180 -119.9 36.22 4.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 23.1 ptt-85 -69.55 154.95 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.784 0.326 . . . . 0.0 110.709 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -92.31 -173.18 3.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.129 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -154.82 49.03 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.6 t -145.26 158.19 43.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.28 136.21 33.2 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 t -174.03 -177.1 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.368 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 50.8 p-10 -144.97 136.44 25.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -146.35 165.19 30.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.638 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.47 93.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 31' ' ' HIS . 23.8 p-10 -169.81 117.01 0.57 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -70.97 12.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -58.48 -20.88 49.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.195 0.522 . . . . 0.0 110.288 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -63.92 -40.45 96.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.883 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.62 -33.93 25.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.066 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.12 126.12 2.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -64.47 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.795 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -83.59 120.09 25.53 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.045 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 38' ' ' ASN . 1.6 t -100.35 153.5 19.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.0 m-20 -116.52 -142.91 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.37 171.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.605 0.566 . . . . 0.0 110.882 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 41' ' ' LYS . 81.8 mt -147.03 165.53 6.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 40' ' ' ILE . 26.8 tttt -129.38 118.58 22.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.78 125.18 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.194 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -119.83 86.94 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.851 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.08 132.57 4.48 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.15 165.21 11.73 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -103.99 173.76 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.643 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 34.4 m95 -146.17 141.6 27.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -110.67 121.72 46.01 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.172 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.16 133.78 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.1 m-85 -100.74 170.06 8.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 30.5 tt0 -86.33 -34.42 20.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.702 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.5 mmp_? -122.27 160.08 49.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.238 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 37.0 Cg_exo -60.31 150.72 78.69 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.035 1.823 . . . . 0.0 111.095 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.3 t-20 89.81 12.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.82 0.7 . . . . 0.0 110.895 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 19.0 m-85 63.02 53.41 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.05 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.47 22.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.014 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 134.88 -45.19 1.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 5.7 m-85 -163.12 175.45 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.564 0.697 . . . . 0.0 111.074 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.426 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 1.6 mpt? -142.85 88.44 2.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.426 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' C ' HD12 ' A' ' 61' ' ' ILE . 78.5 m-85 -89.67 127.34 35.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -100.91 123.09 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.5 91.44 29.14 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.57 169.49 20.87 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.745 2.297 . . . . 0.0 112.078 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.6 tm0? -44.79 100.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.216 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.7 162.37 32.38 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -106.85 135.45 48.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.861 0.362 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 39' ' ' SER . 29.8 m-85 -127.15 91.78 45.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.109 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 0.92 9.66 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.556 2.171 . . . . 0.0 111.816 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 92.0 mt-10 -148.95 150.49 32.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.346 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -68.94 -0.96 6.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.245 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 3.8 pt20 -102.65 -9.01 20.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.816 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -88.77 -20.35 24.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.37 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.437 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 1.1 p-90 -105.73 16.32 25.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.5 mtm 49.29 57.26 6.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.991 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -85.89 -171.5 48.03 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 tp -123.68 -75.62 0.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 79' ' ' ARG . 17.0 t-20 -133.76 46.65 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.118 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 40.5 17.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.773 0.32 . . . . 0.0 110.717 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.633 ' O ' HD23 ' A' ' 80' ' ' LEU . 33.6 ttm180 -77.9 111.4 13.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.265 0.555 . . . . 0.0 110.182 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 79' ' ' ARG . 28.6 mt -155.81 131.05 9.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.445 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -139.22 -3.15 1.58 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.022 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -143.52 142.86 31.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.8 p -146.9 141.05 26.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.322 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -144.23 149.22 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.524 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.37 143.97 30.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' ALA . 6.0 t -142.68 141.31 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -121.84 124.57 44.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.69 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.587 HD11 ' OE1' ' A' ' 178' ' ' GLU . 2.6 pp -83.13 129.98 58.92 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -78.23 157.27 29.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.618 2.212 . . . . 0.0 112.203 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.3 t -64.94 139.97 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.098 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . -138.98 -70.56 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.64 -14.12 2.05 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' GLY . 58.4 tt0 -113.34 -47.94 2.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.599 0.238 . . . . 0.0 110.527 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' GLN . 91.8 m-85 39.12 93.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.185 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.2 ttmt -106.8 134.97 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.3 tt -130.93 142.98 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.884 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 130' ' ' CYS . 48.2 mt-30 -126.63 108.42 11.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.518 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.8 pt -102.98 134.1 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -108.63 135.09 50.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -58.58 -35.1 71.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.26 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.49 162.85 12.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -77.15 -39.09 28.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -78.75 27.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.849 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.9 m-85 52.83 70.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.585 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.2 m -156.79 162.06 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.829 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.4 -137.0 13.39 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -93.71 127.01 39.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 0.0 110.037 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.413 ' C ' ' SD ' ' A' ' 108' ' ' MET . 1.9 tmm? -123.02 143.53 49.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.199 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -116.67 134.42 54.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.413 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 6.6 tm-20 -134.03 148.8 51.13 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.5 m 138.49 158.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 125.065 1.478 . . . . 0.0 110.4 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 2.4 t -98.61 158.5 15.57 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 153.94 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 5.3 p30 -88.36 122.55 32.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.7 m -118.09 110.24 39.97 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.471 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.6 -61.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.194 1.93 . . . . 0.0 111.857 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.5 m -124.69 120.45 31.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.704 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -60.51 -50.05 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.5 ptp -57.83 14.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.663 0.268 . . . . 0.0 111.033 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.704 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -128.34 -54.41 1.27 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.522 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.6 tt0 -77.25 -35.4 55.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.642 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 63.1 m-85 -118.31 2.75 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.727 0.299 . . . . 0.0 110.994 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 57.83 31.07 19.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.626 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.8 OUTLIER -131.9 142.95 49.81 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -109.8 5.1 22.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.74 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -155.74 160.34 40.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.509 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.6 mt -140.37 130.99 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -92.54 -24.24 18.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -151.45 142.33 22.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.437 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.601 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 1.8 m -117.15 -26.63 6.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 67.76 -172.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.68 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.466 HG22 ' H ' ' A' ' 156' ' ' GLU . 12.9 t -81.25 137.15 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.448 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -126.6 166.36 17.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.806 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 81.8 tt0 -72.99 150.94 42.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.136 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 45.46 -127.81 8.42 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.13 137.64 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 0.0 110.352 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.98 166.58 14.25 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 82.8 mt -113.87 131.9 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.052 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.38 125.89 51.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.16 142.14 42.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.946 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.93 -31.91 34.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.911 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.0 mt -111.11 146.16 33.95 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.455 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 56.5 Cg_endo -65.88 160.91 41.77 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.491 2.127 . . . . 0.0 111.293 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.6 m-80 80.84 9.41 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.866 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.7 m-85 77.44 33.94 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.35 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -113.26 -179.85 3.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.582 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.17 -164.17 40.16 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.676 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 39.2 ttp180 -76.64 146.95 37.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.765 0.317 . . . . 0.0 110.303 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -107.2 147.85 29.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 41.4 m-85 -127.52 134.07 49.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 59' ' ' MET . 41.9 tp -96.3 124.19 40.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.379 . . . . 0.0 110.112 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.8 mp -86.47 46.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.46 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.72 -41.37 96.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.573 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -58.13 159.81 5.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 156' ' ' GLU . 63.4 pttt -100.48 141.69 32.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.388 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' H ' HG22 ' A' ' 132' ' ' VAL . 80.0 tt0 57.83 151.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -145.56 83.37 1.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 20.6 mmt180 -65.16 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.638 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 35.5 mtpt -120.65 166.87 14.23 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.249 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.471 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.0 Cg_exo -68.04 -33.17 26.37 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.837 1.692 . . . . 0.0 113.197 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.5 pt -85.2 5.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.394 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 63.5 m-20 -64.02 -31.21 72.31 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.424 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.926 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 28.2 p90 -95.14 29.36 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.461 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.65 23.98 63.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.413 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.926 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.6 124.92 37.92 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.636 0.255 . . . . 0.0 111.49 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -23.97 64.04 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.62 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.76 162.26 28.84 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.72 6.21 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.885 2.39 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.34 116.42 16.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.567 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.6 p -155.94 150.78 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.353 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.33 -146.42 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 4.3 m -84.16 -140.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.913 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 p90 179.87 179.22 0.54 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.438 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.701 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -161.46 144.8 12.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.813 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.79 143.0 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.6 mt -82.07 143.58 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.908 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.55 132.14 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.945 0.402 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 2.2 pm0 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.449 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' LYS . 17.0 t 46.48 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 5' ' ' GLY . 17.4 ptmt 31.17 57.67 0.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.39 0.431 . . . . 0.0 110.994 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.5 m 40.69 -90.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.559 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 120.1 -55.48 0.62 Allowed Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.543 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 7.8 t -150.53 143.04 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.396 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -134.39 132.7 39.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.4 tt -118.05 141.64 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.287 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 11' ' ' TYR . 61.1 m -130.82 125.24 33.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.445 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.79 120.39 37.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.803 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -120.03 142.19 49.05 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.8 mt-10 -59.56 -27.05 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 18' ' ' VAL . 90.0 m-20 -119.49 -159.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttm -111.78 175.03 5.59 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.712 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.89 11.6 3.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m-85 57.35 52.1 9.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.985 ' O ' HG22 ' A' ' 18' ' ' VAL . 6.8 pt20 -118.42 -163.85 0.98 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.3 m 90.0 -140.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.682 1.239 . . . . 0.0 111.443 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.858 ' N ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -113.75 34.07 4.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.874 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 12.1 ptt-85 -76.64 159.76 29.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.794 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' CYS . 10.0 p90 -149.17 81.59 1.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.313 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -38.98 85.11 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.612 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' TYR . 44.0 t -134.99 128.91 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.664 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.8 p-10 -86.73 135.21 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.3 m -173.11 -179.36 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.852 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 43.2 p-10 -129.96 123.01 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.869 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.3 m -148.96 167.46 25.7 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.318 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.68 82.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 27.3 p-10 -168.88 127.36 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -72.15 16.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.686 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -60.31 -12.37 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.484 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -67.24 -41.64 85.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.627 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.499 ' CE2' ' OH ' ' A' ' 21' ' ' TYR . 52.5 m-85 -81.48 -34.68 31.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.188 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -165.35 124.82 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.007 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -79.79 17.72 0.89 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' LEU . 95.0 mtt180 -157.78 138.63 13.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.3 t -141.16 143.73 34.41 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.706 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.593 ' O ' ' O ' ' A' ' 39' ' ' SER . 41.4 m-20 -118.78 -137.45 0.35 Allowed 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -31.95 165.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.793 0.683 . . . . 0.0 110.905 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.7 mt -145.09 165.13 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.124 0.488 . . . . 0.0 111.024 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' HG22 ' A' ' 40' ' ' ILE . 32.5 tttt -132.31 115.65 15.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -115.89 126.58 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -123.44 87.76 2.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 89.25 125.81 2.73 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.06 165.31 33.8 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.1 m -113.03 119.86 39.34 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.645 0.259 . . . . 0.0 110.954 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 41.5 m95 -94.91 150.96 19.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.25 132.42 55.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.594 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -119.36 134.71 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.191 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.88 169.03 9.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.82 -32.95 16.69 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.34 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -123.46 161.93 42.96 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.125 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 31.9 Cg_exo -60.46 150.54 80.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.261 1.974 . . . . 0.0 111.174 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 90.0 20.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.658 0.599 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 51.9 50.42 18.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.27 133.51 29.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.346 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.66 130.44 4.5 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' GLY . 8.4 m-85 44.89 178.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.141 0.496 . . . . 0.0 110.445 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.415 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 7.0 mtt -154.01 89.1 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.467 ' C ' HD12 ' A' ' 61' ' ' ILE . 99.4 m-85 -95.15 116.04 28.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.006 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.797 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -97.94 128.07 49.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.9 94.95 46.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -79.46 167.96 20.46 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.321 2.014 . . . . 0.0 111.707 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.1 tm0? -41.65 98.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.03 155.11 23.08 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.78 135.12 39.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.8 m-85 -131.01 92.38 33.73 Favored Pre-proline 0 C--O 1.224 -0.24 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.18 -28.06 6.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.923 1.748 . . . . 0.0 112.101 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 61.1 mt-10 -124.23 158.87 31.45 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.658 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -76.38 7.61 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.876 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.3 pt20 -101.01 -11.84 19.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.97 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -95.66 -12.29 25.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.751 0.31 . . . . 0.0 111.268 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.18 14.77 19.49 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.203 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.1 mtm 48.49 56.74 7.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 111.025 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.69 178.19 50.78 Favored Glycine 0 C--N 1.33 0.243 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 tt -124.92 -72.2 0.68 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.942 0.401 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.807 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -137.21 44.06 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.802 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 38.7 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.758 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.4 tpm_? -79.11 111.37 15.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 49' ' ' VAL . 70.2 mt -155.06 132.24 10.97 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.53 0.519 . . . . 0.0 110.736 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.3 t -149.72 51.93 0.93 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.825 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.3 m 162.03 143.53 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 110.495 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.1 p -144.48 135.96 25.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.948 0.404 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -138.74 146.77 41.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.79 137.07 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.206 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -133.38 136.69 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.217 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 87' ' ' HIS . 14.8 m-70 -110.87 155.41 22.65 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 88' ' ' LEU . 3.4 mp -96.42 131.25 28.82 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.269 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.23 141.88 20.97 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 C-N-CA 122.093 1.862 . . . . 0.0 112.237 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.8 p -63.38 161.29 14.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.817 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.37 -59.2 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.91 15.49 81.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.578 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 50.4 tt0 -140.29 -94.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 7.8 m-85 93.57 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 110.684 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 34.3 ttpt -96.21 136.07 37.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 1.5 tt -122.29 129.68 75.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.798 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 110' ' ' GLU . 73.1 mt-30 -118.47 106.16 12.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.833 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.2 pt -105.28 134.57 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -107.75 136.88 46.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.634 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.37 -36.62 76.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -102.85 165.11 11.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.203 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.4 -36.58 26.45 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.41 28.62 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.717 0.294 . . . . 0.0 110.788 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 54.03 67.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 m -156.47 160.78 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.46 -143.63 15.78 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -97.14 98.47 10.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.145 0.497 . . . . 0.0 109.945 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 108' ' ' MET . 5.7 tmm? -90.42 145.25 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.38 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -114.77 134.08 55.39 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 39.3 tt0 -134.64 149.49 50.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.794 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.9 m 138.16 157.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.94 1.4 . . . . 0.0 110.389 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -97.79 154.26 17.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 159.26 169.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.7 p30 -89.52 125.86 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 172' ' ' SER . 34.8 m -120.82 113.71 32.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.524 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 67.8 Cg_endo -80.36 -58.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.032 1.821 . . . . 0.0 111.985 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -125.01 119.93 30.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.885 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.48 -50.25 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.051 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 8.7 ptt? -57.24 14.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.243 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.706 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.9 tp10 -127.85 -53.32 1.33 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.238 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.419 HE22 ' CG ' ' A' ' 113' ' ' GLU . 49.2 tt0 -78.49 -34.91 47.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -118.98 2.27 11.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.667 0.27 . . . . 0.0 110.991 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 57.69 32.05 21.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.791 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.48 ' SD ' HD12 ' A' ' 98' ' ' ILE . 1.5 ptp -132.8 138.8 47.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -103.99 6.12 35.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -158.7 164.06 36.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.722 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 129' ' ' SER . 12.7 mt -142.52 134.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.833 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -96.37 -22.18 17.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.3 OUTLIER -136.57 -171.62 2.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.785 0.326 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.2 m -166.29 -26.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 68.0 tttt 71.67 171.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.722 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 133' ' ' LEU . 98.0 t -42.92 -42.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.671 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 3.5 tp 83.66 -142.12 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.003 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -163.24 132.08 3.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.89 -122.75 29.9 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.95 140.55 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.702 0.287 . . . . 0.0 110.512 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.722 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -141.29 163.82 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 109.959 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.8 mt -112.63 131.17 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.542 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -105.38 127.86 53.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.119 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.404 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 82.8 m-85 -109.31 148.04 31.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.277 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -86.11 -34.23 20.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.817 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.84 148.15 37.63 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 59.5 Cg_endo -66.9 159.99 49.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.004 1.803 . . . . 0.0 110.738 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 7.1 m-80 83.19 9.1 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.915 0.759 . . . . 0.0 110.771 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 6.0 m-85 77.06 41.06 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.416 0.448 . . . . 0.0 111.427 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' GLY . 81.4 mtp180 -125.38 -171.38 2.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.118 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.29 124.29 0.01 OUTLIER Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.1 ttp180 -5.16 122.15 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.297 0.645 . . . . 0.0 112.673 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 13.2 mp0 -96.6 165.95 11.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.892 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.537 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 81.5 m-85 -130.34 134.55 47.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.874 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.415 ' H ' ' HB3' ' A' ' 59' ' ' MET . 46.6 tp -93.49 128.36 39.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 0.0 110.095 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.6 mp -94.06 120.03 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 155' ' ' LYS . 59.2 t0 -86.72 23.09 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 tttp 64.56 -5.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.613 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 153' ' ' ASP . 88.3 tttt -67.62 138.04 56.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -49.48 142.43 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.179 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 155' ' ' LYS . 42.0 m-85 -119.12 90.96 3.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -77.85 -18.33 56.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.596 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -137.26 156.53 75.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.428 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.474 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 14.4 Cg_endo -58.05 -43.74 45.6 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.404 2.069 . . . . 0.0 113.106 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.9 pt -77.92 3.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 26.4 t0 -64.29 -32.96 74.76 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.908 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.897 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 17.7 p90 -95.06 28.75 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.538 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.04 60.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.279 -0.963 . . . . 0.0 111.682 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.897 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.42 123.27 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.027 0.441 . . . . 0.0 111.326 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.67 -34.09 77.09 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -145.93 163.13 32.54 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.916 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.01 5.09 0.14 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.477 2.118 . . . . 0.0 112.065 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -72.8 110.46 7.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.704 0.288 . . . . 0.0 111.437 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.7 p -152.5 146.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 172' ' ' SER . 78.8 mm-40 -102.0 -145.85 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.082 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.58 ' HA ' HG23 ' A' ' 118' ' ' ILE . 9.8 p -79.94 -143.69 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.939 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 23.9 p90 179.96 177.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.722 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.4 ptt180 -162.38 144.36 10.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.058 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.695 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.32 149.48 20.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.842 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.73 140.92 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.004 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.58 138.28 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.0 0.428 . . . . 0.0 110.099 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.402 179.702 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 p -155.37 161.88 40.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.825 0.345 . . . . 0.0 110.489 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 4' ' ' THR . 23.5 tptt -148.45 170.99 16.79 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.24 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.441 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 1.7 t -161.12 49.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.28 -76.45 1.23 Allowed Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.526 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.0 t -150.1 141.18 23.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -137.29 135.77 37.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.768 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.73 141.79 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 21' ' ' TYR . 60.2 m -136.76 127.16 26.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.349 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.99 127.37 52.56 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.206 0.526 . . . . 0.0 110.226 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.51 142.58 50.87 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.406 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.5 mt-10 -61.18 -25.42 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.955 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -118.35 -159.24 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.9 pttp -112.84 176.27 5.09 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.683 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.47 11.53 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.514 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 2.0 m-85 57.89 53.24 7.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.109 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.683 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.2 pt20 -119.96 -163.9 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 19' ' ' ARG . 10.1 t 86.45 -136.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 O-C-N 123.596 0.56 . . . . 0.0 110.587 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.764 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.1 ptp180 -119.92 35.35 4.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 13.6 ptt-85 -71.1 154.61 41.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 9' ' ' THR . 35.4 m-85 -94.78 -170.53 2.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.581 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -157.72 48.47 0.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -141.04 147.16 38.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.397 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.2 p-10 -87.27 140.54 29.44 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 5.8 t -175.48 -175.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.363 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 25' ' ' CYS . 94.2 m-20 -142.26 134.14 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.21 170.71 19.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.25 77.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.273 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 31' ' ' HIS . 24.5 p-10 -169.39 123.11 0.78 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -68.92 12.41 0.15 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.069 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.499 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -60.4 -17.15 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.996 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 32' ' ' THR . 86.8 m -70.97 16.58 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.698 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' HIS . 57.5 m-85 -137.34 -32.56 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.044 0.45 . . . . 0.0 110.276 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.87 129.37 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.658 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -63.19 -83.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.428 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 80.6 mtp85 -74.15 161.69 29.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 110.083 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.8 OUTLIER -146.62 145.8 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.3 m120 -112.93 -141.48 0.38 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -37.14 172.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.607 0.567 . . . . 0.0 110.965 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' N ' ' A' ' 41' ' ' LYS . 83.8 mt -146.5 167.28 7.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.046 0.451 . . . . 0.0 110.533 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.58 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.0 tttt -132.63 120.32 21.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.4 128.22 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.659 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.27 88.39 2.83 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.23 132.64 5.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 167.17 3.15 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 47' ' ' TRP . 35.8 m -98.81 172.95 7.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.943 0.402 . . . . 0.0 110.544 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.666 ' N ' HG22 ' A' ' 46' ' ' THR . 16.2 m95 -147.89 145.05 28.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.598 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.34 121.59 44.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.27 134.87 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.599 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -109.18 171.63 7.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 55.8 mt-10 -94.71 -29.51 14.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.91 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 4.1 mmp_? -112.23 148.97 40.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.675 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.6 Cg_endo -61.37 148.53 92.7 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.956 1.771 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.9 t-20 87.44 18.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 61.39 58.52 2.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.23 156.66 48.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 98.8 -157.12 20.2 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.5 m-30 -46.49 173.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 149' ' ' GLN . 54.8 mtt -144.48 110.69 5.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.302 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 65.5 m-85 -116.28 131.32 56.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.083 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -107.36 130.97 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.35 88.44 42.15 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.23 169.38 15.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.88 2.386 . . . . 0.0 111.32 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 6.3 tm0? -45.9 98.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -171.98 150.98 13.82 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -93.68 136.69 33.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 15.4 m-85 -132.2 93.04 27.12 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.35 -27.19 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 43.6 mt-10 -123.98 154.53 39.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -70.55 7.36 1.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.969 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.8 pt20 -101.23 -11.42 19.52 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.16 -15.67 27.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.286 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.543 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -113.51 15.37 19.04 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.438 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 74' ' ' MET . 4.1 mpp? 47.25 57.24 5.97 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.77 176.75 53.6 Favored Glycine 0 N--CA 1.459 0.228 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 76' ' ' LEU . 3.1 tt -124.93 -72.22 0.68 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.847 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -131.03 45.14 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 38' ' ' ASN . 99.1 m-20 37.53 21.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.822 0.344 . . . . 0.0 110.847 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ASN . 33.0 ttm180 -79.5 112.61 16.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.331 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD11 ' CH2' ' A' ' 73' ' ' TRP . 51.7 mt -154.18 128.76 9.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.565 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 82' ' ' SER . 2.5 t -149.3 51.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.263 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 165.32 137.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.05 0.452 . . . . 0.0 110.238 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.02 132.2 23.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.273 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.4 144.9 44.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.405 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.0 140.29 36.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.488 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.7 t -131.48 134.21 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -121.27 140.11 52.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.056 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.88 149.25 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.032 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.19 173.22 8.85 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.529 2.153 . . . . 0.0 111.992 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -57.36 162.77 2.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.939 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.35 96.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.77 149.41 17.34 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 31.3 tt0 -61.38 -73.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 5.6 m-30 118.49 147.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.157 1.536 . . . . 0.0 110.717 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -171.79 132.89 0.73 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.098 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -126.24 136.6 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 130' ' ' CYS . 26.1 mt-30 -119.5 107.95 13.92 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.344 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.51 135.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 28.3 m-85 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.24 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.65 163.96 12.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.427 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.78 -44.59 24.75 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.715 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -74.01 31.78 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.733 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 102' ' ' GLY . 48.1 m-85 50.19 77.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 0.0 109.907 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.3 m -157.4 -163.11 1.3 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.802 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.98 -137.03 50.32 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -91.81 134.19 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.65 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 41.3 ttp -124.35 142.29 51.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.18 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -122.72 134.88 54.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.488 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -135.12 153.18 52.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 19.2 m 136.02 156.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.592 1.183 . . . . 0.0 110.208 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -99.02 154.76 17.84 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' THR . 12.2 pt-20 152.0 137.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 22.8 p-10 -55.59 127.79 31.51 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 77.3 m -119.55 114.74 34.26 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -78.03 -66.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.098 1.866 . . . . 0.0 112.176 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.0 m -121.27 120.0 33.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.928 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.6 pt -60.91 -48.59 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 10.3 ptm -57.5 13.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.636 0.255 . . . . 0.0 111.273 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' H ' ' C ' ' A' ' 118' ' ' ILE . 76.1 tt0 -126.66 -53.86 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -78.3 -35.52 47.72 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.886 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -117.47 2.48 12.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 111.024 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 56.78 29.54 16.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.353 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' HD12 ' A' ' 118' ' ' ILE . 8.4 ptm -131.06 136.08 48.12 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -103.91 4.61 34.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -155.28 160.49 40.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.234 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -139.73 130.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -91.67 -21.51 20.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.114 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.0 m -153.01 143.19 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.269 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 4.2 m -113.45 -18.02 12.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.588 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 130' ' ' CYS . 43.4 tttm 49.86 172.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 98.6 t -61.65 129.54 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -106.05 -105.05 0.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.502 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' H ' ' CG ' ' A' ' 133' ' ' LEU . 78.4 tt0 -172.09 132.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.358 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.17 -111.99 4.32 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.73 136.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 110.667 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.725 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -134.52 157.76 45.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.3 mt -106.71 133.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.26 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -104.55 128.49 52.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.778 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE1' ' NE2' ' A' ' 149' ' ' GLN . 82.8 m-85 -112.98 141.89 46.31 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -80.88 -33.07 34.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.7 147.49 35.87 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.197 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.76 163.42 30.62 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.088 1.858 . . . . 0.0 111.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.472 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.8 m-80 77.84 8.18 2.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.629 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 77.12 41.54 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.763 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.47 -177.6 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.358 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.19 -160.83 42.75 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.496 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 54.1 ttp180 -68.7 162.09 26.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.474 ' NE2' ' CE1' ' A' ' 140' ' ' TYR . 82.9 mt-30 -130.8 148.27 52.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.496 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 12.2 m-85 -128.09 132.21 49.02 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.0 tp -92.76 118.88 31.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.014 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -86.35 129.87 34.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.798 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -125.88 73.65 1.36 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.219 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 155' ' ' LYS . 63.3 mttp 46.9 -151.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 154' ' ' LYS . 20.6 tptp 60.02 131.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.561 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.74 141.33 57.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -97.54 85.77 3.69 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.015 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -63.22 -31.43 72.57 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.807 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 5.9 mtpm? -125.48 165.24 27.61 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.155 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.8 Cg_exo -66.1 -38.81 20.5 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.736 1.624 . . . . 0.0 113.044 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 14.8 pt -83.45 3.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.177 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -60.86 -35.41 76.52 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.989 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.929 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 33.5 p90 -90.87 31.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.06 23.46 71.59 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.385 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.929 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.72 125.46 35.69 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.78 0.324 . . . . 0.0 111.316 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.62 -24.8 64.61 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.848 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.75 161.64 29.54 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.56 -1.29 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.738 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.38 116.77 12.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.691 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.0 p -154.39 148.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -98.68 -143.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.364 0.415 . . . . 0.0 111.354 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.572 ' HA ' HG23 ' A' ' 118' ' ' ILE . 11.1 p -83.3 -141.25 0.06 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.047 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' N ' ' OG ' ' A' ' 172' ' ' SER . 14.0 p90 179.05 178.02 0.48 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.342 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.725 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.9 ptt180 -159.08 140.86 13.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.66 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.58 147.93 35.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.838 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.07 137.49 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.979 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.11 132.8 58.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.416 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 1.5 pm0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.213 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.0 t 51.52 172.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.391 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 5' ' ' GLY . 68.5 mttm -112.33 15.73 20.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m 40.02 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' LYS . . . 153.44 -39.17 0.71 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.576 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 9.7 t -150.6 142.02 23.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -139.09 135.79 34.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.9 tt -118.02 140.96 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.839 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.85 125.8 24.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.17 125.19 49.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.9 144.26 49.87 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.022 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 47.6 mt-10 -67.2 -29.71 69.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.171 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -125.81 121.63 33.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ASP . 14.2 pttt -41.66 176.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.438 0.637 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.727 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.8 m-80 76.66 7.7 3.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 62.13 34.84 16.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.727 ' NE2' HD22 ' A' ' 15' ' ' ASN . 9.3 pt20 -112.26 144.54 41.5 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.698 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.922 HG22 ' H ' ' A' ' 19' ' ' ARG . 8.5 p 138.96 -139.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.959 1.412 . . . . 0.0 110.242 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.922 ' H ' HG22 ' A' ' 18' ' ' VAL . 11.0 ptp85 -115.53 32.8 5.84 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -78.72 166.57 22.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.402 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 23' ' ' CYS . 3.6 m-85 -148.99 84.99 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.091 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -43.61 79.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.47 0.653 . . . . 0.0 112.396 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 21' ' ' TYR . 8.6 t -134.41 130.01 36.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.712 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 2.5 p-10 -86.55 138.75 31.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 t -168.82 175.99 5.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.928 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 38.8 p-10 -127.74 122.57 33.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.836 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -153.86 170.03 21.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.465 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.77 -45.43 70.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.111 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 81' ' ' SER . 64.7 t0 -171.21 129.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.1 p90 -75.31 12.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.058 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -58.68 -8.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -67.63 -38.21 83.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.439 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -81.09 -35.82 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.49 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.47 131.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.179 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.8 m -61.89 -83.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.06 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 99.8 mtt180 -73.46 162.18 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.431 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.15 147.22 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.113 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.732 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -114.17 -141.32 0.38 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -38.36 173.75 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 111.307 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 53.3 mt -147.33 166.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.373 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 18.5 tttt -130.14 119.67 23.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 66.4 t -120.7 125.73 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -123.59 87.68 2.78 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.063 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.83 134.48 6.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.47 164.25 3.99 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.6 m -110.07 116.21 31.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.463 0.173 . . . . 0.0 111.055 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 18.0 m95 -92.61 155.08 18.0 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -121.61 132.97 54.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.618 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HB ' HD22 ' A' ' 80' ' ' LEU . 18.7 m -123.01 137.72 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.76 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -107.04 169.11 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.714 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 8.0 mp0 -90.57 -31.54 16.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.337 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.0 mmp_? -116.46 153.97 48.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.373 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 28.9 Cg_exo -59.34 146.13 95.73 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.472 1.448 . . . . 0.0 112.282 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.5 t-20 87.33 30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 49.94 60.02 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.091 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.62 168.17 20.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.751 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 77.58 128.19 0.4 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' ' O ' ' A' ' 57' ' ' GLY . 3.7 m-85 37.49 -174.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.455 0.645 . . . . 0.0 110.857 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.778 ' H ' HH12 ' A' ' 148' ' ' ARG . 56.4 mtt -153.57 144.98 23.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.566 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.541 ' C ' HD12 ' A' ' 61' ' ' ILE . 73.9 m-85 -155.43 123.35 5.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.403 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -106.63 129.38 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.311 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.81 97.81 42.79 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 163.77 30.69 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.983 1.789 . . . . 0.0 111.495 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -43.46 103.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.607 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.96 155.21 16.65 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.28 136.6 35.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.52 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 38.4 m-85 -126.94 91.31 47.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.867 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -82.03 2.42 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.971 1.781 . . . . 0.0 111.957 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 39' ' ' SER . 68.2 mt-10 -152.79 154.01 34.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -70.35 -0.97 9.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.175 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -100.4 -9.71 21.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.15 -17.81 28.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.376 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.499 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -112.91 14.74 19.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.269 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.1 mtm 48.88 56.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 111.322 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -80.33 -179.5 52.71 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.25 -70.99 0.73 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.316 0.579 . . . . 0.0 110.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.862 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.15 45.94 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.034 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 37.88 22.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.847 0.356 . . . . 0.0 111.283 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 9.4 tpp180 -77.51 111.83 13.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.393 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.62 127.28 9.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.018 0.437 . . . . 0.0 110.293 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.76 52.24 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.696 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 164.46 137.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.387 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -142.0 131.22 23.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -136.11 144.44 45.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.46 141.39 36.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.391 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.5 t -136.38 137.39 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.369 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -110.76 160.95 16.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp -79.64 141.52 56.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.673 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.43 162.36 41.69 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.519 2.146 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -74.57 156.12 37.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.309 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 139.4 -147.47 19.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.14 -41.89 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.57 -174.86 2.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.629 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 65.4 m-85 -141.87 96.56 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.93 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 33.6 ttmt -98.62 134.01 42.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 7.0 tt -125.91 133.65 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.041 0.448 . . . . 0.0 110.849 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 130' ' ' CYS . 81.8 mt-30 -119.94 106.83 12.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.275 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.98 137.47 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' LYS . 69.0 m-85 -109.06 139.17 44.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.918 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -77.44 18.35 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.443 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 98.1 mttt -154.79 154.28 32.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.218 0.532 . . . . 0.0 110.752 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -74.73 -21.01 79.28 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.39 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.36 27.56 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.806 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 51.93 68.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -157.82 162.95 38.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.18 -145.73 17.08 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -93.33 98.46 11.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.047 0.451 . . . . 0.0 110.095 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.416 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.1 tmm? -91.27 142.04 28.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.06 133.38 56.09 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.843 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.7 tm-20 -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.558 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 138.09 153.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.966 1.417 . . . . 0.0 110.797 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 4.6 t -93.92 156.4 16.65 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.5 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.6 mt-10 148.74 138.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 24.5 p-10 -57.43 129.34 41.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 77.2 m -122.33 113.18 30.99 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -64.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.528 1.485 . . . . 0.0 112.144 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -119.83 120.38 36.31 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -59.43 -49.04 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.738 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 118' ' ' ILE . 17.6 ptm -58.04 15.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.573 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.9 tp10 -127.51 -54.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.491 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.8 tt0 -77.06 -37.38 54.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.842 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 59.2 m-85 -116.12 3.52 13.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.452 0.168 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 58.99 26.87 15.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.4 ' N ' ' HA ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -128.97 138.81 52.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -102.69 5.13 38.83 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.44 162.99 39.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.809 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' SER . 13.2 mt -141.24 131.78 26.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.485 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -107.94 18.07 21.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.714 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 1.0 OUTLIER -170.24 -177.48 2.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.814 0.34 . . . . 0.0 110.277 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.548 ' N ' ' OG ' ' A' ' 129' ' ' SER . 1.6 m -169.73 -27.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.493 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt 51.82 -171.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.903 0.382 . . . . 0.0 110.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.5 m -65.27 127.36 26.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 130' ' ' CYS . 16.2 mt -101.31 -119.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 95' ' ' LYS . 84.0 tt0 -164.22 131.1 3.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.54 -105.46 0.66 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -159.85 142.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.607 0.242 . . . . 0.0 110.685 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.77 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.56 164.3 30.54 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 109.856 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.2 138.78 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.974 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -111.13 134.09 52.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -112.97 146.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.075 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -80.34 -33.14 37.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 142' ' ' LEU . 95.6 mt -112.47 148.29 38.88 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.3 Cg_endo -65.47 166.37 19.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.106 1.87 . . . . 0.0 111.949 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 77.74 7.8 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.311 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.84 42.55 0.14 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -129.42 -173.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.566 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.73 -50.05 3.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.995 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.778 HH12 ' H ' ' A' ' 59' ' ' MET . 6.3 ttp85 177.26 -172.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 109.788 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -146.43 143.91 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.027 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.81 137.08 49.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.279 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.784 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.3 mp -89.85 128.86 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.055 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 44.3 t0 -55.32 -109.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.639 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 153' ' ' ASP . 6.1 tmtt? -177.79 -3.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.425 ' H ' ' H ' ' A' ' 154' ' ' LYS . 86.2 tttt -79.08 -73.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.465 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -171.47 156.28 4.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.484 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.469 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 11.8 m-85 -135.24 96.44 3.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.276 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' GLY . 13.6 ptm180 -109.8 2.22 19.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.989 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -143.38 166.52 19.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.755 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 34.6 Cg_exo -60.6 -51.76 4.68 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.126 1.884 . . . . 0.0 113.376 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 161' ' ' ILE . 12.4 pt -71.89 -4.25 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.0 m-20 -59.05 -40.26 84.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.545 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.9 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 37.5 p90 -95.34 30.72 2.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.58 23.06 78.57 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.9 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -87.23 123.51 32.32 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.608 -0.348 . . . . 0.0 111.826 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.07 67.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.856 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 p -154.7 153.94 28.45 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.14 1.01 4.39 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.892 2.395 . . . . 0.0 112.157 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.97 52.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.119 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.2 p -91.81 148.43 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 109.919 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.7 mm-40 -98.42 -142.41 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.025 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.551 ' HA ' HG23 ' A' ' 118' ' ' ILE . 2.2 t -84.76 -141.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 21.7 p90 -179.43 175.31 0.92 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.77 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.8 ptt180 -157.78 140.92 15.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.158 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.599 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.37 143.97 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.858 -178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -81.77 138.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.845 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.5 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.215 179.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -75.48 169.17 18.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.629 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.58 -51.86 37.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m 39.08 -101.68 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.44 -45.62 2.89 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.579 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.6 t -152.08 143.78 23.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.452 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -137.02 136.51 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.788 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -120.46 144.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.441 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 21' ' ' TYR . 31.5 m -140.11 128.59 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -119.47 126.88 52.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 0.0 110.231 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.72 145.47 48.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 -179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 18' ' ' VAL . 41.7 mt-10 -66.95 -30.96 71.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.719 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 14' ' ' LYS . 96.5 m-20 -127.81 124.63 38.07 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -40.63 175.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.444 0.465 . . . . 0.0 110.499 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.704 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.6 m-80 78.02 6.03 2.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.375 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 1.7 m-85 60.85 41.55 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.704 ' NE2' HD22 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.94 146.68 43.8 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.316 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 19' ' ' ARG . 11.0 p 132.57 -132.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 125.006 1.441 . . . . 0.0 110.375 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.789 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.8 ptp180 -119.73 35.8 4.72 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.429 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 17.0 ptt-85 -73.27 156.98 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.803 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.599 ' O ' HG23 ' A' ' 9' ' ' THR . 25.3 m-85 -97.97 -173.29 2.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -155.37 45.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.74 149.38 43.53 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.521 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 53.2 p-10 -88.76 143.18 27.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.185 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.88 -173.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.147 0.499 . . . . 0.0 110.039 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.4 p-10 -138.49 129.8 27.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.15 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.0 m -144.91 163.62 33.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.492 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.314 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 31' ' ' HIS . 38.6 p-10 -168.15 122.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.081 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -70.11 9.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.722 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -63.64 -17.72 63.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.402 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.514 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -70.49 16.23 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.468 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -138.95 -27.55 0.82 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.474 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -169.3 115.05 0.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.041 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -72.34 17.15 0.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 34' ' ' LEU . 91.1 mtt180 -157.17 137.76 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.705 0.288 . . . . 0.0 110.424 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 2.3 t -142.01 143.08 33.0 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' O ' ' O ' ' A' ' 39' ' ' SER . 51.2 m-20 -112.8 -140.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.804 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -37.8 174.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 O-C-N 123.805 0.69 . . . . 0.0 110.49 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 41' ' ' LYS . 82.4 mt -146.92 168.8 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.0 111.184 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.0 ttmt -133.8 112.46 11.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.13 128.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.171 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -125.26 86.27 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.187 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 6' ' ' THR . . . 95.57 127.89 5.39 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.86 168.0 16.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -114.95 121.19 42.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 110.817 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.579 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 17.7 m95 -94.76 156.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.35 136.45 53.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.957 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' HB ' HD22 ' A' ' 80' ' ' LEU . 3.0 m -127.02 142.1 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.464 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.35 170.43 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -91.15 -31.91 16.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.63 -179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -118.48 154.05 52.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.148 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 26.8 Cg_endo -61.96 151.43 81.41 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.661 2.241 . . . . 0.0 111.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 87.54 14.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 61.5 56.67 2.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.583 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.4 131.87 23.74 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.905 0.383 . . . . 0.0 110.694 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.693 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.7 137.64 8.41 Favored Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.693 ' O ' ' O ' ' A' ' 57' ' ' GLY . 39.3 m-85 41.62 168.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.482 0.658 . . . . 0.0 110.927 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.2 mtm -154.98 90.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.918 -0.489 . . . . 0.0 110.039 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.717 ' OH ' HD22 ' A' ' 76' ' ' LEU . 79.9 m-85 -101.76 126.04 48.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 110.471 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.13 128.44 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.24 98.9 51.7 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.39 168.44 20.0 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.608 2.206 . . . . 0.0 111.52 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -44.5 104.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.822 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.58 159.34 24.49 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -101.18 139.83 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 23.3 m-85 -129.82 91.61 39.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.192 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.16 3.58 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.882 2.388 . . . . 0.0 112.099 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -153.5 153.13 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.606 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -71.38 2.83 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.92 -10.61 20.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.69 -15.78 26.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.358 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -110.16 14.67 22.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.255 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.9 mtm 52.41 54.55 10.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.435 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -87.69 172.46 42.58 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.007 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -129.31 -50.84 1.19 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 111.51 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.74 ' O ' ' N ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -139.49 39.39 2.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' ASN . 98.4 m-20 31.19 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.422 0.452 . . . . 0.0 111.26 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.74 ' N ' ' O ' ' A' ' 77' ' ' ASN . 35.1 ttm180 -80.65 119.65 23.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 55.4 mt -155.79 130.33 9.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' SER . 4.6 t -144.35 50.24 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.79 138.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.877 0.37 . . . . 0.0 110.533 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.1 p -142.63 132.52 24.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.482 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -138.55 146.19 41.58 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.385 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.459 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.08 142.17 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.492 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 4.8 t -138.82 138.63 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.012 0.434 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -123.08 135.6 54.47 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.671 ' H ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -90.54 144.94 31.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.584 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.68 136.74 21.52 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.46 2.107 . . . . 0.0 111.977 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -67.14 116.85 8.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.95 -145.21 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.92 14.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 55.4 tt0 -131.86 -107.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' O ' ' A' ' 93' ' ' GLN . 11.6 m-85 92.08 113.98 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 123.801 0.688 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -105.28 138.01 42.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.691 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 133' ' ' LEU . 16.5 tt -126.15 137.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.243 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -124.35 127.3 47.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 pt -127.3 145.57 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 13.8 m-85 -118.91 133.78 55.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -55.11 -30.56 59.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.373 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -107.75 164.37 12.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.348 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -78.64 -37.49 26.64 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.693 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -80.05 28.01 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 53.63 67.91 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.784 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 m -155.14 159.77 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.171 0.51 . . . . 0.0 110.546 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.46 -139.63 14.63 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -83.92 128.1 34.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.627 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 38.2 ttp -123.69 138.6 54.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.229 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.15 129.07 56.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.833 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 111' ' ' THR . 74.8 tt0 -130.91 145.04 51.89 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.7 m 136.41 153.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.928 1.393 . . . . 0.0 110.648 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 9.0 t -94.3 159.88 14.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 153.93 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 125.64 29.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 41.8 m -125.8 110.57 25.09 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.6 -60.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.715 2.277 . . . . 0.0 112.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 m -121.65 116.94 25.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.086 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.726 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -58.76 -50.37 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.4 ptt? -56.46 12.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.729 0.3 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' A' ' 118' ' ' ILE . 27.3 tp10 -126.76 -54.87 1.41 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.362 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.599 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.7 tt0 -77.89 -34.0 51.74 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.543 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -117.77 2.99 12.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 55.19 30.55 14.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.228 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.8 ptm -131.37 135.6 47.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -102.84 4.27 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.288 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -155.6 161.9 40.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 110.3 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 129' ' ' SER . 14.3 mt -142.63 132.72 23.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.481 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.8 m-70 -112.11 14.38 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.566 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 3.8 p -152.0 163.64 38.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 129' ' ' SER . 1.2 m 171.07 60.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' CYS . 22.7 pttp -48.75 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' LYS . 99.5 t -34.87 137.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -109.2 136.36 48.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.349 0.595 . . . . 0.0 110.756 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -66.1 131.47 46.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.861 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 55.69 -100.14 0.09 OUTLIER Glycine 0 CA--C 1.52 0.351 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.57 136.71 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.565 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -137.56 155.23 49.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 176' ' ' ILE . 81.0 mt -105.29 134.96 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.424 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.591 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -107.64 127.9 54.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.3 m-85 -112.09 144.13 41.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.13 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -81.18 -36.13 30.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.2 mt -106.27 148.45 36.69 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.338 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.474 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 55.3 Cg_endo -66.72 159.92 48.88 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.311 2.007 . . . . 0.0 111.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 6.2 m-80 81.44 10.5 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.593 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.48 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.1 m-85 72.14 59.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.183 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 147' ' ' GLY . 77.4 mtp180 -143.53 -173.03 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.449 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 60.82 134.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 147' ' ' GLY . 62.5 ttp180 -6.86 126.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.067 0.51 . . . . 0.0 111.642 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -108.33 169.16 8.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.499 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.545 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 34.0 m-85 -133.63 138.39 45.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.146 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -103.69 116.51 32.46 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.625 ' N ' HD13 ' A' ' 151' ' ' LEU . 8.9 mp -86.24 127.9 34.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.056 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.583 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 33.0 t0 -96.07 -168.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.086 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 24.9 pttm -78.08 -5.45 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.537 ' O ' ' CE1' ' A' ' 157' ' ' TYR . 69.9 mmtt -70.14 161.58 29.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.391 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -87.28 153.23 21.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 23.3 m-85 -124.66 92.04 3.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.485 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.567 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 72.8 ttt180 -81.74 -20.49 39.21 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 11.0 mtmm -129.11 168.1 17.35 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 121.087 0.47 . . . . 0.0 110.862 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.1 Cg_exo -66.27 -38.0 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.061 1.84 . . . . 0.0 113.893 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 9.3 pt -83.7 1.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.524 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.567 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 26.3 m-20 -59.84 -35.57 75.02 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.39 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.965 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 23.5 p90 -91.29 32.39 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.577 0.227 . . . . 0.0 111.076 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.29 26.39 68.36 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.324 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.965 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.57 125.64 39.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.177 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.53 64.05 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.67 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.51 162.61 26.62 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.411 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 1.85 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.21 110.63 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.4 p -153.02 145.18 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 118' ' ' ILE . 77.2 mm-40 -96.24 -146.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.513 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.7 t -81.82 -140.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.746 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.4 p90 178.23 179.96 0.32 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 123.523 0.514 . . . . 0.0 110.362 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.785 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.5 ptt180 -162.52 143.28 10.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.923 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.741 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.51 145.82 37.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -178.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.448 HD11 HG13 ' A' ' 138' ' ' ILE . 5.4 mt -88.7 137.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.203 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.84 90.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.641 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.421 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.7 p -77.82 9.86 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.614 0.245 . . . . 0.0 110.765 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp 57.74 -111.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.803 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 m -56.65 -71.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.361 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.15 156.95 1.23 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.608 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -86.83 136.93 32.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -132.76 134.72 45.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.81 139.59 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 28.0 m -134.74 127.47 31.02 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.33 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -120.04 124.17 45.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.094 0.474 . . . . 0.0 110.031 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.94 142.96 49.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.263 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.6 mt-10 -60.62 -28.54 68.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.88 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -115.91 -159.09 0.7 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 12.7 pttt -113.75 173.28 6.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.668 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-80 74.76 12.04 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.634 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.467 ' O ' ' CZ ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.64 45.25 16.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.668 ' NE2' HD22 ' A' ' 15' ' ' ASN . 21.5 pt20 -119.28 149.04 42.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.976 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.8 p 132.4 -133.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 125.235 1.585 . . . . 0.0 110.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.819 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.3 ptp180 -119.39 33.9 5.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.629 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' CZ ' ' O ' ' A' ' 16' ' ' PHE . 16.3 ptt-85 -75.12 160.67 30.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 36.7 m-85 -100.16 -168.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.501 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.8 p-10 -159.64 53.82 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.557 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.0 t -141.15 149.99 42.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.632 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 p30 -88.84 140.65 29.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.1 m 179.38 -170.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.7 124.78 25.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.63 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m -136.7 155.6 49.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.534 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.92 87.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.442 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -172.33 132.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.893 0.377 . . . . 0.0 110.046 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -76.75 10.48 2.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.622 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -55.74 -25.19 39.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.503 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.7 t -66.3 -40.24 89.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.528 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 32' ' ' THR . 72.2 m-85 -82.32 -35.46 27.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.694 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.92 127.88 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.413 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -64.39 -87.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.882 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.64 121.4 27.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.167 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 7.7 t -103.91 153.68 20.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.637 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.43 -136.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -36.5 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.612 0.57 . . . . 0.0 110.78 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 41' ' ' LYS . 85.2 mt -144.93 166.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.578 ' N ' HG22 ' A' ' 40' ' ' ILE . 38.6 tttt -132.8 120.36 21.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -119.57 127.42 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.991 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -127.61 86.72 2.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.007 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 138.2 -131.92 5.61 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' H ' HG22 ' A' ' 6' ' ' THR . . . -63.14 -154.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 10.1 t -100.91 175.7 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 31.1 m95 -149.51 148.47 29.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.985 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -119.37 126.5 51.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.776 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -119.8 136.34 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.11 169.06 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 72.8 mt-10 -94.9 -30.24 14.27 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 2.0 mmp_? -116.58 153.14 48.97 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.0 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.8 Cg_exo -58.69 147.23 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.875 1.717 . . . . 0.0 111.378 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.5 t-20 88.13 35.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.65 0.594 . . . . 0.0 110.843 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' H ' ' CB ' ' A' ' 82' ' ' SER . 3.7 m-85 41.59 56.84 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.785 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.59 133.75 24.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 112.72 130.07 5.28 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' GLY . 6.9 m-85 41.72 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.326 0.584 . . . . 0.0 110.481 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 149' ' ' GLN . 55.4 mtt -154.22 98.13 2.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.036 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.498 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.5 m-85 -105.11 119.97 40.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.907 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -102.0 125.28 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.72 88.67 40.02 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.07 170.87 12.23 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.998 2.466 . . . . 0.0 111.162 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -48.38 99.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -172.34 150.57 13.01 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -93.1 137.22 32.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 17.1 m-85 -131.41 82.21 62.73 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.504 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.59 -34.15 96.72 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.78 2.32 . . . . 0.0 112.162 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 71' ' ' GLN . 65.4 mt-10 -126.3 157.72 37.64 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.676 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 55.5 p90 -72.39 13.5 0.33 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.752 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 69' ' ' GLU . 66.0 mt-30 -100.67 -12.82 18.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -95.95 -10.88 27.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.684 0.278 . . . . 0.0 111.533 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.794 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -114.32 16.06 17.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.9 mtm 47.19 57.32 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.856 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -77.25 174.98 54.39 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -125.66 -71.67 0.69 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.217 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.602 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.2 t-20 -128.93 45.82 2.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.291 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' ASN . 93.4 m-20 37.15 22.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' ASN . 32.0 ttm180 -81.55 113.89 19.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.843 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.794 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.3 mt -154.65 130.9 10.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.015 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 82' ' ' SER . 9.9 t -132.33 -125.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.549 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.533 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.7 m -31.78 147.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 110.978 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.83 139.17 24.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.163 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.401 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 62.9 ttm-85 -142.76 149.61 38.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.22 29.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.192 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 48' ' ' ALA . 3.3 t -139.54 139.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.705 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.6 158.94 17.12 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.159 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.8 mp -90.22 143.76 30.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.87 167.32 27.52 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.534 2.156 . . . . 0.0 112.036 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 m -57.21 147.28 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.64 -123.44 0.26 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.77 -70.64 1.35 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 52.1 tt0 -178.7 117.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.785 0.326 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.02 168.25 20.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -172.46 130.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.288 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.3 tt -127.95 139.17 52.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.6 mt-30 -120.53 106.52 11.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.12 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.44 137.23 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.1 OUTLIER -111.8 135.19 52.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.216 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.28 -34.81 64.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -105.86 166.62 10.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -81.75 -40.39 10.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -76.36 28.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.785 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 68.0 m-85 53.54 68.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 m -155.22 159.83 40.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.4 -136.72 13.14 Favored Glycine 0 N--CA 1.463 0.461 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.64 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.7 tm0? -90.69 135.83 33.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.507 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 44.0 ttp -127.21 138.84 53.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.64 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 62.8 m-85 -115.81 132.13 56.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.397 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 76.5 tt0 -133.26 147.21 51.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 15.7 m 137.6 158.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.988 1.43 . . . . 0.0 110.046 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -101.79 157.03 17.14 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 112' ' ' THR . 12.2 mt-10 151.61 140.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 18.4 p30 -58.25 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 73.6 m -121.45 116.97 30.51 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.93 -67.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.074 1.849 . . . . 0.0 111.926 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.401 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 29.6 m -118.71 123.01 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.308 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.0 pt -63.94 -50.33 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.479 ' H ' HG13 ' A' ' 118' ' ' ILE . 24.2 ptm -56.27 12.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.454 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.716 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.0 tt0 -126.82 -52.31 1.45 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.3 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 44.5 tt0 -78.26 -36.05 47.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.677 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 70.1 m-85 -117.8 4.03 12.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.876 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 57.13 29.82 17.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.608 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.1 ptp -131.36 136.26 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -102.79 6.58 39.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -157.85 163.85 37.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.531 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.7 mt -143.12 135.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -97.21 -21.09 17.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 2.2 t -152.08 142.49 22.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 131' ' ' LYS . 82.1 m -114.61 -8.83 12.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.892 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 56.0 tttt 50.12 174.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.436 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 88.7 t -65.85 146.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -140.3 160.26 40.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 70.0 tt0 -76.83 137.53 39.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.93 -146.77 48.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.32 133.82 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.772 0.32 . . . . 0.0 110.147 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.623 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -124.07 152.4 42.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.422 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 69.7 mt -104.37 135.86 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.102 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.68 132.36 54.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.504 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' OH ' ' NE2' ' A' ' 149' ' ' GLN . 76.1 m-85 -111.43 141.69 44.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.269 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -78.06 -34.5 50.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.69 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -110.28 147.11 35.64 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.314 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 54.2 Cg_endo -64.21 161.96 31.9 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.184 1.923 . . . . 0.0 111.46 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.4 m-80 79.72 9.26 1.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.973 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.7 m-85 79.3 40.91 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -124.95 -172.2 2.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.874 0.369 . . . . 0.0 110.699 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.631 ' O ' ' O ' ' A' ' 148' ' ' ARG . . . 67.22 104.38 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.66 ' CG ' ' H ' ' A' ' 149' ' ' GLN . 19.9 ttp180 34.54 -170.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.135 0.55 . . . . 0.0 110.665 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.66 ' H ' ' CG ' ' A' ' 148' ' ' ARG . 59.7 mt-30 -157.49 137.0 12.07 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.771 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.549 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.1 m-85 -123.76 132.57 53.83 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.68 129.83 55.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.655 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 133' ' ' LEU . 11.0 mp -96.06 128.41 42.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.29 18.69 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.497 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.49 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 65.9 tttp 57.42 104.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.516 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -151.07 -79.42 0.12 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.449 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -164.28 -38.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.49 ' OH ' ' N ' ' A' ' 154' ' ' LYS . 20.6 m-85 46.62 78.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.63 -16.68 26.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -127.59 156.05 75.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.49 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -56.77 -46.32 30.38 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.97 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 165' ' ' ALA . 12.9 pt -82.25 3.35 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.305 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.0 -35.59 80.73 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.714 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.956 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 18.3 p90 -90.6 28.89 1.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.353 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.3 23.98 62.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.357 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.956 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.62 124.17 36.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 111.294 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.92 69.82 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 169' ' ' ALA . 1.4 p -150.32 157.35 37.05 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.69 -3.18 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 112.049 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.43 110.96 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 111.665 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.546 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.7 p -153.65 147.69 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.002 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.14 -141.85 0.34 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.2 m -83.62 -139.04 0.06 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.899 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.1 p90 179.31 178.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.384 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.623 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.6 ptt180 -160.93 143.44 12.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.39 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.73 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -57.07 146.64 26.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.019 -178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -83.91 143.17 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.87 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.77 132.46 56.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.469 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.395 179.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -74.32 144.15 44.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.604 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -47.49 -65.12 0.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -120.8 80.37 1.62 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.922 0.392 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 131.25 10.61 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.7 t -94.76 151.11 19.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -138.94 136.95 35.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.69 142.68 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.969 0.414 . . . . 0.0 110.362 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -137.43 128.45 27.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -118.12 122.3 42.73 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.09 142.37 47.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' H ' HG11 ' A' ' 18' ' ' VAL . 97.5 mt-10 -58.44 -27.12 64.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.428 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -120.03 -159.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 15.9 pttt -112.09 175.56 5.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.69 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.99 12.79 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.729 0.3 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.1 48.89 14.62 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.69 ' NE2' HD22 ' A' ' 15' ' ' ASN . 20.6 pt20 -126.43 154.21 43.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.753 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.5 p 129.01 -132.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 125.298 1.624 . . . . 0.0 110.338 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.753 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.5 ptp180 -118.3 30.67 7.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.688 0.28 . . . . 0.0 110.466 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -72.94 161.65 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.174 0.512 . . . . 0.0 111.481 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -100.65 -169.23 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.367 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -159.16 51.67 0.37 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.1 m -140.44 153.46 46.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.066 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -89.5 137.91 31.91 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -176.35 -174.18 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.015 0.436 . . . . 0.0 110.273 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.0 p-10 -140.59 131.87 26.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.086 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -144.66 165.5 27.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.379 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.19 97.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.4 p-10 -171.88 124.32 0.54 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.019 0.437 . . . . 0.0 110.167 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -68.48 10.32 0.26 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -56.3 -18.35 10.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.472 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.3 m -65.26 -40.76 94.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.84 -36.27 28.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.54 124.83 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -79.4 17.11 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.938 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -157.57 138.54 13.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.859 0.361 . . . . 0.0 110.725 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' C ' HD22 ' A' ' 38' ' ' ASN . 1.9 t -143.43 146.16 33.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.209 0.528 . . . . 0.0 110.376 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.6 m120 -118.1 -135.99 0.34 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.83 168.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.682 0.613 . . . . 0.0 111.037 -179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.613 HD12 HD21 ' A' ' 62' ' ' LEU . 84.3 mt -145.97 164.49 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.34 121.68 25.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 62' ' ' LEU . 69.2 t -121.68 126.95 75.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.047 0.451 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -124.64 88.66 2.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.29 -135.27 8.23 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -53.31 -160.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -102.0 174.76 5.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 27.6 m95 -148.77 146.27 27.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.459 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 123.88 49.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.113 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.5 t -121.05 137.08 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.907 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 27.1 m-85 -111.33 174.07 6.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.549 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -100.89 -28.25 12.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.048 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 6.7 mmp_? -114.39 148.73 40.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.0 Cg_endo -59.59 145.46 97.99 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.855 1.704 . . . . 0.0 111.647 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.2 t-20 89.21 18.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 50' ' ' TYR . 4.3 m-85 60.5 61.18 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.211 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.35 178.16 8.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.062 0.458 . . . . 0.0 110.972 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.57 -49.53 3.68 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.761 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 25.2 m-85 -145.04 173.96 11.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.058 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 2.1 mpt? -149.73 114.84 5.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.477 ' C ' HD12 ' A' ' 61' ' ' ILE . 62.5 m-85 -126.43 127.36 45.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.388 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -99.04 121.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.2 mp -112.28 93.82 23.95 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.412 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.88 168.64 20.59 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.214 1.943 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.48 99.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -170.95 148.62 11.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.462 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -92.05 134.19 35.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.574 0.226 . . . . 0.0 110.506 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 10.7 m-85 -130.84 94.2 29.21 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.155 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HE ' ' A' ' 72' ' ' ARG . 58.3 Cg_endo -75.62 -32.15 4.92 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.029 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -127.17 161.84 27.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.241 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 54.9 p90 -61.52 -42.57 99.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.959 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 4.3 pt20 -53.66 -13.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HE ' ' HD2' ' A' ' 68' ' ' PRO . 5.4 tpp180 -99.78 -22.31 15.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.959 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.752 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 62.4 t90 -99.05 2.19 45.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.57 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.5 mtm 53.61 49.96 18.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.44 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.24 52.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.47 -72.48 0.68 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.17 0.51 . . . . 0.0 111.112 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.851 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -128.97 47.58 2.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.681 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 39.66 17.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.0 OUTLIER -81.36 118.57 22.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.779 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' CG1' ' A' ' 49' ' ' VAL . 50.6 mt -155.34 130.4 9.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.336 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -129.69 -124.57 0.21 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.757 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 2.8 p -36.1 148.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.111 0.481 . . . . 0.0 111.24 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.7 p -146.97 139.52 24.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.119 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -142.58 149.15 38.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.593 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.33 151.42 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 99.2 t -136.3 138.92 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -111.86 158.79 19.01 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.098 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.0 mp -87.38 148.96 45.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.673 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.36 158.31 57.94 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.603 2.202 . . . . 0.0 112.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.2 t -65.84 166.46 11.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.49 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.76 -168.26 0.06 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . -133.28 -97.64 0.64 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' O ' ' O ' ' A' ' 94' ' ' TYR . 36.0 tt0 62.94 -56.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.945 0.438 . . . . 0.0 111.379 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 93' ' ' GLN . 70.1 m-85 55.71 139.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 0.0 110.472 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -172.51 126.14 0.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.704 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.87 136.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 111.157 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 130' ' ' CYS . 73.1 mt-30 -119.32 113.4 20.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.269 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 98' ' ' ILE . 17.7 pt -110.91 135.63 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.637 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 5.9 m-85 -108.13 135.43 49.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.159 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.02 -34.94 72.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.63 162.17 13.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.258 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -74.0 -42.41 37.27 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -76.85 31.19 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.815 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 102' ' ' GLY . 60.6 m-85 52.11 70.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.6 m -157.58 163.72 38.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.919 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.25 -139.18 14.47 Favored Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.09 131.71 34.58 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.637 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 38.8 ttp -124.29 139.37 53.97 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.367 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -116.77 132.67 56.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.691 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.3 tt0 -133.39 146.43 51.23 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.567 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 17.3 m 137.46 157.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.178 1.549 . . . . 0.0 110.656 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -95.71 157.07 16.06 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 112' ' ' THR . 7.3 mt-10 155.87 165.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 5.8 p30 -82.79 124.05 29.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 172' ' ' SER . 17.4 m -120.8 109.23 36.13 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.8 -57.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.939 1.759 . . . . 0.0 112.066 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 118.21 27.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.939 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.39 -49.43 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.845 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.631 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.8 ptp -57.33 14.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.581 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.0 tt0 -128.02 -54.05 1.3 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.239 0.542 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 122' ' ' PHE . 50.2 tt0 -76.08 -38.0 57.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 61.7 m-85 -116.52 4.92 13.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.595 0.236 . . . . 0.0 111.256 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 58.04 27.9 15.52 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -130.37 138.73 50.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -103.19 5.77 37.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.97 164.37 36.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 129' ' ' SER . 11.2 mt -142.4 133.09 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.723 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -96.16 -23.49 16.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -130.08 -174.41 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 129' ' ' SER . 60.3 m -160.74 -29.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' CYS . 61.1 tttt 52.38 172.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.298 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.403 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.9 p -64.36 148.8 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.676 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -139.98 162.46 35.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 135' ' ' GLY . 13.2 tm-20 -74.41 141.22 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.342 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 134' ' ' GLU . . . 54.61 -145.25 28.6 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.94 135.77 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.15 165.92 14.68 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.431 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -110.1 132.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.004 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.0 m-85 -104.87 126.29 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.376 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -109.79 146.53 34.84 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.212 0.32 . . . . 0.0 111.162 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -84.98 -34.09 22.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.191 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 142' ' ' LEU . 93.8 mt -109.42 148.73 38.66 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.966 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.453 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 63.4 Cg_endo -67.7 162.12 40.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.118 1.879 . . . . 0.0 111.354 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 6.0 m-80 81.52 8.65 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.726 0.641 . . . . 0.0 110.522 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 4.6 m-85 76.53 43.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.306 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -128.05 -173.56 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.355 . . . . 0.0 110.414 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.34 126.57 0.01 OUTLIER Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' C ' ' O ' ' A' ' 147' ' ' GLY . 70.7 ttt180 -8.74 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.327 0.663 . . . . 0.0 112.259 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 15.7 mp0 -103.64 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.777 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -138.93 142.15 38.47 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.203 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -103.47 116.4 32.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 151' ' ' LEU . 10.5 mp -76.38 131.66 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.519 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 25.7 t0 -103.52 -174.21 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 65.6 tttm -64.0 -33.25 75.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -54.69 133.45 46.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.748 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.23 -175.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 55.4 m-85 -142.74 83.43 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.358 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.522 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 80.4 mtp180 -77.89 -13.9 59.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.875 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -139.98 157.65 68.93 Favored Pre-proline 0 C--O 1.223 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.263 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.447 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.61 -41.84 66.81 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.5 2.133 . . . . 0.0 113.169 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -80.57 3.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.464 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 71.9 m-20 -64.21 -33.14 75.11 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.267 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.911 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 21.9 p90 -92.5 29.89 1.63 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.65 70.49 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.84 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.911 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.5 122.5 32.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.721 -0.282 . . . . 0.0 111.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.23 73.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.615 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.6 p -151.22 158.68 34.45 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.988 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.99 2.37 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 122.479 2.119 . . . . 0.0 112.081 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.19 48.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.9 p -89.51 146.33 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 109.789 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.631 HE22 ' CE ' ' A' ' 119' ' ' MET . 78.4 mm-40 -99.98 -144.37 0.33 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.55 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.597 ' HA ' HG23 ' A' ' 118' ' ' ILE . 6.5 p -82.89 -142.83 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.519 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 179.73 177.96 0.59 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.395 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.5 ptt180 -159.15 142.15 14.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.842 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.619 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -57.46 142.28 44.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.831 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.33 135.83 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.943 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -131.91 132.61 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.273 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.306 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t -63.17 -66.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.666 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 4' ' ' THR . 8.7 ptmm? -142.36 36.91 1.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.354 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 3' ' ' LYS . 65.9 p 50.26 -136.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -114.29 4.97 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.595 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.2 p -84.71 134.2 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.663 0.268 . . . . 0.0 110.391 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.93 129.63 45.73 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -118.09 141.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -134.75 125.02 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.512 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.66 125.2 50.29 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.83 141.66 51.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.832 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 96.7 mt-10 -60.48 -25.91 66.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.368 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -118.93 -160.58 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' C ' ' ND2' ' A' ' 15' ' ' ASN . 12.2 pttt -111.51 174.87 5.66 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.7 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 74.32 10.95 4.23 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.421 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.1 m-85 60.67 37.82 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.988 0.423 . . . . 0.0 110.806 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.7 ' NE2' HD22 ' A' ' 15' ' ' ASN . 17.5 pt20 -111.62 146.54 37.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.618 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.832 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.2 p 133.29 -135.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 124.988 1.43 . . . . 0.0 110.264 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.832 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.6 ptp180 -118.47 33.17 5.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.269 . . . . 0.0 110.309 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 156.64 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 19.5 m-85 -95.82 -170.63 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.87 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -158.76 51.81 0.4 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.9 m -142.04 151.01 42.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.211 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.1 p-10 -89.88 138.26 31.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -174.23 -177.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.379 . . . . 0.0 110.095 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -132.72 125.9 31.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.966 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.1 m -141.81 160.1 40.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.1 84.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.397 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 36.5 p-10 -171.24 134.0 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -80.28 12.57 2.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.439 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.16 -19.1 30.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.752 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 18.2 m -66.76 -42.22 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.362 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 48.8 m-85 -78.72 -32.33 46.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.25 132.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 p -63.17 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -74.51 163.95 27.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' C ' HD22 ' A' ' 38' ' ' ASN . 16.8 t -150.46 150.17 30.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.702 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -120.48 -138.65 0.33 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -34.38 166.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.447 0.642 . . . . 0.0 110.921 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 62' ' ' LEU . 75.4 mt -144.95 163.7 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.721 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -129.74 122.48 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.5 t -124.91 126.03 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.88 87.71 2.8 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.988 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 87.97 132.81 4.01 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.8 156.31 11.57 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m -105.58 114.9 29.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 39.9 m95 -94.17 151.13 19.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.023 0.44 . . . . 0.0 110.063 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 134.51 54.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.4 t -119.44 133.68 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -99.71 168.51 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -84.35 -36.53 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.352 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -121.87 164.34 25.81 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.9 Cg_exo -63.31 148.94 92.49 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.841 1.694 . . . . 0.0 111.75 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.3 t-20 87.96 21.36 0.05 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' CE2' ' NH2' ' A' ' 84' ' ' ARG . 3.7 m-85 55.2 63.67 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.268 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.89 161.72 36.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.225 0.536 . . . . 0.0 110.663 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.62 -152.89 21.73 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.667 ' CD1' ' NH2' ' A' ' 148' ' ' ARG . 3.3 m-30 -51.5 173.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.258 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtt -145.47 108.65 4.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.219 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.4 m-85 -106.5 127.12 53.06 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -95.33 123.45 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.706 ' CG ' ' HE1' ' A' ' 73' ' ' TRP . 10.3 mp -112.95 94.0 27.51 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.688 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.54 161.32 28.21 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.058 1.838 . . . . 0.0 111.422 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -43.96 106.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.953 0.406 . . . . 0.0 110.533 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.99 161.13 28.67 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -103.12 136.52 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 110.449 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -131.99 97.11 18.91 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -77.9 -23.7 9.13 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 121.566 1.511 . . . . 0.0 112.249 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.56 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 68.9 mt-10 -137.94 160.47 39.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.196 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -70.86 17.59 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.21 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.9 pt20 -98.86 -19.88 17.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -104.86 -11.97 16.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.168 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.706 ' HE1' ' CG ' ' A' ' 62' ' ' LEU . 60.5 t90 -97.5 2.57 50.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 110.898 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.1 mtm 46.27 56.47 6.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.78 178.02 51.21 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.46 -71.08 0.74 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.853 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -133.46 42.56 2.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.62 -178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 39.94 19.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -78.18 110.37 13.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' CG1' ' A' ' 49' ' ' VAL . 98.9 mt -153.87 129.67 10.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -149.05 52.83 0.97 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.494 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER 163.76 140.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 0.0 110.608 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 p -144.77 137.47 26.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.625 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 38.7 ttm180 -141.14 147.08 37.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.487 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.3 137.98 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' THR . 16.5 t -136.82 138.04 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -118.33 161.88 19.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp -80.69 131.94 59.38 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.479 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.52 147.46 40.95 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.076 1.851 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -63.94 151.61 42.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.979 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 152.35 26.43 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 94' ' ' TYR . . . -122.81 -127.79 3.32 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 67.62 -41.66 0.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.948 0.44 . . . . 0.0 110.751 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 92' ' ' GLY . 3.2 m-85 37.38 77.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.97 131.95 49.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.844 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.5 tt -126.42 136.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.051 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' CYS . 25.7 mt-30 -121.77 117.06 25.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.481 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD12 ' SD ' ' A' ' 124' ' ' MET . 25.7 pt -115.3 139.19 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.628 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 27.7 m-85 -111.99 133.71 54.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.385 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.77 -33.99 67.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.937 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.16 161.72 13.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.664 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -73.52 -48.52 17.78 Favored Glycine 0 N--CA 1.462 0.412 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.872 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.0 32.28 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.426 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 102' ' ' GLY . 39.6 m-85 51.23 77.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -157.22 -167.57 2.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.35 -135.67 47.91 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.92 136.36 33.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 110.379 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.628 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 43.1 ttp -127.91 142.08 51.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.475 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 130.74 56.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.277 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 111' ' ' THR . 83.4 tt0 -131.02 143.19 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.56 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 11.9 m 139.07 155.76 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.927 1.392 . . . . 0.0 110.442 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 111' ' ' THR . 15.0 t -98.53 154.52 17.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' OE2' ' NE2' ' A' ' 121' ' ' GLN . 14.4 pt-20 159.94 167.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.82 124.65 31.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.544 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 56.6 m -121.99 111.58 32.37 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.244 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' ' OG ' ' A' ' 172' ' ' SER . 72.9 Cg_endo -80.48 -57.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.729 1.619 . . . . 0.0 111.576 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -123.01 120.29 32.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.749 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.4 pt -61.11 -50.57 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.937 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.411 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.8 ptt? -57.99 14.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 111.649 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' H ' ' C ' ' A' ' 118' ' ' ILE . 74.2 tt0 -127.57 -54.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 109.889 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.544 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 47.0 tt0 -79.03 -34.91 43.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.946 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.99 1.24 13.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.992 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 58.05 28.62 16.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.455 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' HD12 ' A' ' 98' ' ' ILE . 8.9 ptm -131.31 137.44 48.8 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -104.89 5.14 32.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.187 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.88 159.58 40.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -139.44 130.92 34.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -100.18 -23.95 14.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -147.26 136.9 22.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.86 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 19.9 m -115.18 -16.3 11.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.443 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt 47.9 -171.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.329 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.87 142.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.349 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.16 -127.99 0.29 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -160.46 131.48 5.62 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.57 -102.26 0.31 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.85 139.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.611 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -136.43 162.55 32.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.85 131.67 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.232 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.609 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -104.46 126.57 51.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.36 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 142.13 41.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.26 0.35 . . . . 0.0 111.273 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -79.24 -35.13 42.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.16 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 149.17 38.6 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.21 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 66.5 Cg_endo -68.04 159.92 50.89 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.883 1.722 . . . . 0.0 111.173 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.481 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.2 m-80 83.34 10.4 0.52 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.96 0.787 . . . . 0.0 110.563 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.54 45.01 0.19 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.363 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 147' ' ' GLY . 79.4 mtp180 -130.46 -172.22 2.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.98 129.63 0.01 OUTLIER Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' NH2' ' CD1' ' A' ' 58' ' ' TYR . 63.7 ttt180 -8.65 127.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.421 0.718 . . . . 0.0 112.897 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 9.9 mp0 -103.23 167.35 9.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -132.52 136.86 46.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.026 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 61' ' ' ILE . 57.1 tp -95.77 126.58 41.13 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.74 141.91 28.65 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.521 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 53.0 t0 -134.28 -125.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -77.85 -147.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.64 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 58.75 156.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.115 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -94.67 1.03 55.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.208 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 54.9 m-85 55.59 71.89 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.419 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -62.48 -42.17 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.694 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -120.6 158.51 51.42 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.45 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 13.3 Cg_endo -56.46 -39.24 92.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.09 1.86 . . . . 0.0 113.133 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.8 pt -78.66 3.23 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 44.2 t0 -66.62 -32.03 73.1 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.077 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.833 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -93.28 27.77 2.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 21.44 59.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.942 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.833 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -93.34 124.12 37.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.35 -29.97 70.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.553 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.32 157.26 33.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.21 5.43 1.49 Allowed 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 123.116 2.544 . . . . 0.0 112.132 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.63 49.43 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.482 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.609 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -89.55 150.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.048 0.452 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.2 mm-40 -100.38 -146.03 0.34 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.92 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 118' ' ' ILE . 7.3 p -80.37 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.258 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.526 ' N ' ' OG ' ' A' ' 172' ' ' SER . 19.8 p90 179.31 178.05 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.45 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.719 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.0 ptt180 -162.89 145.99 10.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.017 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.581 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -56.69 150.87 15.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.629 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.0 mt -88.77 65.11 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.05 128.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.192 0.52 . . . . 0.0 110.083 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.339 -179.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -124.01 -98.37 0.43 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -79.06 -74.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.669 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 84.5 m -136.75 145.71 44.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.568 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -48.57 155.85 1.4 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.515 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -87.62 135.82 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 110.205 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -130.58 131.85 45.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.4 142.72 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -136.25 127.15 27.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.297 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 126.08 48.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.091 0.472 . . . . 0.0 110.299 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -125.29 142.85 51.26 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.679 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.2 mt-10 -59.91 -25.41 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.116 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.4 m-20 -118.99 -160.32 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 10.8 pttt -114.15 179.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.556 0.535 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.692 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.7 m-80 75.32 10.29 3.61 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.347 0.404 . . . . 0.0 111.399 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.3 m-85 61.16 46.12 8.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.692 ' NE2' HD22 ' A' ' 15' ' ' ASN . 12.7 pt20 -113.28 -160.11 0.71 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.825 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.9 t 82.85 -140.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 123.57 0.544 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.5 ptp85 -119.83 33.89 5.44 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -71.34 157.01 38.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.234 0.54 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -93.29 -171.91 2.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.451 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -156.86 51.91 0.5 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.33 153.55 42.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 44.8 p-10 -90.71 139.4 30.76 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -171.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.12 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -133.62 124.87 27.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.009 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 m -133.74 154.33 51.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.37 96.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 34.3 p-10 -171.58 131.07 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.06 0.457 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -80.86 13.61 2.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -57.56 -25.95 60.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.337 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.55 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 19.3 m -66.17 -42.76 88.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -79.49 -32.38 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.62 131.77 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 p -63.69 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.252 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -74.91 166.11 24.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.711 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' C ' HD22 ' A' ' 38' ' ' ASN . 5.9 t -147.85 147.32 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -120.45 -140.04 0.34 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.1 163.39 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 O-C-N 123.847 0.717 . . . . 0.0 110.957 -179.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.4 mt -144.37 163.27 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.707 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' N ' HG22 ' A' ' 40' ' ' ILE . 23.8 tttt -130.2 118.68 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 69.7 t -115.04 121.44 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -121.58 89.48 3.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.48 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 130.36 -136.12 8.7 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' HG22 ' A' ' 6' ' ' THR . . . -54.15 -157.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 47' ' ' TRP . 28.6 m -101.77 172.84 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.807 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.673 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -148.07 144.12 27.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -120.06 131.74 55.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.883 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.28 131.85 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -99.33 169.45 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 58' ' ' TYR . 5.3 tt0 -87.1 -34.95 18.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.031 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.25 159.82 41.87 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.258 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.5 Cg_exo -62.0 147.18 95.66 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.877 1.718 . . . . 0.0 111.764 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.1 t-20 88.01 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.598 0.561 . . . . 0.0 111.029 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 46.83 59.38 4.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.747 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.408 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 122.72 -153.86 16.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' NH1' ' A' ' 148' ' ' ARG . 3.2 m-85 -47.05 170.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mpt? -141.9 105.61 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.9 m-85 -105.8 124.08 48.99 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.789 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -96.79 121.53 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.115 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 61' ' ' ILE . 6.5 mp -121.31 87.4 44.61 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -68.45 169.01 18.06 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.857 2.372 . . . . 0.0 111.445 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.512 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -46.05 105.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.467 . . . . 0.0 110.49 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.2 159.82 27.26 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.79 135.5 43.22 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.35 96.71 20.96 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.226 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.6 -23.62 12.66 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.671 1.581 . . . . 0.0 112.285 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 71' ' ' GLN . 67.3 mt-10 -132.07 155.17 48.56 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.135 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -73.94 13.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.0 mt-30 -104.47 -13.92 15.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.055 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -92.26 -14.07 29.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.712 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' NE1' ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -110.08 20.7 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.107 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 mtm 48.56 56.86 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.776 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.46 171.78 54.76 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 -72.54 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.943 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.05 39.48 3.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.106 -178.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 39.77 21.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.034 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.671 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 mmp_? -76.15 107.86 8.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.191 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' ARG . 20.7 mt -153.58 127.49 8.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 t -135.25 -0.13 2.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.92 149.88 30.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.711 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.0 p -145.18 138.61 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.92 150.82 36.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.27 142.74 31.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -128.94 134.88 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -107.11 158.33 17.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.865 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.85 138.68 27.72 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.093 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.38 172.08 16.82 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.686 2.258 . . . . 0.0 111.697 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -45.35 132.93 7.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.99 -149.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.49 -133.69 11.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -105.77 178.69 4.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' O ' ' CB ' ' A' ' 112' ' ' THR . 90.1 m-85 -134.26 95.36 3.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.975 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 30.5 ttmt -97.61 128.02 44.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.58 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.1 tt -128.6 138.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' OE1' HG11 ' A' ' 132' ' ' VAL . 34.5 mt-30 -120.85 121.24 37.7 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.483 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.421 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.9 pt -118.47 133.53 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.05 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -105.3 135.13 47.23 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.095 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -59.09 -37.1 76.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.974 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -100.15 163.13 12.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.86 -18.48 63.34 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.07 27.21 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.349 . . . . 0.0 110.409 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 57.3 m-85 55.24 63.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -155.53 161.16 40.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.33 -133.06 11.43 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -92.98 131.16 38.22 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.195 0.522 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 49.4 ttp -127.17 141.85 51.64 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.337 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -115.1 131.33 56.96 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.5 tt0 -131.66 144.92 51.37 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.8 m 138.65 156.2 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 125.12 1.513 . . . . 0.0 110.573 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' THR . 11.2 t -100.24 155.69 17.63 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 121' ' ' GLN . 13.8 pt-20 157.59 169.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.58 124.06 31.7 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 60.3 m -121.91 111.24 32.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.49 -57.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.136 1.89 . . . . 0.0 111.976 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -123.77 121.41 35.38 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.7 pt -62.38 -51.72 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.972 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.46 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.4 ptt? -56.88 14.48 0.0 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.607 0.241 . . . . 0.0 111.579 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.4 tt0 -127.72 -53.31 1.34 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.9 tt0 -79.87 -34.01 39.56 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.788 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -118.13 1.99 11.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.922 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 56.81 30.65 18.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.73 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.431 ' N ' ' HA ' ' A' ' 119' ' ' MET . 8.5 ptm -132.61 136.05 46.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.101 0.477 . . . . 0.0 109.815 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -103.76 6.28 36.67 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -156.24 161.17 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.56 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.1 mt -141.55 132.24 26.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -99.82 -24.3 14.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.079 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 1.8 t -143.95 133.4 23.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.886 0.374 . . . . 0.0 111.561 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 74.86 1.46 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.176 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HZ2' ' HD1' ' A' ' 104' ' ' PHE . 22.8 pttm -99.22 -177.57 3.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.125 0.488 . . . . 0.0 110.744 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 HG11 ' OE1' ' A' ' 97' ' ' GLN . 60.7 t 47.23 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -97.65 -161.74 0.9 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.83 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.519 ' CB ' ' H ' ' A' ' 95' ' ' LYS . 49.9 tp10 -154.13 131.21 11.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.176 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.47 -95.08 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' GLU . 13.8 p -161.56 140.63 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -140.59 162.92 34.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.058 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 76.8 mt -118.44 137.61 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.469 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.42 130.69 55.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -112.47 146.49 38.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 111.102 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.89 -33.96 45.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.041 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.51 147.01 35.19 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -66.65 159.65 50.0 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.301 2.0 . . . . 0.0 111.512 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.1 m-80 82.4 9.64 0.73 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.895 0.747 . . . . 0.0 110.549 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.6 m-85 76.51 35.1 0.44 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -114.29 -179.22 3.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 -157.75 41.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.613 ' NH1' ' CE2' ' A' ' 58' ' ' TYR . 59.2 ttt180 -75.44 157.76 33.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.588 0.232 . . . . 0.0 110.459 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -121.63 147.02 46.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.486 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 43.4 m-85 -127.72 133.6 49.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.4 tp -103.54 125.75 50.27 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -105.06 78.76 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.664 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 66.4 t0 -66.02 -37.37 85.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.186 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.98 155.8 37.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -96.38 6.48 48.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.79 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -149.43 152.25 35.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' OH ' ' CA ' ' A' ' 152' ' ' LEU . 96.4 m-85 -150.95 99.94 2.75 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.275 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 46.9 mmm-85 -63.63 -43.91 95.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.941 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -123.24 158.81 57.06 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.583 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.7 Cg_endo -55.82 -44.73 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.857 1.705 . . . . 0.0 113.1 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 165' ' ' ALA . 10.7 pt -74.31 2.35 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.769 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 54.3 t0 -67.12 -32.11 73.03 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.95 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.836 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.1 p90 -93.26 28.17 2.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.826 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.69 21.95 58.95 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.96 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.836 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -94.85 125.18 39.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.024 0.44 . . . . 0.0 111.677 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.55 68.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.535 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -151.05 163.08 24.89 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.387 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.1 7.06 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.084 2.523 . . . . 0.0 111.911 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.48 111.05 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.613 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.576 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -153.34 147.34 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -101.4 -146.48 0.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.581 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.5 t -80.8 -141.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 19.5 p90 179.53 178.64 0.52 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.55 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.78 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.8 ptt180 -161.73 144.41 11.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.084 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -60.28 142.17 55.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.795 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.46 139.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.99 133.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.33 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 t -67.74 -40.52 84.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.69 94.53 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -136.16 -101.0 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.12 -15.91 30.94 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 6' ' ' THR . 1.0 OUTLIER -79.79 123.09 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.404 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -128.01 129.25 46.41 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 tt -119.12 143.13 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.88 125.77 29.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.145 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -118.09 121.35 40.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.175 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -120.42 141.84 49.76 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 18' ' ' VAL . 99.7 mt-10 -58.9 -26.88 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' H ' HG21 ' A' ' 18' ' ' VAL . 88.1 m-20 -117.03 -160.75 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 14.8 pttt -111.8 175.73 5.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.653 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 75.84 13.21 2.84 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.21 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 56.8 53.92 7.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.653 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.3 pt20 -123.29 -161.42 0.96 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 19' ' ' ARG . 8.4 t 87.38 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 123.423 0.452 . . . . 0.0 110.714 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.779 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.5 ptp180 -117.11 29.25 8.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.062 0.458 . . . . 0.0 110.568 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 163.22 26.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.56 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -151.38 84.56 1.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.428 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -40.52 86.36 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.722 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' A' ' 21' ' ' TYR . 18.7 t -134.08 129.45 36.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 40.0 p-10 -84.65 131.14 34.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.4 m -172.05 178.96 2.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.84 123.74 29.72 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.764 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.11 166.52 26.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.739 0.304 . . . . 0.0 110.324 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.22 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.144 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' HIS . 37.2 p-10 -171.77 125.09 0.57 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.882 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.04 17.17 0.06 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.553 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.4 p80 -57.86 -15.76 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.6 p -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 30.1 m-85 -80.5 -38.18 30.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.0 110.189 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -162.02 126.68 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.787 -178.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.1 p -79.9 16.76 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.962 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' LEU . 13.7 mmm-85 -159.51 145.06 15.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 5.7 t -144.11 146.0 32.51 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.281 0.562 . . . . 0.0 110.877 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' SER . 17.2 m-20 -119.02 -137.26 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.24 166.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.611 0.57 . . . . 0.0 110.882 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 41' ' ' LYS . 75.9 mt -146.32 165.26 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.234 0.54 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' HG22 ' A' ' 40' ' ' ILE . 16.2 ttmt -133.36 118.05 18.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.207 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -118.32 128.27 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.82 87.54 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.89 142.08 7.01 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.5 162.21 1.24 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 p -96.63 167.51 11.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.133 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 45.2 m95 -144.62 139.54 28.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -118.05 127.31 53.68 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.38 135.55 60.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -101.33 172.6 6.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.596 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 1.5 mp0 -99.14 -30.61 12.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 1.6 mmp_? -116.46 139.01 24.87 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.602 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.9 Cg_exo -47.66 148.29 5.98 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.744 1.629 . . . . 0.0 111.933 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.1 t-20 87.6 33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.582 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 1.2 m-85 40.84 58.33 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.5 135.14 24.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 124.59 -155.71 18.4 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.619 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 3.3 m-85 -43.54 167.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.9 mtt -135.27 131.59 36.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.387 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 56.1 m-85 -134.68 120.57 19.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.288 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -98.02 127.8 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 61' ' ' ILE . 9.3 mp -121.45 88.22 45.97 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.11 162.29 42.34 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.609 2.206 . . . . 0.0 111.056 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.533 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -42.88 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.35 155.78 24.06 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -99.72 136.03 40.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 19.1 m-85 -129.26 82.64 67.7 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.147 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.33 -38.19 91.71 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.641 2.228 . . . . 0.0 112.257 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.3 mt-10 -121.62 162.47 20.62 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 110.609 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -73.6 9.44 1.4 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.942 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -101.66 -10.59 19.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.09 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -96.04 -14.11 23.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.508 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -113.0 13.61 19.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.109 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.3 mtm 49.46 56.69 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.933 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.482 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.76 177.52 51.71 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.7 tt -125.0 -71.45 0.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.813 0.34 . . . . 0.0 111.127 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.852 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.12 44.84 2.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 -178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HB3' ' HE ' ' A' ' 36' ' ' ARG . 79.6 m-20 40.78 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.2 tpm_? -79.86 114.35 18.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.153 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 73' ' ' TRP . 59.9 mt -152.76 131.37 12.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -126.62 -125.65 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 t -38.34 153.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.821 0.343 . . . . 0.0 111.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -148.58 143.02 26.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.365 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.489 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 60.9 ttm-85 -144.35 149.71 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.45 139.4 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 48' ' ' ALA . 52.2 t -128.51 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.616 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 87' ' ' HIS . 3.4 m-70 -121.35 119.57 32.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.789 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -77.75 142.88 66.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.485 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.94 149.76 10.92 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.875 1.717 . . . . 0.0 111.915 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -70.46 157.54 37.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.273 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.9 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.74 0.39 18.45 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 112' ' ' THR . 58.2 tt0 -116.78 -44.72 2.81 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.742 0.306 . . . . 0.0 110.277 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 93.5 m-85 39.99 90.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.253 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.2 ttpt -105.02 133.12 50.33 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.51 140.81 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.247 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -122.0 109.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.2 pt -104.73 132.92 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.401 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 49.8 m-85 -99.15 176.94 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.203 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -102.78 -40.57 6.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.97 164.83 11.63 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.598 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.93 72.9 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.06 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -82.39 34.82 0.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.312 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 52.16 72.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.941 0.401 . . . . 0.0 111.142 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.0 m -157.49 160.99 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.02 -133.67 11.47 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -89.35 133.86 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.605 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.4 ttp -130.23 135.84 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.371 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -116.03 135.11 54.25 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.482 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.6 tt0 -134.21 147.49 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.066 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.3 m 139.93 160.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.846 1.341 . . . . 0.0 110.279 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 1.6 t -100.81 156.61 17.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.0 mm-40 155.41 173.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.83 123.32 33.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 31.0 m -118.01 110.09 40.29 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.6 Cg_endo -79.52 -58.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.031 1.821 . . . . 0.0 111.971 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.9 m -126.73 119.46 26.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.132 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.7 pt -59.58 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.213 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.493 ' H ' HG13 ' A' ' 118' ' ' ILE . 25.7 ptt? -58.02 14.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.375 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.702 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.4 tp10 -127.11 -54.22 1.39 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -79.39 -33.98 42.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.826 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.23 2.65 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 57.04 29.47 16.54 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.359 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' MET . 8.7 ptm -132.22 137.35 47.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -105.21 6.36 32.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.003 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.7 162.11 38.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 129' ' ' SER . 11.2 mt -143.62 137.89 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.608 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 128' ' ' HIS . 14.3 m-70 -110.47 18.34 19.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -176.55 -171.23 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 0.8 OUTLIER 179.51 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.313 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 130' ' ' CYS . 5.2 ttpp 41.58 -163.67 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.434 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 132' ' ' VAL . 12.6 p -71.27 132.27 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.206 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -110.41 -99.63 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.323 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 35.3 tp10 -170.49 146.8 2.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 40.65 -114.14 0.5 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -148.29 131.75 8.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.645 0.259 . . . . 0.0 110.622 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.703 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.62 167.25 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.475 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 78.4 mt -114.86 131.34 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -103.04 125.82 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -110.56 139.29 45.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.093 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -78.31 -32.24 49.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.077 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.46 147.28 36.04 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.669 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 64.6 Cg_endo -67.01 160.57 46.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.013 1.808 . . . . 0.0 110.921 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.507 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 7.9 m-80 83.19 7.76 0.71 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.793 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.516 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 m-85 78.31 37.69 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.591 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -122.11 -169.98 1.98 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.23 121.24 0.01 OUTLIER Glycine 0 C--N 1.329 0.192 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.619 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 60.8 ttp180 -7.19 119.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.094 0.558 . . . . 0.0 112.127 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.8 172.79 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.469 -178.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 35.5 m-85 -137.82 140.01 40.28 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.608 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.56 126.21 44.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.5 mp -91.05 137.14 32.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.337 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 155' ' ' LYS . 48.3 t0 -111.55 35.26 3.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 54.69 6.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.733 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 153' ' ' ASP . 62.5 tttp -74.34 138.02 43.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 57.0 mp0 -47.42 138.57 7.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.319 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 39.1 m-85 -116.81 77.29 1.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -69.1 -24.07 64.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.348 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -140.79 166.11 25.11 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.115 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 25.9 Cg_exo -59.99 -46.4 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.972 1.781 . . . . 0.0 113.206 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.53 -1.05 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.804 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.63 -36.96 84.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.338 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.927 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 26.5 p90 -99.51 27.06 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.576 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.09 61.83 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.036 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.927 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -92.05 121.45 33.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.009 0.433 . . . . 0.0 111.484 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.63 78.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.778 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -147.1 153.4 45.14 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.414 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.98 3.88 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.844 2.363 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.28 50.76 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.382 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 139' ' ' PHE . 7.1 p -86.48 151.46 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.435 ' HB3' ' H ' ' A' ' 172' ' ' SER . 75.9 mm-40 -103.33 -145.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.157 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.579 ' HA ' HG23 ' A' ' 118' ' ' ILE . 8.3 p -81.51 -144.5 0.05 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.93 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.461 ' N ' ' OG ' ' A' ' 172' ' ' SER . 16.7 p90 -179.77 178.15 0.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.306 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.703 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 27.1 ptt180 -163.74 146.28 9.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.218 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.701 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.21 147.75 12.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.475 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 69.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.741 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 177' ' ' VAL . 23.5 m -64.19 109.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.978 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.537 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 4' ' ' THR . 37.8 m -59.98 -44.17 94.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.643 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 51.08 -81.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 2' ' ' SER . 14.7 t -136.26 166.99 22.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.84 50.29 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.564 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.0 t -93.4 143.03 26.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 110.287 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -131.51 132.83 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.708 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.453 HG21 ' CE3' ' A' ' 47' ' ' TRP . 11.1 tt -120.2 145.34 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.348 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -138.75 127.49 23.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -117.12 123.9 47.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -122.36 143.23 49.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.098 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' H ' HG11 ' A' ' 18' ' ' VAL . 99.2 mt-10 -65.29 -29.53 70.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' LYS . 95.6 m-20 -129.0 125.6 37.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.796 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.564 ' O ' ' O ' ' A' ' 13' ' ' ASP . 13.3 pttt -41.31 175.74 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.943 0.777 . . . . 0.0 110.476 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.726 HD22 ' NE2' ' A' ' 17' ' ' GLN . 3.0 m-80 77.47 5.21 3.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.445 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 2.0 m-85 62.55 36.8 13.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.726 ' NE2' HD22 ' A' ' 15' ' ' ASN . 9.5 pt20 -112.65 143.87 43.11 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.615 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 19' ' ' ARG . 11.0 p 136.0 -136.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 125.332 1.645 . . . . 0.0 110.676 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 18' ' ' VAL . 16.9 ptp180 -120.33 35.08 4.98 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.782 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 16' ' ' PHE . 6.2 ptt85 -69.25 -162.86 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.335 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.25 -167.99 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.08 52.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -140.74 146.02 37.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 45.0 p-10 -88.03 139.42 30.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.6 t -176.4 -173.54 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -137.25 128.46 27.9 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.022 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.48 160.22 41.46 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.573 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.59 -44.86 73.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.293 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -171.43 133.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -74.3 10.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.694 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -61.1 -16.31 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.443 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 17.0 m -63.88 -37.91 89.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.553 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -88.3 -35.18 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.873 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -160.06 118.64 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 36' ' ' ARG . 23.2 t -73.07 18.36 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 34' ' ' LEU . 86.0 mtt180 -160.14 143.48 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.571 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 6.1 t -144.5 146.37 32.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 39' ' ' SER . 6.1 m120 -118.84 -137.17 0.34 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -37.14 170.57 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.197 0.522 . . . . 0.0 110.27 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 41' ' ' LYS . 79.1 mt -148.19 169.15 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.189 0.519 . . . . 0.0 110.837 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.641 ' N ' HG22 ' A' ' 40' ' ' ILE . 2.8 tttm -137.42 119.26 15.21 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.63 131.5 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.398 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.03 87.67 2.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.076 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 93.25 126.76 4.32 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.65 166.96 21.48 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 14.7 t -116.13 122.94 46.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.082 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 20.1 m95 -94.57 154.75 17.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.87 132.88 55.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.441 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -120.82 134.9 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.497 ' CD2' ' SD ' ' A' ' 59' ' ' MET . 68.7 m-85 -97.2 161.56 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.91 -40.83 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.163 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -119.25 155.61 53.47 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.412 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.3 Cg_endo -59.98 150.66 77.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.695 2.264 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.6 t-20 87.13 22.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.819 0.7 . . . . 0.0 110.391 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' H ' ' CB ' ' A' ' 82' ' ' SER . 25.2 m-85 57.11 62.65 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.513 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.68 159.1 42.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 95.55 -155.57 21.33 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -67.39 153.95 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.274 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.497 ' SD ' ' CD2' ' A' ' 50' ' ' TYR . 3.0 mmt -118.96 106.0 12.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.014 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' C ' HD12 ' A' ' 61' ' ' ILE . 72.1 m-85 -96.19 131.57 42.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.243 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.813 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -105.96 130.0 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 73' ' ' TRP . 5.3 mp -115.65 95.22 42.94 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 165.51 31.25 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.614 2.209 . . . . 0.0 112.225 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -44.53 102.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.598 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.08 162.35 29.84 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 41' ' ' LYS . 84.1 tt0 -103.27 137.47 41.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 10.2 m-85 -128.81 92.72 39.28 Favored Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.53 -5.8 13.42 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.625 2.217 . . . . 0.0 111.923 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 60.5 mt-10 -154.54 153.33 31.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 51.4 p90 -61.39 -45.12 95.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.913 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 6.6 pt20 -46.0 -17.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.6 ttt180 -102.45 -19.02 15.09 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 59.8 t90 -97.83 2.4 49.3 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.0 mtm 49.81 55.02 10.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.86 -179.36 50.08 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.04 -73.68 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.959 0.409 . . . . 0.0 110.777 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -128.8 47.13 2.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.156 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 38.93 21.4 0.0 OUTLIER 'General case' 0 C--N 1.34 0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.491 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 77' ' ' ASN . 7.3 tpp180 -85.27 116.4 23.59 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.175 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 49' ' ' VAL . 57.3 mt -153.18 128.73 10.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.447 . . . . 0.0 110.777 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 82' ' ' SER . 35.0 t -125.92 -130.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 4.5 m -33.13 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.774 0.321 . . . . 0.0 110.747 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.5 p -148.68 143.68 26.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.299 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -142.18 147.28 36.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.95 141.86 35.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.267 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 46' ' ' THR . 45.0 t -132.05 135.3 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -103.42 163.66 12.14 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.126 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 88' ' ' LEU . 9.4 mp -92.88 116.3 66.28 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.985 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.86 163.1 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.204 1.936 . . . . 0.0 112.484 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' GLY . 25.8 t -71.2 164.97 24.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.49 63.35 0.11 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' SER . . . -62.58 -107.08 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.58 ' O ' ' O ' ' A' ' 94' ' ' TYR . 34.8 tp60 -143.29 -21.0 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.58 ' O ' ' O ' ' A' ' 93' ' ' GLN . 47.5 m-85 52.7 133.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.643 0.735 . . . . 0.0 110.579 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -168.8 124.37 0.92 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 17.9 tt -121.27 131.13 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.197 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 130' ' ' CYS . 76.7 mt-30 -118.8 118.08 30.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.4 pt -118.71 142.14 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.612 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 6.7 m-85 -116.24 133.37 56.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.165 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.11 -31.98 53.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.269 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -103.56 165.07 11.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -79.58 -46.36 8.01 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.05 30.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 102' ' ' GLY . 66.1 m-85 51.58 76.69 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 110.411 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 m -156.49 -165.29 1.85 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.643 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.54 -138.32 48.45 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 21.8 tm0? -85.95 140.18 30.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.612 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 18.1 ttp -126.76 138.26 53.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 60.9 m-85 -116.08 130.99 57.06 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.556 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -132.23 147.08 52.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.4 m 137.61 154.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 125.196 1.56 . . . . 0.0 110.262 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.495 ' O ' HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -97.46 159.63 14.81 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 9.2 mt-10 153.78 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 4.4 p30 -80.22 125.46 29.88 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.54 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 51.2 m -122.98 111.79 30.65 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.556 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.95 -60.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.675 2.25 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -122.19 121.25 36.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.723 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.9 pt -63.25 -50.49 78.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' HG13 ' A' ' 118' ' ' ILE . 13.2 ptp -55.71 13.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' A' ' 118' ' ' ILE . 81.5 tt0 -128.29 -52.58 1.29 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.46 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.54 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 49.9 tt0 -77.91 -35.62 50.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.769 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -119.42 2.4 11.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.804 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 56.49 35.05 25.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.478 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -133.04 135.21 45.26 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -101.34 4.73 41.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.874 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -157.45 163.29 38.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 110.25 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 129' ' ' SER . 14.4 mt -143.12 134.88 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.791 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -98.79 -18.83 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 1.4 p -134.48 -174.41 3.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 129' ' ' SER . 6.8 m -165.22 -31.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.924 0.393 . . . . 0.0 110.274 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 58.72 166.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.107 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.443 ' C ' HD13 ' A' ' 133' ' ' LEU . 12.2 p -76.08 140.49 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 123.455 0.472 . . . . 0.0 110.06 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.907 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -127.95 179.87 5.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.09 151.62 26.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.63 -128.91 37.06 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.47 135.02 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 0.0 110.168 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.785 ' HE1' ' N ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -120.62 155.26 34.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.656 179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.77 134.93 48.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.76 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.79 131.1 55.29 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.507 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 80.1 m-85 -110.47 142.46 42.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.943 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -75.92 -35.83 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.757 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.97 147.48 36.29 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.456 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 51.8 Cg_endo -65.39 161.57 37.45 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.219 1.946 . . . . 0.0 111.356 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 143' ' ' PRO . 4.1 m-80 79.4 10.86 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.781 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 7.6 m-85 76.04 40.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.18 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -119.93 179.54 4.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.752 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.17 -156.93 38.29 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.558 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.0 ttp180 -70.37 164.53 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.397 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 140' ' ' TYR . 81.0 mt-30 -133.74 149.24 51.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 110.875 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 6.4 m-85 -134.39 137.91 44.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.25 127.99 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.55 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.8 mp -91.75 97.11 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.66 -104.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -159.93 77.11 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.463 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 156' ' ' GLU . 98.8 mttt -140.72 13.94 2.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 155' ' ' LYS . 42.1 tp10 60.39 148.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.118 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -126.84 147.25 50.04 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -145.72 -2.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -149.66 158.18 37.83 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.577 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.555 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.2 Cg_endo -55.49 -41.99 72.49 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.399 2.066 . . . . 0.0 113.169 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 165' ' ' ALA . 17.6 pt -85.74 2.8 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -64.11 -34.49 78.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.139 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.852 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.7 p90 -91.88 28.69 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.643 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.35 56.95 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.704 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.852 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -97.57 124.94 42.03 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.195 0.522 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.67 67.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.856 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.45 163.26 27.1 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.408 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.48 0.19 3.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.19 2.593 . . . . 0.0 111.555 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.82 110.94 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.54 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.1 p -154.21 147.61 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.433 ' HA ' HD11 ' A' ' 118' ' ' ILE . 80.3 mm-40 -100.11 -144.64 0.33 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.504 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.9 t -80.02 -139.88 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.196 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 15.5 p90 178.34 -179.62 0.31 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.368 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.712 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 23.3 ptt180 -162.43 142.73 9.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.785 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.83 146.55 53.74 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.592 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.11 57.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.022 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 94' ' ' TYR . 29.0 t -132.96 91.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.291 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -89.3 10.97 20.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 5' ' ' GLY . 35.5 ttpt -154.11 -65.26 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.689 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' GLY . 1.4 m 61.89 16.15 7.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 3' ' ' LYS . . . -51.2 -175.44 0.02 OUTLIER Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.658 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -141.51 128.3 20.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -127.23 130.12 49.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -119.01 140.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.989 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -136.17 126.64 26.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.492 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -120.96 127.2 51.59 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.116 0.484 . . . . 0.0 110.027 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -125.31 143.96 50.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.641 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 96.7 mt-10 -61.92 -25.85 67.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.3 m-20 -116.87 -161.2 0.79 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.4 pttp -112.62 176.63 4.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.676 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 76.06 12.41 2.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.596 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.6 m-85 58.7 50.26 9.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.369 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.676 ' NE2' HD22 ' A' ' 15' ' ' ASN . 11.9 pt20 -118.24 -163.13 0.93 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 ' H ' ' A' ' 19' ' ' ARG . 7.5 t 86.35 -138.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.719 0.637 . . . . 0.0 110.584 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG12 ' A' ' 18' ' ' VAL . 18.9 ptp180 -120.41 34.32 5.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.805 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptt85 -70.92 158.37 36.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.071 0.462 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 13.6 m-85 -95.47 -171.56 2.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.597 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -157.02 48.0 0.43 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.7 m -142.1 153.39 44.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.368 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 50.0 p-10 -90.45 139.46 30.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 t -173.8 -177.97 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.343 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 45.1 p-10 -136.54 128.82 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.207 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 m -148.21 165.17 31.74 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.411 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.69 -45.61 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.0 p-10 -169.32 125.1 0.88 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 38.6 p90 -74.23 12.43 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -59.53 -16.92 27.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.566 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 13.4 m -62.29 -37.93 87.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.663 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 57.2 m-85 -81.71 -33.19 31.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.671 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.08 129.31 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.059 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 p -61.74 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.251 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 72.3 mtp85 -73.93 162.87 28.62 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.556 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -148.26 147.53 29.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.291 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.5 m120 -116.71 -139.67 0.37 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.71 168.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.668 0.605 . . . . 0.0 110.862 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 41' ' ' LYS . 68.3 mt -145.57 165.24 10.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.508 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 40' ' ' ILE . 30.8 tttt -131.57 121.25 24.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.33 127.62 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.202 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -124.79 87.65 2.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.078 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.22 137.8 8.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.96 159.43 2.48 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.432 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 81.1 m -105.55 114.28 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.658 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 34.6 m95 -92.71 152.08 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.047 0.451 . . . . 0.0 109.935 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.2 139.43 52.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.558 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.13 141.97 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.542 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 49.9 m-85 -103.43 168.98 8.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.495 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 66.0 tt0 -84.37 -33.96 23.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -121.1 156.87 56.64 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.299 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.4 Cg_endo -60.23 152.65 64.8 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 111.612 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.5 t-20 88.74 17.96 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.553 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 58.53 53.89 5.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.66 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.83 132.12 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.466 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 118.63 126.62 3.6 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' O ' ' O ' ' A' ' 57' ' ' GLY . 5.5 m-85 41.11 -176.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 110.323 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.542 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 80.9 mmm -153.08 102.26 2.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.497 ' C ' HD12 ' A' ' 61' ' ' ILE . 57.9 m-85 -108.15 119.45 39.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.232 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.7 mp -98.38 121.95 49.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.43 95.39 31.36 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.489 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.71 166.03 24.1 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.327 2.018 . . . . 0.0 111.495 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.0 tm0? -44.95 101.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -174.14 154.32 19.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.61 135.29 36.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 13.0 m-85 -132.86 89.77 33.79 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -25.51 16.02 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.573 1.515 . . . . 0.0 112.224 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 71' ' ' GLN . 90.5 mt-10 -126.06 156.46 39.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.949 0.404 . . . . 0.0 110.626 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -71.38 9.23 0.83 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.911 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.1 -15.21 16.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.182 0.515 . . . . 0.0 110.657 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 71' ' ' GLN . 1.2 tpm_? -89.87 -16.1 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.527 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -111.18 17.08 20.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.118 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mpp? 48.29 56.92 6.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.347 . . . . 0.0 110.918 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.93 177.85 53.89 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.91 -72.79 0.66 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.586 0.231 . . . . 0.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' ARG . 12.5 t-20 -129.68 44.92 2.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.376 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.25 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.7 tpm_? -77.34 110.99 12.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.262 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 73' ' ' TRP . 70.6 mt -152.2 127.7 10.03 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.313 0.383 . . . . 0.0 110.503 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 82' ' ' SER . 1.7 t -149.44 52.14 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.197 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER 163.91 138.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.593 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.1 p -143.02 132.61 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -138.6 146.48 41.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.632 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.29 141.05 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.155 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.02 140.35 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.2 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -122.96 142.24 51.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 110.183 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.64 153.33 47.83 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.693 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.96 129.78 11.78 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.323 2.015 . . . . 0.0 111.801 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.4 t -69.48 125.23 26.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.295 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.39 169.19 41.43 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.01 8.2 Favored Glycine 0 N--CA 1.467 0.7 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.89 152.11 34.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -141.13 176.93 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.391 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -172.76 129.99 0.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.17 141.66 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.232 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 9.1 mp0 -122.69 121.78 37.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.582 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 124' ' ' MET . 19.2 pt -115.82 132.32 65.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.817 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -97.39 174.49 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.28 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -118.3 20.94 12.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.323 0.582 . . . . 0.0 109.66 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -154.55 153.55 31.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.049 0.452 . . . . 0.0 110.782 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.04 -29.49 70.62 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.737 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 63.2 t0 -95.49 31.81 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.985 0.421 . . . . 0.0 110.705 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 50.65 74.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.316 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 m -161.49 165.95 27.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.11 -143.24 16.28 Favored Glycine 0 N--CA 1.467 0.748 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -95.2 127.2 41.07 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.063 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -115.56 144.97 43.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -115.71 132.53 56.61 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.327 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.9 tt0 -132.77 147.57 52.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.6 m 138.04 154.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 125.178 1.549 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' THR . 0.1 OUTLIER -97.16 156.85 16.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.5 mm-40 148.97 137.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 37.5 p-10 -55.55 129.88 40.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 80.0 m -121.06 116.69 31.12 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.18 -66.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.578 1.519 . . . . 0.0 112.252 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HG ' ' A' ' 172' ' ' SER . 31.4 m -120.62 120.49 35.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.268 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.4 pt -60.24 -49.15 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.473 ' H ' HG13 ' A' ' 118' ' ' ILE . 16.4 ptm -57.18 13.8 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.1 tp10 -127.24 -53.51 1.38 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.144 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.3 tt0 -77.68 -35.45 52.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.803 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.75 3.04 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.071 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 57.77 30.21 18.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.445 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -131.9 137.08 47.86 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.41 5.62 37.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.53 162.96 38.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 ' SG ' ' A' ' 130' ' ' CYS . 17.7 mt -142.38 133.69 25.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -96.74 -22.98 16.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -150.95 141.12 22.21 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.306 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.8 m -147.66 68.44 1.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' VAL . 61.0 pttt -96.66 168.59 10.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.791 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' LYS . 24.3 t 53.54 111.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.751 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 -123.2 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.107 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -171.94 131.11 0.65 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.4 -119.74 17.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 136' ' ' VAL . 27.4 m -146.62 135.27 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -125.05 164.58 19.89 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.421 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 65.0 mt -111.6 134.98 52.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.919 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.599 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -107.21 129.67 54.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.756 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -113.21 155.15 25.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.42 ' OE1' ' NH2' ' A' ' 148' ' ' ARG . 83.8 tt0 -92.11 -33.18 14.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.513 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.534 HD12 ' CA ' ' A' ' 147' ' ' GLY . 90.0 mt -111.42 148.26 38.42 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.472 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.8 Cg_endo -64.89 161.67 35.49 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.932 1.755 . . . . 0.0 111.339 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.5 m-80 79.99 7.95 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.418 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.8 m-85 76.98 44.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -130.31 -170.11 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.401 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.534 ' CA ' HD12 ' A' ' 142' ' ' LEU . . . 71.12 29.67 68.49 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.791 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 17.4 ttp-105 85.8 167.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.122 0.542 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 59' ' ' MET . 3.0 mp0 -131.35 163.89 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.396 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.526 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 66.0 m-85 -137.54 140.73 41.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -95.98 134.73 38.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.867 0.365 . . . . 0.0 110.396 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 151' ' ' LEU . 5.4 mp -104.75 -161.92 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.817 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.529 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 6.1 t70 71.13 81.53 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 110.813 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -156.83 -64.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.149 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -160.75 154.88 22.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.504 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -42.26 117.09 0.93 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.405 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 60.9 m-85 -74.91 83.37 2.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.53 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 12.0 tpt180 -60.58 -41.66 95.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.286 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 34.3 mtpt -124.19 158.02 62.27 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.321 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 9.5 Cg_endo -53.57 -38.11 83.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.505 2.137 . . . . 0.0 113.708 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 165' ' ' ALA . 14.9 pt -78.51 3.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.071 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 8.3 m-20 -64.29 -33.4 75.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.876 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 22.8 p90 -91.33 30.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.473 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.89 72.41 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.133 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.876 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -91.34 127.24 36.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.009 0.433 . . . . 0.0 111.763 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.83 63.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.688 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -155.26 163.34 24.9 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.407 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.35 5.47 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.199 2.599 . . . . 0.0 111.956 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -69.77 106.29 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.406 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.599 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.5 p -150.15 143.79 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -101.1 -142.79 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.045 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.563 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.1 m -81.39 -141.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -179.54 175.16 0.91 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.733 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 24.2 ptt180 -156.6 139.0 14.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.117 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.572 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 150.32 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 176' ' ' ILE . 7.9 mt -89.55 135.74 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.071 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 84.5 t -132.38 129.51 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE2' ' OG1' ' A' ' 46' ' ' THR . 95.2 mt-10 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.556 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m 55.83 -117.61 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.737 0.304 . . . . 0.0 110.511 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -158.87 52.71 0.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.423 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 -40.16 7.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.24 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.5 176.86 28.02 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -79.4 123.23 27.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.936 0.398 . . . . 0.0 110.511 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -119.34 125.17 48.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.624 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 tt -116.94 141.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -131.44 125.31 32.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -117.64 123.0 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.73 142.64 48.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 45.2 mt-10 -58.66 -25.33 62.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 11' ' ' TYR . 86.1 m-20 -121.89 -158.37 0.77 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.7 pttp -111.27 174.15 6.0 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.698 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.8 m-80 75.05 12.34 3.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.1 m-85 57.4 47.85 15.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.051 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.698 ' NE2' HD22 ' A' ' 15' ' ' ASN . 21.3 pt20 -124.84 153.27 42.81 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.027 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.6 p 129.57 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 125.135 1.522 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.797 ' H ' HG22 ' A' ' 18' ' ' VAL . 17.1 ptp180 -119.51 35.2 4.92 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.657 0.383 . . . . 0.0 110.366 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 25.7 ptt-85 -69.37 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.719 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -144.5 -167.39 2.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -161.68 54.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.2 t -140.14 143.31 36.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.302 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 46.7 p-10 -89.07 139.81 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.97 -170.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.061 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 41.6 p-10 -137.5 128.2 26.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.758 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 m -142.46 159.61 41.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.58 70.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.981 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.92 134.87 0.59 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 0.0 110.063 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -77.3 10.41 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.708 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -59.67 -16.17 24.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -64.29 -35.85 82.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.512 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -87.87 -37.24 16.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.892 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -159.33 121.18 3.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -76.41 18.31 0.32 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.569 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' LEU . 68.4 mtp180 -158.33 137.37 11.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.433 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 1.8 t -142.97 146.34 33.83 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 39' ' ' SER . 53.2 m-20 -120.12 -135.72 0.32 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -32.64 167.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.817 0.698 . . . . 0.0 111.03 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.631 HD12 HD21 ' A' ' 62' ' ' LEU . 77.2 mt -146.34 165.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 40' ' ' ILE . 28.8 tttt -129.91 134.56 47.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -124.22 146.5 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.985 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.27 87.85 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 73.38 95.93 0.09 OUTLIER Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.38 152.96 9.91 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 89.6 m -93.52 167.13 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.622 ' N ' HG22 ' A' ' 46' ' ' THR . 36.0 m95 -149.79 144.67 26.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.517 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.81 53.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.685 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 137.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -103.99 168.01 9.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.583 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -79.03 -33.55 44.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.402 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -124.39 165.52 24.22 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.122 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 30.9 Cg_exo -61.39 153.36 66.43 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.272 1.981 . . . . 0.0 111.493 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 89.24 18.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.845 0.716 . . . . 0.0 110.722 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 56.61 47.81 17.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.604 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.33 131.75 28.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.38 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 121.19 126.09 3.26 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' O ' ' A' ' 57' ' ' GLY . 11.9 m-85 42.27 179.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.399 0.618 . . . . 0.0 110.536 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 149' ' ' GLN . 39.5 mtt -152.82 136.03 15.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 95.7 m-85 -144.17 122.49 12.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.589 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -95.29 122.15 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.716 HD11 ' HE1' ' A' ' 73' ' ' TRP . 10.5 mp -116.3 92.81 37.52 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.762 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.81 171.27 13.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.648 2.232 . . . . 0.0 111.786 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 3.1 tm0? -48.05 98.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.591 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.72 150.92 15.88 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -95.58 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.74 91.08 34.61 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.38 -19.29 13.36 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.9 1.733 . . . . 0.0 112.086 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' C ' ' OG ' ' A' ' 39' ' ' SER . 47.1 mt-10 -138.13 155.66 48.51 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.075 0.464 . . . . 0.0 110.318 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 71' ' ' GLN . 50.0 p90 -59.61 -42.44 92.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.013 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 6.4 pt20 -50.42 -16.16 0.32 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.559 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 70' ' ' TYR . 3.2 mmp_? -100.36 -21.01 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' HE1' HD11 ' A' ' 62' ' ' LEU . 65.6 t90 -100.74 3.51 42.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.591 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 46.28 56.35 6.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.527 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.29 -179.36 51.61 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.1 tt -123.78 -71.58 0.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 110.74 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' ARG . 21.7 t-20 -132.78 46.21 2.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.247 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 39.23 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.759 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -79.51 109.3 13.75 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.044 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.62 128.33 9.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.469 0.481 . . . . 0.0 109.931 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -148.7 53.35 0.99 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.071 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER 162.42 141.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.475 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.94 126.95 20.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.115 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -131.06 141.89 50.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.259 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.75 139.8 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.0 t -133.62 137.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -111.93 159.81 18.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.28 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.34 126.61 78.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.68 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' CG ' HG12 ' A' ' 136' ' ' VAL . 81.5 Cg_endo -77.79 144.69 22.11 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.254 1.969 . . . . 0.0 112.341 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.4 t -63.22 137.0 58.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.89 -76.35 0.03 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.86 -83.23 0.32 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.647 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 49.4 tt0 -66.67 -70.06 0.27 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.612 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 4.3 m-30 99.97 80.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.147 1.529 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -99.35 137.39 37.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.725 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' HB ' ' CE3' ' A' ' 137' ' ' TRP . 16.2 tt -126.31 136.73 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.034 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.532 HE21 ' CD ' ' A' ' 110' ' ' GLU . 96.0 mt-30 -121.1 113.13 19.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.221 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' SD ' ' A' ' 124' ' ' MET . 23.1 pt -110.98 138.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -112.44 133.17 54.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.096 0.474 . . . . 0.0 110.123 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -56.32 -32.04 64.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -106.37 163.54 12.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.343 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -75.84 -42.29 25.99 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -77.3 28.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 110.729 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' GLY . 70.7 m-85 52.4 71.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 m -155.55 161.55 40.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.61 -137.52 13.83 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 18.9 tm0? -87.73 131.03 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.295 0.569 . . . . 0.0 110.386 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -127.11 140.96 51.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.454 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 68.9 m-85 -115.93 131.09 57.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.567 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 111' ' ' THR . 78.3 tt0 -131.24 144.69 51.5 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.039 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.8 m 137.87 155.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.051 1.469 . . . . 0.0 110.478 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' THR . 1.7 t -95.07 158.5 15.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 154.84 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.8 p-10 -84.69 125.96 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.586 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 57.0 m -124.04 110.91 29.0 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.347 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.53 -57.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 0.0 111.975 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.8 m -123.69 119.51 30.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.3 pt -61.21 -49.74 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.856 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.462 ' H ' HG13 ' A' ' 118' ' ' ILE . 15.6 ptt? -57.43 14.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.701 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.8 tt0 -128.1 -54.33 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.389 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.586 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.3 tt0 -77.37 -35.26 54.69 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.651 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.7 m-85 -119.02 1.63 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 57.92 32.2 21.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.854 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -131.86 136.31 47.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 4.53 37.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.736 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.88 162.66 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.41 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 129' ' ' SER . 14.2 mt -141.77 131.43 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -94.7 -23.46 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -133.01 -172.92 3.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 0.0 110.744 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.77 ' O ' HD21 ' A' ' 133' ' ' LEU . 9.4 m -163.14 -28.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.187 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 38.5 tttp 59.0 171.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' O ' HD23 ' A' ' 133' ' ' LEU . 8.5 p -64.76 133.38 30.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 130' ' ' CYS . 10.2 mt -122.51 156.44 34.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.587 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.42 141.22 52.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.317 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.35 -118.85 8.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.401 HG12 ' CG ' ' A' ' 89' ' ' PRO . 13.0 p -156.14 140.91 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.405 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.82 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.78 162.51 20.75 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.758 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.468 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 72.7 mt -105.91 130.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.876 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.3 m-85 -105.29 125.87 51.47 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.258 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -108.81 142.62 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.996 0.427 . . . . 0.0 111.088 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -78.14 -36.19 48.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.295 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.16 147.99 36.21 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 159.34 51.82 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.263 1.975 . . . . 0.0 111.487 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 4.4 m-80 77.58 12.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.468 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.5 m-85 72.07 63.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -144.55 175.67 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.214 -0.304 . . . . 0.0 110.371 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.09 -151.91 30.67 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 57.5 ttp180 -77.88 154.43 31.73 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' MET . 77.1 mt-30 -123.77 154.33 39.68 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 24.6 m-85 -129.79 135.23 48.18 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.219 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.7 120.08 37.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.014 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.9 mp -84.83 129.31 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.0 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 38.5 p30 -106.0 138.51 42.05 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -47.54 99.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.556 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -149.14 -94.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.485 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -173.55 -28.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 153' ' ' ASP . 3.3 m-85 54.95 68.84 0.8 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -79.53 -9.51 59.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -142.52 156.52 63.47 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.499 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.8 Cg_endo -57.85 -44.44 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.382 2.055 . . . . 0.0 113.018 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.7 pt -79.41 1.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.441 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -62.95 -33.56 75.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.979 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.9 p90 -92.38 29.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.606 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.07 23.86 60.66 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.973 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.63 125.64 40.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.943 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -68.5 -22.75 64.52 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.625 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.56 162.99 24.98 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.474 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.62 5.59 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.049 2.499 . . . . 0.0 111.797 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.56 110.61 6.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.5 p -153.68 147.69 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -100.37 -143.76 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.337 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.635 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.42 -142.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.221 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.7 p90 178.91 178.98 0.42 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.82 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.3 ptt180 -160.93 142.47 11.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.754 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.581 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -59.25 149.09 29.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.75 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 7.8 mt -86.18 134.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.273 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.55 132.85 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.402 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.376 179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 76.58 21.21 1.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.666 0.27 . . . . 0.0 110.476 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' A' ' 4' ' ' THR . 30.2 tptt -88.76 -137.73 0.11 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 82.7 p -64.0 163.5 12.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.13 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.86 112.74 1.9 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.59 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.1 p -146.05 136.67 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -133.0 133.44 43.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 tt -121.0 142.22 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 110.149 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -135.02 126.48 28.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.516 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -119.4 124.22 46.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 110.099 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.99 142.09 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.762 -178.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' H ' HG21 ' A' ' 18' ' ' VAL . 97.4 mt-10 -61.1 -26.57 67.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.364 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -117.63 -161.22 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 8.1 pttm -112.1 173.43 6.36 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.665 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.76 10.9 2.13 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.546 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 58.04 51.12 9.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.542 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.952 ' O ' HG22 ' A' ' 18' ' ' VAL . 11.7 pt20 -114.72 -166.66 1.13 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.1 m 89.42 -140.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 124.27 0.981 . . . . 0.0 111.65 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.825 ' H ' HG23 ' A' ' 18' ' ' VAL . 15.8 ptp180 -116.72 34.44 5.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.151 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 17.8 ptt-85 -71.39 157.08 38.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.228 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 30.9 m-85 -99.04 -169.54 1.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.149 177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -159.23 53.82 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.559 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -142.16 152.09 42.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 35.7 p30 -90.94 139.19 30.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.8 t -174.74 -175.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 44.0 p-10 -136.45 128.58 29.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.007 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.7 m -147.06 164.62 32.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.642 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.74 -44.77 86.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.142 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 31' ' ' HIS . 34.7 p-10 -171.24 125.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.0 109.833 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 42.9 p90 -74.99 13.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.724 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -58.81 -17.83 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.505 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 12.0 m -62.93 -39.26 94.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.77 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 58.4 m-85 -79.79 -33.91 40.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.534 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.01 130.19 2.21 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.2 m -62.89 -83.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.3 mtt85 -72.95 162.03 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 110.403 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.78 147.44 29.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 39' ' ' SER . 1.7 m-20 -116.68 -140.46 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -34.54 167.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.579 0.55 . . . . 0.0 111.138 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 61.8 mt -144.53 163.74 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.198 0.523 . . . . 0.0 110.551 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 28.8 tttt -130.47 120.86 24.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.13 122.89 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 43' ' ' GLU . 5.2 tm-20 -123.07 91.02 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.516 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 129.63 -137.52 9.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.53 -157.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' N ' ' A' ' 47' ' ' TRP . 34.5 m -99.19 172.45 7.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.611 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.664 ' N ' HG22 ' A' ' 46' ' ' THR . 34.6 m95 -147.92 144.32 27.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.963 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.92 127.17 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.4 132.2 65.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.54 168.26 9.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.585 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -34.26 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.682 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.95 162.23 42.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.5 Cg_exo -61.13 149.88 87.05 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.772 1.648 . . . . 0.0 111.681 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.2 t-20 87.77 15.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.951 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 61.76 63.93 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.195 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.2 160.18 40.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 91.42 -154.06 22.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.403 ' CD2' ' HD2' ' A' ' 148' ' ' ARG . 5.1 m-30 -54.33 159.03 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mpt? -133.95 126.85 31.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' C ' HD12 ' A' ' 61' ' ' ILE . 96.4 m-85 -121.21 128.96 52.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -99.55 121.23 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD21 ' NE1' ' A' ' 73' ' ' TRP . 8.2 mp -118.46 88.16 33.01 Favored Pre-proline 0 N--CA 1.461 0.12 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.417 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.11 168.33 19.38 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.535 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 1.9 tm0? -46.36 102.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 154.08 20.16 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -96.7 134.8 39.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -130.89 92.82 32.85 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.67 -27.9 4.63 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.638 1.559 . . . . 0.0 112.339 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 80.7 mt-10 -124.07 159.55 29.67 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 110.535 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -77.23 7.63 4.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.648 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 39.0 mt-30 -98.42 -12.89 20.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.23 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -104.49 -12.07 16.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.765 ' NE1' HD21 ' A' ' 62' ' ' LEU . 58.7 t90 -100.08 2.01 42.83 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.978 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.5 mtm 48.72 55.41 9.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.959 0.409 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.08 178.89 50.95 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.65 -71.64 0.71 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.006 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 79' ' ' ARG . 15.9 t-20 -131.92 43.79 2.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 39.16 20.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 77' ' ' ASN . 13.0 tpp85 -78.15 111.74 14.39 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 ' CG1' ' A' ' 49' ' ' VAL . 73.6 mt -154.2 130.25 10.28 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.373 0.42 . . . . 0.0 110.547 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -150.65 53.8 0.89 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.158 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.94 138.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.483 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.28 134.29 25.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 110.283 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -138.52 145.34 40.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.33 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.78 143.29 34.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.443 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 48' ' ' ALA . 66.2 t -125.95 132.91 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -116.27 105.55 12.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.497 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.6 151.77 68.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 128.33 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.351 1.367 . . . . 0.0 111.351 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.2 m -75.09 143.28 43.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.612 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 38.39 41.06 1.03 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.93 -134.16 1.45 Allowed Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 52.1 tt0 -148.1 151.06 34.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 0.0 110.362 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -121.75 145.49 47.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.254 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -173.47 125.15 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -130.0 140.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.375 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' CYS . 77.5 mt-30 -120.85 107.62 12.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.053 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.8 pt -104.63 133.5 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 110.344 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.42 135.93 48.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.328 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -58.9 -36.14 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.237 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -103.61 163.69 12.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.317 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 129' ' ' SER . . . -80.01 -37.37 22.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.9 27.78 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.0 110.769 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 53.65 69.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 m -155.97 160.96 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.172 0.51 . . . . 0.0 110.899 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.87 -135.4 12.53 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -95.23 129.22 42.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 110.469 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.577 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 40.2 ttp -121.12 140.39 52.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.091 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -115.12 134.24 55.34 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.9 tm-20 -133.95 148.34 51.16 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 16.1 m 137.58 154.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 125.032 1.457 . . . . 0.0 110.966 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -94.75 155.72 16.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.6 mm-40 155.65 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.15 122.88 28.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 41.4 m -121.33 109.4 35.0 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.92 -58.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.957 1.772 . . . . 0.0 112.192 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.6 m -122.46 118.69 28.93 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -59.47 -50.12 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 120.244 -0.583 . . . . 0.0 109.681 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.587 ' CE ' HE22 ' A' ' 171' ' ' GLN . 16.9 ptp -56.78 14.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' H ' ' C ' ' A' ' 118' ' ' ILE . 29.7 tp10 -127.6 -53.5 1.35 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 109.905 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 48.4 tt0 -77.46 -37.1 52.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CZ ' ' NE2' ' A' ' 121' ' ' GLN . 67.3 m-85 -116.78 4.43 13.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.22 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 58.2 28.61 16.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -131.7 139.97 49.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -104.08 6.7 36.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.5 163.15 38.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.899 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -140.85 131.54 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.637 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -97.38 -24.42 15.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.632 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 102' ' ' GLY . 3.6 m -146.49 135.91 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLN . 54.1 t -108.72 -9.66 15.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.725 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HG2' ' H ' ' A' ' 132' ' ' VAL . 23.6 tttp 42.4 -168.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' H ' ' HG2' ' A' ' 131' ' ' LYS . 10.0 t -70.5 139.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CG ' ' H ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -121.81 -109.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 135' ' ' GLY . 4.2 tm-20 -171.71 141.39 1.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.532 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 48.41 -103.42 0.07 OUTLIER Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 136' ' ' VAL . 12.7 p -161.11 133.82 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.56 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.779 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -123.36 163.46 20.75 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 77.0 mt -108.77 131.1 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.24 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.1 m-85 -103.22 124.62 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.396 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -107.97 140.51 41.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.156 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.95 -34.68 44.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.53 149.1 39.39 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.833 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 67.1 Cg_endo -67.92 161.41 44.2 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.168 1.912 . . . . 0.0 111.72 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 6.0 m-80 81.89 9.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.563 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.9 m-85 77.78 39.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.59 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -121.6 -174.64 2.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 65.1 119.28 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 147' ' ' GLY . 37.2 ttp-105 -6.32 123.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.366 0.666 . . . . 0.0 112.735 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.553 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -91.1 169.75 10.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.452 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.13 140.65 42.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 61' ' ' ILE . 52.7 tp -96.65 128.7 43.85 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.0 mp -90.71 117.93 29.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 18.7 t70 -81.65 -155.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.111 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 72.3 mmtt -96.58 78.21 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 157' ' ' TYR . 43.2 tttm -151.97 158.41 43.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 110.253 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -81.81 -12.76 58.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 155' ' ' LYS . 51.7 m-85 57.09 88.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.666 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -82.04 -8.46 59.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.097 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -144.96 156.67 55.15 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.178 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 16.3 Cg_endo -57.86 -46.9 23.34 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.294 1.996 . . . . 0.0 113.265 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 165' ' ' ALA . 19.9 pt -77.61 2.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.639 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 42.3 t0 -64.25 -33.23 75.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.579 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.863 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 16.8 p90 -92.41 30.14 1.55 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.707 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.03 21.11 68.69 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.829 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.863 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.47 123.99 34.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.46 72.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.33 156.55 33.68 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.68 1.92 2.85 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 123.222 2.615 . . . . 0.0 111.995 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.94 50.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG21 ' CD2' ' A' ' 139' ' ' PHE . 6.1 p -89.91 150.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 110.023 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.587 HE22 ' CE ' ' A' ' 119' ' ' MET . 76.2 mm-40 -100.73 -144.57 0.34 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.086 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -82.46 -141.82 0.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.262 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 179.26 178.29 0.5 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.779 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.2 ptt180 -159.63 142.39 13.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.106 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.481 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -57.62 138.8 54.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.164 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.47 137.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.065 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 77.2 t -131.76 132.76 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.598 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.45 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -85.85 164.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.82 0.343 . . . . 0.0 110.405 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -71.27 -75.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -45.03 7.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 29.82 4.04 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.0 t -147.98 140.19 24.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.816 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -139.41 135.0 33.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.098 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.6 tt -120.58 145.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.446 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -139.38 128.31 23.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -118.48 125.73 50.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.45 140.38 53.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.541 -178.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.1 mt-10 -59.44 -23.99 63.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.423 ' H ' HG21 ' A' ' 18' ' ' VAL . 89.5 m-20 -119.44 -160.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 pttm -111.98 177.1 4.76 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.669 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.1 m-80 76.22 10.22 3.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.8 m-85 59.97 50.02 7.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.241 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.669 ' NE2' HD22 ' A' ' 15' ' ' ASN . 15.1 pt20 -118.05 -158.53 0.72 Allowed 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 19' ' ' ARG . 4.0 t 81.62 -139.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.21 0.319 . . . . 0.0 110.691 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.787 ' H ' HG12 ' A' ' 18' ' ' VAL . 10.6 ptp85 -116.89 35.9 4.42 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.932 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.7 ptt-85 -70.07 152.08 44.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.25 0.548 . . . . 0.0 111.27 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.19 -174.41 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -157.03 47.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 110.47 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.0 m -140.11 144.06 36.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.043 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.1 p-10 -87.39 139.76 30.23 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -178.77 -171.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.9 124.28 29.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.751 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.3 m -135.97 156.98 47.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.791 0.329 . . . . 0.0 110.582 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.32 93.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.389 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 32.3 p-10 -171.24 114.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.083 0.468 . . . . 0.0 109.943 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 44.7 p90 -78.74 11.21 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.641 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -66.44 -24.28 66.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.392 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 5.7 t -52.54 -21.67 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.946 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CB ' HD23 ' A' ' 34' ' ' LEU . 67.0 m-85 -95.99 -38.61 10.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.26 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -151.99 115.68 4.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.702 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 p -74.21 18.95 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.705 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 34' ' ' LEU . 92.5 mtt180 -158.04 141.69 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -141.29 142.05 33.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 -179.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 39' ' ' SER . 4.3 m-20 -120.03 -139.95 0.34 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -35.36 166.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.22 0.533 . . . . 0.0 110.799 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 64.9 mt -145.72 164.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.193 0.52 . . . . 0.0 110.574 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 25.9 ttmt -131.29 119.65 22.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.02 125.56 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.018 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.64 88.44 2.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.404 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 83.69 129.63 1.65 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.79 161.45 20.0 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.5 m -98.26 169.69 9.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.651 ' N ' HG22 ' A' ' 46' ' ' THR . 31.7 m95 -147.07 141.1 25.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.63 127.5 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 80' ' ' LEU . 2.0 t -118.52 133.75 64.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' CD2' ' C ' ' A' ' 55' ' ' PHE . 57.6 m-85 -98.54 169.5 9.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -86.37 -36.53 19.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.532 -179.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -123.95 165.34 24.27 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.946 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 24.6 Cg_exo -61.69 149.7 88.8 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.821 1.68 . . . . 0.0 111.429 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.41 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.69 0.619 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 82' ' ' SER . 7.8 m-85 45.13 54.35 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.6 136.93 26.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.919 0.39 . . . . 0.0 111.278 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 105.1 143.26 11.83 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' C ' HH21 ' A' ' 148' ' ' ARG . 1.7 m-85 8.3 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 O-C-N 124.286 0.639 . . . . 0.0 112.032 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.501 ' C ' HH22 ' A' ' 148' ' ' ARG . 23.9 mtt -96.59 124.25 40.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.486 ' C ' HD12 ' A' ' 61' ' ' ILE . 69.4 m-85 -105.72 128.88 53.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.366 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -100.24 130.41 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.698 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -129.92 97.8 22.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.32 171.06 16.61 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.353 2.036 . . . . 0.0 111.632 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -44.08 101.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.783 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.71 158.6 27.81 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -103.58 136.59 43.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 35.4 m-85 -131.32 95.54 24.04 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.773 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.59 -13.48 16.4 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.872 1.714 . . . . 0.0 112.64 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.54 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 28.6 mt-10 -144.5 154.35 42.81 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 42.2 p90 -75.7 16.5 0.38 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.644 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' GLU . 71.9 mt-30 -96.7 -17.96 19.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.815 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -101.35 -5.56 25.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.26 11.49 17.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mtm 49.86 57.41 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.787 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -71.21 173.6 42.53 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.03 -72.45 0.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.067 0.461 . . . . 0.0 110.4 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.836 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -135.2 42.71 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.982 -178.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 39.88 19.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 111.033 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.59 114.75 19.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.019 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.525 HD11 ' CH2' ' A' ' 73' ' ' TRP . 62.5 mt -152.42 129.79 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.067 0.461 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 82' ' ' SER . 40.4 t -125.19 -125.94 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 2.0 m -35.08 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.904 0.383 . . . . 0.0 111.017 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.4 p -149.83 145.4 26.56 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -147.86 152.29 37.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -82.48 141.97 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.066 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.6 t -124.76 132.17 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -98.9 161.79 13.44 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 88' ' ' LEU . 10.7 mp -88.31 128.32 53.74 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.806 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.51 173.38 14.6 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.304 2.003 . . . . 0.0 112.027 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.8 p -50.61 128.97 21.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.04 -130.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.25 -138.06 13.68 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE21 ' CG2' ' A' ' 112' ' ' THR . 56.7 tt0 -111.1 121.06 44.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.357 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -80.09 111.33 16.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 35.5 ttmt -113.16 133.47 55.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.211 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.14 137.33 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.21 115.4 22.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.482 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.4 pt -113.36 134.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 1.5 m-85 -103.2 136.37 43.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.613 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.45 -37.43 83.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.429 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -99.54 162.56 12.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 110.324 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 128' ' ' HIS . . . -84.14 -14.98 70.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -98.03 29.31 3.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.803 0.335 . . . . 0.0 110.534 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 54.37 62.62 2.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 m -157.37 162.51 39.06 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.977 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.98 -143.57 15.73 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -97.01 102.09 13.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.256 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 48.3 ttp -87.17 146.43 26.02 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.717 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.63 132.66 56.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 77.2 tt0 -133.0 145.3 50.74 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.009 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 9.3 m 139.15 156.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 125.045 1.466 . . . . 0.0 110.262 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.465 ' CG2' HE21 ' A' ' 93' ' ' GLN . 10.1 t -98.23 156.75 16.55 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.2 mm-40 155.92 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.9 p-10 -86.6 123.85 32.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 35.3 m -116.46 111.76 41.72 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.171 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -81.77 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.739 1.626 . . . . 0.0 111.597 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 m -125.35 120.76 32.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.8 pt -61.14 -50.43 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.872 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.426 ' HA ' ' N ' ' A' ' 124' ' ' MET . 17.9 ptm -57.66 16.15 0.0 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.462 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' H ' ' C ' ' A' ' 118' ' ' ILE . 75.1 tt0 -128.81 -53.62 1.23 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 109.898 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -78.62 -36.14 44.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.872 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.3 2.53 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.17 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 58.86 30.59 20.31 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.426 ' N ' ' HA ' ' A' ' 119' ' ' MET . 1.0 OUTLIER -131.91 136.99 47.8 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -101.63 6.6 42.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.073 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.95 163.08 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.701 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 129' ' ' SER . 11.3 mt -142.38 135.76 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.419 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 15.3 m-70 -110.59 17.4 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.569 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -169.23 -178.16 3.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.712 0.292 . . . . 0.0 110.688 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' CG ' ' A' ' 157' ' ' TYR . 1.8 p -168.93 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt 48.13 -171.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.47 145.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.29 162.29 33.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 71.4 tt0 -78.93 141.25 37.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.702 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 -137.42 49.74 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 m -137.51 135.0 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.64 0.257 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.752 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.91 13.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.0 mt -119.25 137.01 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.317 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -111.67 133.91 53.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 71.2 m-85 -111.34 146.05 37.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.165 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -79.24 -32.65 43.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.91 147.93 38.8 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 57.9 Cg_endo -65.52 162.94 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.049 1.832 . . . . 0.0 111.8 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m-80 80.83 8.49 1.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.268 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.0 m-85 78.38 36.39 0.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -121.66 -171.9 2.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.064 0.459 . . . . 0.0 110.707 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.34 -54.7 3.9 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.067 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.811 HH11 ' H ' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -178.41 -165.64 0.09 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.107 0.48 . . . . 0.0 110.452 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.811 ' H ' HH11 ' A' ' 148' ' ' ARG . 71.5 mt-30 -153.19 141.87 20.95 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.314 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.95 133.94 47.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.681 0.277 . . . . 0.0 110.674 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -101.35 126.76 48.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.6 mp -89.37 131.38 35.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.987 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 56.4 t0 -144.35 -17.91 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.198 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -69.66 142.65 53.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.364 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -39.57 92.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.428 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -137.8 151.58 48.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.6 ' CG ' ' SG ' ' A' ' 130' ' ' CYS . 5.2 m-85 -121.64 87.05 2.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.083 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.545 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -67.07 -37.26 83.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.608 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 10.9 mtpp -129.44 157.48 76.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 10.5 Cg_endo -54.43 -40.03 85.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.749 2.299 . . . . 0.0 113.029 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.0 pt -72.49 2.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.598 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 12.7 m-20 -65.91 -31.36 72.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.849 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.895 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 10.9 p90 -96.32 28.57 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.25 64.07 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.061 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.895 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.46 122.65 33.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 111.71 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.58 74.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.679 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.85 157.7 34.27 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.15 6.63 0.8 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.989 2.459 . . . . 0.0 112.138 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.31 47.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.732 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' HD11 ' A' ' 118' ' ' ILE . 3.4 p -90.66 150.86 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -105.15 -142.75 0.37 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.928 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.7 p -80.68 -143.87 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.285 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.5 p90 -179.39 176.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.205 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.752 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -160.77 143.36 12.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.118 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.658 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -58.24 146.98 32.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.792 -179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.0 mt -85.15 140.34 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.266 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.0 t -133.53 129.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.703 0.287 . . . . 0.0 110.442 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.218 -0.563 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.346 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -61.36 -67.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.717 0.294 . . . . 0.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -57.29 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.159 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 m -47.16 141.68 4.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.414 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.62 62.33 0.39 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 9.5 t -87.12 138.0 31.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.387 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HZ1' ' CG2' ' A' ' 9' ' ' THR . 20.7 ttpp -136.05 133.65 37.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.869 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -118.91 141.71 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.413 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.518 ' CG2' ' HZ1' ' A' ' 7' ' ' LYS . 19.0 p -133.96 125.44 28.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.52 120.5 39.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -118.6 139.75 50.99 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.674 ' H ' HG21 ' A' ' 18' ' ' VAL . 96.0 mt-10 -58.78 -24.16 61.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.237 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -121.48 -160.12 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.5 pttt -110.92 173.8 6.16 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.692 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.2 m-80 77.47 10.91 2.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.924 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.9 OUTLIER 56.97 52.61 9.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.469 179.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.989 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.9 pt20 -117.08 -164.17 0.97 Allowed 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.2 m 86.43 -137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.157 0.911 . . . . 0.0 111.951 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.869 ' H ' HG23 ' A' ' 18' ' ' VAL . 12.7 ptp180 -118.27 36.32 4.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.86 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.54 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 22.2 ptt-85 -70.87 155.76 40.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' OH ' ' CZ ' ' A' ' 33' ' ' TYR . 22.6 m-85 -91.66 -176.13 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.141 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -155.71 48.7 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.499 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 85.1 m -144.28 154.73 43.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 48.0 p-10 -91.41 137.06 32.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.34 -172.07 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.91 128.43 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.848 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 m -136.21 155.22 50.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.225 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.81 88.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.91 121.43 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -78.83 12.02 2.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.6 -24.44 60.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.6 p -60.71 -34.51 74.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.642 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CZ ' ' OH ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -83.85 -37.56 22.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.489 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -162.8 115.89 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.492 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -74.48 19.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 34' ' ' LEU . 15.0 mmt-85 -157.97 140.73 14.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.96 144.18 33.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.53 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' SER . 28.9 m-20 -118.45 -139.78 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -33.94 168.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.811 0.695 . . . . 0.0 110.806 -179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 41' ' ' LYS . 92.7 mt -145.89 164.93 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.148 0.499 . . . . 0.0 110.89 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' N ' HG22 ' A' ' 40' ' ' ILE . 29.1 tttt -131.81 116.03 16.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.6 t -116.99 126.24 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.142 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.75 87.45 2.74 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.105 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 86.67 132.48 3.31 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.04 165.84 15.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 47' ' ' TRP . 88.1 m -99.4 169.08 9.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.346 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.639 ' N ' HG22 ' A' ' 46' ' ' THR . 43.6 m95 -144.19 138.29 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.268 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.59 123.0 49.32 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.684 HG12 HD22 ' A' ' 80' ' ' LEU . 2.3 t -115.31 132.87 63.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -104.13 171.68 7.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.961 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 81.7 mt-10 -95.14 -29.62 14.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -114.11 151.95 45.39 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.2 Cg_endo -60.61 147.8 93.46 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.226 1.951 . . . . 0.0 111.34 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.9 t-20 88.07 35.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.708 0.63 . . . . 0.0 110.448 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 43.46 56.08 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.05 135.53 25.84 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.568 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 113.02 127.22 4.66 Favored Glycine 0 N--CA 1.469 0.885 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.6 m-85 41.79 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 110.424 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.889 ' H ' HH12 ' A' ' 148' ' ' ARG . 2.1 mpt? -154.86 115.06 3.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.195 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' C ' HD12 ' A' ' 61' ' ' ILE . 80.7 m-85 -115.97 117.11 29.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.91 129.29 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.59 96.49 30.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.38 169.05 17.68 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.48 2.12 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 2.4 tm0? -44.28 99.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.26 153.81 21.98 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -96.41 132.79 41.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.355 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 17.8 m-85 -129.15 96.05 29.49 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 -31.11 3.41 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.195 1.93 . . . . 0.0 112.43 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 50.2 mt-10 -124.18 160.39 27.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.405 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -71.55 8.52 1.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.163 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -102.18 -11.24 18.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.154 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -93.8 -17.18 23.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.212 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.498 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -110.48 13.17 22.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.41 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 mtm 48.68 56.98 6.83 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.57 178.08 50.65 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 tp -124.64 -72.64 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' ARG . 2.1 t-20 -135.53 43.3 2.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.522 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 40.63 19.29 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 77' ' ' ASN . 17.0 tpp85 -77.02 110.44 11.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.845 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD22 HG12 ' A' ' 49' ' ' VAL . 64.5 mt -154.39 131.17 10.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.399 0.437 . . . . 0.0 110.659 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.0 t -146.27 53.5 1.13 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.613 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 81' ' ' SER . 1.1 t 159.36 145.13 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.331 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.7 p -142.65 134.37 26.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 110.33 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -136.71 143.94 43.62 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.308 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -81.63 140.02 34.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.585 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.4 t -136.09 137.81 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.57 160.03 21.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.208 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.5 mp -87.65 132.0 41.94 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.134 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.37 146.83 36.02 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.1 1.867 . . . . 0.0 112.304 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.7 m -63.24 155.47 28.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.13 -152.32 21.8 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.6 23.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.92 -45.75 5.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.443 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 85.0 m-85 40.97 78.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.16 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 33.8 ttpt -106.93 133.12 52.06 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.49 139.77 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.985 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 130' ' ' CYS . 70.4 mt-30 -121.81 108.7 13.79 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.365 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.6 pt -105.05 132.26 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.198 0.523 . . . . 0.0 110.565 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE2' ' SD ' ' A' ' 108' ' ' MET . 0.2 OUTLIER -108.3 136.09 48.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.826 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -58.62 -35.5 72.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.869 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -102.88 163.68 12.07 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.06 -37.06 23.09 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.19 27.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 110.807 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 65.0 m-85 53.35 68.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.716 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -155.23 159.26 39.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.81 -140.68 15.08 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -98.22 114.79 27.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.049 0.452 . . . . 0.0 110.464 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.527 ' SD ' ' CE2' ' A' ' 99' ' ' PHE . 26.6 ttp -104.17 148.09 26.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.309 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -116.08 133.57 55.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.572 ' O ' ' CB ' ' A' ' 111' ' ' THR . 75.0 tt0 -133.88 147.58 51.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.97 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 10.5 m 139.43 156.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 O-C-N 124.827 1.329 . . . . 0.0 110.599 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 111' ' ' THR . 1.8 t -97.62 157.3 16.11 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CB ' ' O ' ' A' ' 112' ' ' THR . 3.1 mm-40 155.18 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 20.2 p-10 -91.18 125.4 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.565 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 86.3 m -120.03 113.62 34.13 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.48 -60.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.815 1.677 . . . . 0.0 111.944 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -124.36 120.6 32.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.839 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.6 pt -60.83 -50.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.438 ' H ' HG13 ' A' ' 118' ' ' ILE . 12.4 ptp -56.89 15.09 0.0 OUTLIER 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.089 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.709 ' H ' ' C ' ' A' ' 118' ' ' ILE . 26.6 tp10 -128.19 -53.19 1.29 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.414 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 43.7 tt0 -78.59 -33.27 47.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.002 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -121.05 1.13 10.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.752 0.311 . . . . 0.0 110.952 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 57.91 33.69 23.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.73 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.444 ' O ' HD12 ' A' ' 118' ' ' ILE . 1.4 ptp -133.15 132.9 42.17 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -100.16 5.8 44.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.54 161.3 40.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.491 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 129' ' ' SER . 13.5 mt -143.3 135.11 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.154 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -99.74 -22.98 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.8 OUTLIER -126.8 178.89 5.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.024 0.44 . . . . 0.0 110.899 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.542 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 21.4 m -159.03 -34.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.497 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' CYS . 87.6 tttt 56.23 157.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.619 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.46 147.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.226 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 168.38 19.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.32 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 33.2 tp10 -75.84 145.35 40.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.557 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 52.1 -136.49 34.31 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.33 136.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.79 0.328 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.809 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -121.74 167.03 13.43 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 84.2 mt -115.56 132.59 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.007 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.65 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.9 m-85 -103.93 125.55 50.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.433 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -107.75 146.73 31.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -84.21 -34.38 23.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.42 147.68 37.21 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.575 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 58.5 Cg_endo -65.86 159.1 50.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.11 1.873 . . . . 0.0 111.091 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.74 HD22 HH21 ' A' ' 146' ' ' ARG . 6.6 m-80 83.03 9.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.839 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.8 m-85 77.2 36.72 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.225 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.74 HH21 HD22 ' A' ' 144' ' ' ASN . 87.0 mtm180 -118.9 -175.8 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.123 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 62.54 126.49 0.01 OUTLIER Glycine 0 C--O 1.224 -0.501 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.889 HH12 ' H ' ' A' ' 59' ' ' MET . 12.3 ttt85 -9.89 129.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.269 0.629 . . . . 0.0 112.556 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -101.69 169.26 8.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' ' NH2' ' A' ' 148' ' ' ARG . 63.8 m-85 -133.19 137.45 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.92 127.17 37.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.421 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.06 99.22 9.63 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -68.99 -92.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -157.06 -158.33 0.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.51 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 62.64 159.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.546 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 31.8 tp10 -69.16 146.96 52.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.331 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.0 -49.0 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 73.68 -48.35 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.181 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -130.02 157.71 76.15 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.524 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.479 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 19.0 Cg_endo -59.66 -46.36 20.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.273 1.982 . . . . 0.0 113.185 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 165' ' ' ALA . 11.9 pt -74.16 2.72 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.536 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.48 -30.02 70.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.966 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.83 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 8.3 p90 -96.03 27.14 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.56 22.1 56.84 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.719 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.83 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -95.19 124.98 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.592 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.32 -27.54 67.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.896 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -149.07 162.88 27.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.1 7.88 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.034 2.489 . . . . 0.0 111.808 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -73.78 112.77 10.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 139' ' ' PHE . 5.4 p -154.59 149.36 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.22 -146.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.531 ' HA ' HG23 ' A' ' 118' ' ' ILE . 4.9 m -81.46 -141.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.8 p90 179.53 178.51 0.53 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.371 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.809 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.7 ptt180 -159.8 142.33 13.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.892 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -60.09 146.91 41.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.638 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.21 136.76 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.83 129.86 58.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.671 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.6 p -78.04 -148.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -118.6 -59.32 1.89 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.061 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -68.28 172.49 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.1 -103.91 0.21 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.52 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 12.0 t -79.06 129.62 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.089 0.471 . . . . 0.0 110.793 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -135.45 134.88 40.07 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.189 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -116.77 138.46 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.971 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -130.24 124.06 31.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.367 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -117.58 119.78 36.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.358 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -119.13 144.22 46.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.058 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 97.6 mt-10 -61.09 -31.3 70.98 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.482 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -113.4 -161.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 9.2 pttm -112.8 172.83 6.69 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.672 HD22 ' NE2' ' A' ' 17' ' ' GLN . 1.9 m-80 75.79 15.85 2.51 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.41 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' CD2' ' C ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 57.5 49.45 12.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.672 ' NE2' HD22 ' A' ' 15' ' ' ASN . 20.6 pt20 -127.45 156.81 41.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.78 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 19' ' ' ARG . 10.9 p 129.06 -133.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 125.36 1.662 . . . . 0.0 109.952 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.776 ' H ' HG22 ' A' ' 18' ' ' VAL . 18.1 ptp180 -115.25 23.3 12.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.836 0.35 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' H ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -70.8 167.5 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 9.7 p90 -155.87 85.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.506 0.669 . . . . 0.0 110.537 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.9 p-10 -43.12 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.498 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' TYR . 11.8 m -134.85 132.19 38.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.269 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 47.1 p-10 -88.12 136.6 32.9 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 t -173.76 -178.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 110.175 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 40.4 p-10 -131.88 124.03 28.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.1 m -150.83 169.33 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.81 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.36 -49.19 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' HIS . 26.7 p-10 -172.1 127.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -71.93 15.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.779 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.7 p80 -55.03 -18.33 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.303 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.0 p -66.33 -41.01 90.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.143 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.43 -35.68 46.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.04 132.56 3.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.553 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -66.37 -87.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.084 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -82.98 123.74 29.73 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.083 0.468 . . . . 0.0 111.961 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 10' ' ' PHE . 14.0 t -104.12 149.6 25.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.115 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 34.8 m-20 -112.03 -138.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -35.05 172.48 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.476 0.655 . . . . 0.0 111.321 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 41' ' ' LYS . 80.1 mt -146.04 165.6 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 40' ' ' ILE . 31.7 tttt -131.86 118.5 19.93 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.5 t -118.98 127.95 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.999 0.428 . . . . 0.0 109.887 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -126.52 88.4 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 92.4 140.47 9.61 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.549 ' N ' ' OE2' ' A' ' 178' ' ' GLU . . . 64.87 163.13 0.76 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -108.02 115.22 29.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 29.8 m95 -92.42 151.87 20.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.923 0.392 . . . . 0.0 110.103 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.2 135.35 53.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.494 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD22 ' A' ' 80' ' ' LEU . 17.1 m -124.18 139.63 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.201 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -107.7 173.29 6.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.387 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.616 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 65.1 mt-10 -95.78 -28.17 14.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.739 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -115.9 152.52 47.63 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 27.0 Cg_endo -62.17 150.16 87.83 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.032 1.821 . . . . 0.0 111.712 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.4 t-20 88.69 18.85 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 60.29 56.25 3.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.541 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.81 137.25 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 107.31 133.92 7.36 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' O ' ' O ' ' A' ' 57' ' ' GLY . 10.9 m-85 44.02 172.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.319 0.58 . . . . 0.0 110.776 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -153.35 97.31 2.14 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' C ' HD12 ' A' ' 61' ' ' ILE . 79.7 m-85 -105.35 123.21 47.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.014 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.6 mp -101.54 126.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.842 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.7 96.4 49.39 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.187 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.35 167.48 22.96 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.758 1.639 . . . . 0.0 111.309 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -41.94 99.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 67' ' ' TYR . . . -173.59 151.57 13.67 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.572 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -92.36 135.57 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.598 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 65' ' ' GLY . 9.2 m-85 -133.53 90.06 29.87 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.378 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.95 -29.05 8.72 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.579 1.519 . . . . 0.0 111.971 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 52.8 mt-10 -120.97 160.31 23.78 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.131 0.491 . . . . 0.0 110.545 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -73.92 5.4 4.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.368 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 2.2 pt20 -101.25 -10.14 20.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.639 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.97 -16.71 23.67 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.605 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -111.15 14.96 21.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.738 0.304 . . . . 0.0 110.401 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.1 mtm 49.97 56.71 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.3 177.53 53.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 tp -123.74 -68.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.845 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -136.94 46.1 2.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 -178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 38.6 22.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.547 0.213 . . . . 0.0 111.393 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -76.85 111.49 12.44 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 ' CH2' ' A' ' 73' ' ' TRP . 71.8 mt -152.92 128.59 10.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 110.105 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 82' ' ' SER . 3.3 t -148.99 50.83 0.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 162.92 140.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.364 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.8 p -138.29 123.92 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.642 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -129.39 141.86 50.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -83.22 140.84 32.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.12 137.19 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.279 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -120.32 154.73 34.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.689 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.1 mp -85.4 133.58 42.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.678 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 151.36 26.06 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.034 1.823 . . . . 0.0 112.355 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.8 p -66.61 152.91 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.95 -165.47 0.05 OUTLIER Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.95 75.5 0.98 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' LYS . 59.3 tt0 -46.76 120.4 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 73.3 m-85 -66.53 69.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 93' ' ' GLN . 29.7 ttmt -98.97 129.56 45.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 173' ' ' PHE . 3.3 tt -122.27 127.51 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.547 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -114.52 102.55 10.17 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.965 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.2 pt -105.58 136.04 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 18.1 m-85 -106.62 134.27 50.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.385 0.612 . . . . 0.0 110.595 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -57.66 -35.1 70.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.639 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.76 165.3 11.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.83 0.348 . . . . 0.0 110.41 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.63 -37.24 17.49 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -79.0 28.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.559 0.219 . . . . 0.0 111.142 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 129' ' ' SER . 69.2 m-85 54.23 66.18 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.657 0.265 . . . . 0.0 110.844 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.2 m -155.37 162.29 40.84 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.07 -139.62 14.59 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.632 ' NE2' ' CE1' ' A' ' 109' ' ' TYR . 5.6 tt0 -96.14 139.32 32.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.307 0.575 . . . . 0.0 110.63 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 52.3 ttp -122.84 146.09 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.517 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.632 ' CE1' ' NE2' ' A' ' 107' ' ' GLN . 70.7 m-85 -116.27 131.2 57.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.384 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 111' ' ' THR . 7.0 tm-20 -133.08 145.59 50.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.555 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 8.1 m 139.5 150.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.999 1.437 . . . . 0.0 110.753 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.552 ' O ' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -92.78 152.16 19.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER 159.04 164.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 124.21 29.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.555 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 47.4 m -121.96 110.05 33.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.8 -59.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.122 1.882 . . . . 0.0 111.996 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -120.6 120.55 36.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pt -60.68 -51.37 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.421 ' H ' HG13 ' A' ' 118' ' ' ILE . 14.4 ptm -57.18 13.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' H ' ' C ' ' A' ' 118' ' ' ILE . 31.5 tp10 -126.56 -51.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.555 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 52.2 tt0 -79.5 -36.57 38.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.417 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -118.06 2.93 12.11 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.685 0.279 . . . . 0.0 111.13 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 58.31 31.31 20.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.62 133.65 42.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -98.74 6.71 46.76 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.45 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -158.47 164.08 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.9 mt -140.27 130.44 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -96.54 -22.8 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.011 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 104' ' ' PHE . 5.4 t -146.67 135.79 22.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.324 0.583 . . . . 0.0 111.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.52 ' O ' ' O ' ' A' ' 131' ' ' LYS . 9.9 m -133.69 109.95 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.128 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 130' ' ' CYS . 18.5 mmmt -51.35 -162.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.006 0.431 . . . . 0.0 111.357 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.49 8.1 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.669 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.3 mp 42.1 -126.65 0.64 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.078 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -162.21 157.12 22.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 41.74 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 135' ' ' GLY . 15.7 m -155.3 123.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.877 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.632 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -124.5 155.8 38.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.492 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.9 mt -109.35 132.6 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD2' HG21 ' A' ' 170' ' ' VAL . 2.2 m-85 -105.42 127.91 53.24 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' CD2' ' OE1' ' A' ' 149' ' ' GLN . 63.2 m-85 -109.31 143.53 38.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 112.05 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -78.8 -38.02 39.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.258 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.9 mt -106.81 150.81 40.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 84.1 Cg_endo -70.27 161.51 45.75 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.045 1.83 . . . . 0.0 111.421 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.451 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 7.6 m-80 82.12 9.77 0.78 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.542 0.526 . . . . 0.0 109.924 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 5.6 m-85 75.54 48.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.525 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' GLY . 78.6 mtp85 -131.53 -173.34 3.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 111.051 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 60.71 129.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 61.6 ttp180 -7.67 125.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.488 0.715 . . . . 0.0 112.914 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.435 ' OE1' ' CD2' ' A' ' 140' ' ' TYR . 3.2 mm-40 -97.41 165.24 12.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 76.2 m-85 -133.31 138.1 46.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.904 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.31 129.34 50.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 152' ' ' LEU . 10.2 mp -98.77 127.98 44.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.465 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 16.6 m-20 -97.21 -124.34 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.166 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.62 24.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -93.4 34.35 1.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.583 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 97.4 mt-10 53.09 176.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.459 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.465 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 73.6 m-85 -153.01 85.26 1.22 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.466 ' N ' ' OD2' ' A' ' 162' ' ' ASP . 10.8 tpt180 -70.84 -41.59 71.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -121.14 161.2 41.93 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 -34.83 96.08 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.345 2.03 . . . . 0.0 113.332 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.9 pt -79.96 4.27 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.08 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 158' ' ' ARG . 5.8 m-20 -66.81 -30.88 71.18 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.034 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 19.3 p90 -93.36 29.15 2.01 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.489 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.48 74.73 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.038 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.83 126.0 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.35 -22.81 63.72 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.01 163.54 23.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.911 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.8 5.18 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.838 2.359 . . . . 0.0 111.677 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.41 108.38 4.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 118' ' ' ILE . 7.8 p -150.58 146.7 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 172' ' ' SER . 80.3 mm-40 -100.79 -145.3 0.34 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.18 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 118' ' ' ILE . 1.6 t -81.79 -140.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 13.5 p90 179.12 178.57 0.47 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.404 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.632 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.5 ptt180 -162.56 145.01 10.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.804 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -59.52 142.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.602 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.3 136.86 22.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.622 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.29 131.6 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.549 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 33.8 tp10 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.644 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 4' ' ' THR . 8.7 t -170.75 16.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.609 0.242 . . . . 0.0 110.602 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.18 -77.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.949 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -78.26 1.97 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.255 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.82 -150.52 42.99 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.644 ' CB ' ' HE1' ' A' ' 47' ' ' TRP . 1.3 p -143.54 133.15 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -128.6 130.54 47.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.846 0.355 . . . . 0.0 110.799 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -119.55 140.79 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.086 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -132.8 125.2 29.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.278 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.8 122.99 44.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -123.49 142.38 51.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 98.4 mt-10 -66.85 -28.95 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' LYS . 85.5 m-20 -127.07 124.63 39.71 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASP . 6.4 pttm -40.91 -179.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.896 0.748 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.5 m-80 76.66 6.72 3.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.505 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.2 m-85 59.26 48.53 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.569 ' NE2' HD22 ' A' ' 15' ' ' ASN . 7.9 pt20 -117.81 -162.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 19' ' ' ARG . 6.3 t 84.8 -137.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.494 0.496 . . . . 0.0 110.473 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.751 ' H ' HG12 ' A' ' 18' ' ' VAL . 17.2 ptp180 -119.26 36.33 4.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.807 0.337 . . . . 0.0 110.852 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 21.7 ptt-85 -69.53 152.66 44.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 33' ' ' TYR . 18.3 m-85 -94.11 -173.37 3.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -155.71 46.98 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -139.25 147.03 41.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.274 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 52.2 p-10 -88.45 142.94 27.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.0 -171.51 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.849 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -137.6 129.85 29.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.853 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -144.28 162.76 35.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.23 -41.45 84.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' HIS . 41.6 p-10 -172.18 126.57 0.55 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -70.37 10.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.184 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -56.68 -21.12 25.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.79 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.5 m -64.61 -40.33 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.112 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CD1' ' CE1' ' A' ' 21' ' ' TYR . 55.9 m-85 -79.18 -32.13 44.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.731 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.95 132.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.075 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.5 t -62.35 -83.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.66 164.61 26.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.855 0.36 . . . . 0.0 110.088 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.35 149.45 30.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.161 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.2 m-20 -113.44 -143.34 0.39 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -38.34 173.87 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.201 0.525 . . . . 0.0 110.942 -178.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 41' ' ' LYS . 66.1 mt -146.17 165.23 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.038 0.447 . . . . 0.0 110.702 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 40' ' ' ILE . 24.9 tttt -129.38 122.9 30.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.8 125.2 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.951 0.405 . . . . 0.0 109.968 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.25 86.93 2.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.84 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.45 134.63 5.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.96 157.76 5.12 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' VAL . 86.6 m -107.76 116.43 31.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.808 -0.196 . . . . 0.0 110.665 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.644 ' HE1' ' CB ' ' A' ' 6' ' ' THR . 28.5 m95 -93.8 153.24 18.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.243 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -122.79 136.12 54.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.8 139.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 40.1 m-85 -102.76 170.27 8.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.335 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 58' ' ' TYR . 10.6 tt0 -85.07 -35.19 22.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 51' ' ' GLU . 9.5 mmt85 -122.1 161.32 43.36 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.181 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 25.8 Cg_exo -61.49 150.02 87.09 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.783 1.655 . . . . 0.0 111.622 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.8 t-20 89.34 14.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.863 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' H ' ' CB ' ' A' ' 82' ' ' SER . 15.3 m-85 63.12 52.35 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.31 132.01 21.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.616 0.246 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 140.65 -49.46 0.78 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.692 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 13.1 m-85 -160.47 178.14 9.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.227 0.536 . . . . 0.0 110.285 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 50.6 mtt -140.14 88.43 2.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.636 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' C ' HD12 ' A' ' 61' ' ' ILE . 94.5 m-85 -90.32 120.98 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.9 mp -96.33 114.83 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.76 91.55 15.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.82 169.41 22.27 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.078 1.852 . . . . 0.0 111.697 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -45.67 105.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.4 161.22 27.1 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -101.86 135.88 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.631 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -128.12 93.52 38.82 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.149 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' CD ' ' NH1' ' A' ' 72' ' ' ARG . 60.0 Cg_endo -80.06 -1.17 11.21 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 121.793 1.662 . . . . 0.0 111.957 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -150.88 152.53 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.603 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -75.64 8.06 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.851 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -101.18 -12.52 18.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.847 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' NH1' ' CD ' ' A' ' 68' ' ' PRO . 38.3 ttm180 -93.98 -12.34 28.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.437 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.764 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.24 13.51 21.74 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.7 mpp? 48.37 57.99 5.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.482 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -81.57 177.83 53.95 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.471 ' CD2' ' NH1' ' A' ' 148' ' ' ARG . 8.7 mp -116.11 -75.32 0.58 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' ARG . 3.1 t30 -131.11 47.76 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.561 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 41.01 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.944 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ASN . 5.2 tpp85 -81.88 117.2 21.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.013 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.764 HD11 ' CH2' ' A' ' 73' ' ' TRP . 75.0 mt -152.09 127.58 10.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 82' ' ' SER . 36.4 t -124.76 -131.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.208 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.476 ' N ' ' OG ' ' A' ' 81' ' ' SER . 2.8 p -31.37 147.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.201 0.313 . . . . 0.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.7 p -146.7 140.29 25.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -142.12 147.36 36.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.664 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.09 144.74 34.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.909 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 t -137.0 138.05 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -109.26 161.08 15.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.48 136.53 26.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.031 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 130.59 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.063 1.842 . . . . 0.0 112.06 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -75.5 148.25 39.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.384 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 137.79 -42.43 1.29 Allowed Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 94' ' ' TYR . . . 72.7 -138.83 26.53 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.483 HE21 ' CE ' ' A' ' 95' ' ' LYS . 56.8 tt0 65.3 -49.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.822 0.366 . . . . 0.0 110.952 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 92' ' ' GLY . 78.7 m-85 37.4 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.483 ' CE ' HE21 ' A' ' 93' ' ' GLN . 31.0 ttmt -112.4 134.87 53.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 tt -128.6 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.1 mt-30 -122.63 106.55 11.07 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.169 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 98' ' ' ILE . 18.8 pt -105.06 139.48 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.036 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.71 139.71 48.09 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.042 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.47 -36.99 84.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -105.29 163.33 12.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -74.21 -45.76 23.97 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.132 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -73.25 30.58 0.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.617 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 102' ' ' GLY . 67.3 m-85 51.99 71.05 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -156.8 162.89 39.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.19 -136.67 13.25 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -91.6 124.21 35.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.989 0.423 . . . . 0.0 110.302 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 108' ' ' MET . 6.8 tmm? -122.02 141.95 50.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 73.8 m-85 -116.57 132.49 56.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.072 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 80.8 tt0 -131.68 144.79 51.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 14.3 m 138.34 157.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.747 1.279 . . . . 0.0 110.295 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 10.0 t -98.26 156.06 16.89 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 112' ' ' THR . 1.4 mm-40 149.62 137.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 42.1 p-10 -55.18 129.58 38.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.731 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 80.7 m -115.11 108.42 48.23 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.184 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 11.2 Cg_exo -66.23 -75.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.163 1.242 . . . . 0.0 111.927 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -120.28 122.74 41.52 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.732 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 120' ' ' GLU . 3.2 pt -58.25 -49.39 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.019 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.459 ' H ' HG13 ' A' ' 118' ' ' ILE . 11.0 ptm -56.95 12.25 0.0 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.649 0.261 . . . . 0.0 111.539 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.679 ' H ' ' C ' ' A' ' 118' ' ' ILE . 77.2 tt0 -129.05 -53.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.401 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 46.4 tt0 -72.43 -39.73 67.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.33 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 58.4 m-85 -118.78 5.62 11.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.271 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 57.0 28.35 14.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.6 ptm -130.69 136.06 48.43 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -102.21 5.44 40.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.505 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -157.03 162.83 39.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.195 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 129' ' ' SER . 11.9 mt -142.44 132.54 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 16.2 m-70 -101.1 17.06 23.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.678 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -169.71 -174.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.747 0.308 . . . . 0.0 110.197 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 129' ' ' SER . 3.3 m -166.39 -24.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.323 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 130' ' ' CYS . 74.0 tttt 52.57 168.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 133' ' ' LEU . 77.8 t -58.63 152.6 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -145.56 161.9 38.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.473 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 95' ' ' LYS . 44.7 tp10 -72.02 141.11 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.303 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.58 42.58 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.94 139.18 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.563 0.22 . . . . 0.0 110.417 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.23 166.32 14.8 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 70.2 mt -115.86 137.54 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.827 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CE2' ' SG ' ' A' ' 130' ' ' CYS . 4.9 m-85 -110.75 133.01 53.71 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -113.87 136.34 52.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.904 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.91 -33.12 71.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.063 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -110.46 149.15 39.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.324 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 61.4 Cg_endo -67.59 163.04 36.56 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.454 2.102 . . . . 0.0 111.407 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m-80 78.71 8.11 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.315 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.9 m-85 76.9 39.83 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.442 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -118.04 179.39 4.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.49 -159.36 40.58 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.692 ' NH1' ' CZ ' ' A' ' 58' ' ' TYR . 12.7 ttm-85 -66.92 170.03 7.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.79 0.329 . . . . 0.0 110.348 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -135.24 139.62 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.314 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -126.04 134.43 51.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.022 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' SD ' ' A' ' 59' ' ' MET . 10.7 tp -107.27 135.54 48.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.259 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 152' ' ' LEU . 4.6 mp -90.1 118.39 29.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.546 ' N ' ' OH ' ' A' ' 157' ' ' TYR . 48.9 t0 -170.47 26.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' LYS . 45.9 mmtm -125.35 84.34 2.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 154' ' ' LYS . 67.5 mttm 40.87 -165.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.856 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.64 151.16 47.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.546 ' OH ' ' N ' ' A' ' 153' ' ' ASP . 42.4 m-85 -108.27 84.63 1.97 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.819 0.343 . . . . 0.0 110.593 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -79.83 -18.03 51.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.432 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 6.4 mtpm? -128.95 157.02 77.03 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.425 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 11.3 Cg_endo -57.1 -51.68 8.26 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.706 2.271 . . . . 0.0 113.102 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 165' ' ' ALA . 10.2 pt -73.75 0.76 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.767 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.81 -33.46 75.73 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.818 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.877 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 11.8 p90 -91.61 28.68 1.68 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.669 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.56 21.43 64.22 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.146 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -90.65 123.69 34.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.825 0.345 . . . . 0.0 111.493 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.01 71.23 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.534 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -152.19 161.18 30.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.772 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.79 2.82 0.18 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.284 1.989 . . . . 0.0 112.228 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -71.18 108.98 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.239 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.505 ' O ' HD11 ' A' ' 118' ' ' ILE . 4.0 p -152.03 145.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -141.68 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.896 0.379 . . . . 0.0 111.133 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 173' ' ' PHE . 6.5 p -82.93 -143.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.19 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.525 ' N ' ' OG ' ' A' ' 172' ' ' SER . 18.8 p90 -179.89 176.8 0.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.693 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 25.2 ptt180 -159.56 142.51 14.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.018 178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.535 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -55.55 147.35 18.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.549 -179.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -83.67 64.43 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.269 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.66 128.39 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.224 0.535 . . . . 0.0 110.046 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.776 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.8 m -138.08 145.7 42.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.276 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -173.86 86.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.253 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 p 49.33 -139.14 0.84 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.305 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.78 49.73 0.06 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -84.19 135.71 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -135.45 133.31 38.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -118.71 140.02 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 p -136.35 126.44 26.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.194 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.38 125.05 49.2 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.092 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.34 140.67 51.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.594 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.534 ' H ' HG21 ' A' ' 18' ' ' VAL . 98.0 mt-10 -60.14 -25.87 65.83 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.15 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -119.36 -160.61 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 11.0 pttt -111.57 176.17 5.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.588 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.3 m-80 76.27 10.61 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.751 0.31 . . . . 0.0 111.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.561 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 57.91 50.72 9.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 111.16 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.92 ' O ' HG22 ' A' ' 18' ' ' VAL . 9.9 pt20 -113.1 -164.4 0.92 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 17' ' ' GLN . 2.0 m 85.8 -139.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 124.372 1.045 . . . . 0.0 112.048 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.823 ' H ' HG23 ' A' ' 18' ' ' VAL . 16.1 ptp180 -117.66 35.9 4.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 20.6 ptt-85 -70.68 156.13 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.304 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 33' ' ' TYR . 8.5 m-85 -93.6 -174.84 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.032 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -158.2 49.84 0.4 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.591 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.5 m -141.3 150.74 42.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.246 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 49.7 p-10 -90.52 138.77 31.3 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.2 m -179.76 -171.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.32 125.55 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -136.63 155.79 49.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.728 0.299 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.38 81.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -173.25 127.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.76 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -84.81 12.09 7.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -59.71 -26.09 65.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.498 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -60.52 -31.8 70.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.686 -178.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' CE2' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -85.27 -27.32 26.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.4 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.03 124.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.912 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 36' ' ' ARG . 97.5 p -61.8 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.437 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 35' ' ' SER . 2.0 mpt_? -72.77 161.03 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' C ' HD22 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -145.63 145.38 30.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.952 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.5 m120 -113.49 -145.51 0.4 Allowed 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -34.17 170.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.358 0.599 . . . . 0.0 111.297 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 41' ' ' LYS . 71.1 mt -144.37 164.55 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 40' ' ' ILE . 27.7 tttt -130.16 119.11 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.13 125.83 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 109.838 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -123.41 88.33 2.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 133.51 -133.2 6.83 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 6' ' ' THR . . . -55.03 -156.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.062 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' THR . 11.2 t -118.03 125.47 50.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.683 -0.259 . . . . 0.0 110.492 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 85' ' ' ALA . 53.4 m95 -96.63 152.91 18.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.126 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.667 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.86 137.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.014 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -100.4 172.23 7.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 52' ' ' ARG . 42.3 tt0 -85.9 -32.61 21.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.815 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 51' ' ' GLU . 13.1 mmt180 -119.84 161.42 38.18 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.794 -178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 22.1 Cg_exo -63.64 150.32 88.76 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.966 1.777 . . . . 0.0 112.013 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.2 t-20 88.46 21.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.137 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' H ' ' CB ' ' A' ' 82' ' ' SER . 2.6 m-85 57.7 56.0 5.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.467 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.0 130.11 19.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 116.11 127.69 4.15 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 57' ' ' GLY . 4.7 m-30 39.01 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.518 0.675 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.528 ' HB2' ' H ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.9 105.21 2.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.262 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' C ' HD12 ' A' ' 61' ' ' ILE . 85.6 m-85 -107.17 121.73 45.09 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 110.049 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.459 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.26 96.7 50.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.02 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.77 161.9 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.056 1.837 . . . . 0.0 111.698 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -42.09 104.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.484 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.29 159.04 25.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -99.92 135.44 41.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.352 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HB2' ' H ' ' A' ' 40' ' ' ILE . 20.0 m-85 -131.27 92.72 31.72 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.264 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.73 -24.3 11.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.376 1.384 . . . . 0.0 112.141 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -126.14 155.97 40.85 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -74.11 8.76 1.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -103.04 -11.82 17.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -95.31 -14.18 24.16 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.744 0.307 . . . . 0.0 111.496 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.796 ' CH2' HD11 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -109.56 15.49 22.88 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.349 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.7 mtm 49.46 56.42 7.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.991 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -78.37 179.02 52.39 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 tp -123.88 -73.9 0.63 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.091 0.472 . . . . 0.0 110.714 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' ARG . 19.1 t-20 -132.12 45.59 2.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 42.17 16.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.584 0.231 . . . . 0.0 111.195 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ASN . 27.5 ttm180 -81.04 115.32 20.45 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.185 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.796 HD11 ' CH2' ' A' ' 73' ' ' TRP . 64.3 mt -152.24 129.63 11.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.312 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.3 m -123.62 -129.81 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.9 p -36.46 155.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.97 138.46 25.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.123 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -141.36 148.41 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.566 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -80.46 140.25 36.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.983 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.56 136.16 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -110.74 160.71 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.121 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 88' ' ' LEU . 7.2 mp -82.35 147.81 57.59 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.812 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.05 159.28 48.08 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.703 2.269 . . . . 0.0 112.477 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -78.8 166.76 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.517 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.8 -134.77 11.29 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.95 52.13 0.03 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.541 ' NE2' HG21 ' A' ' 112' ' ' THR . 42.6 tp60 -140.93 -34.33 0.51 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.371 0.129 . . . . 0.0 110.675 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 93' ' ' GLN . 58.7 m-85 56.26 145.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 110.164 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -173.68 123.61 0.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.62 137.07 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' CYS . 24.3 mt-30 -119.81 106.37 12.02 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.067 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.8 pt -104.37 136.22 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 0.0 110.484 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -109.46 134.99 51.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.87 -35.62 71.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.32 162.51 12.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.6 -45.06 14.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -73.95 32.25 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.533 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 102' ' ' GLY . 63.5 m-85 50.89 75.54 0.18 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.008 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 m -156.58 -166.14 2.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.789 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.56 -137.59 44.77 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -91.69 137.72 32.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 108' ' ' MET . 8.8 tmm? -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.73 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -116.14 134.24 55.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.579 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 111' ' ' THR . 11.1 tm-20 -134.9 149.28 50.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.568 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 18.3 m 136.92 154.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.978 1.424 . . . . 0.0 110.575 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.541 HG21 ' NE2' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -94.03 156.49 16.57 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.7 mm-40 155.43 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 6.9 p30 -86.14 123.94 32.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.455 ' O ' ' OG ' ' A' ' 172' ' ' SER . 29.4 m -119.14 110.1 38.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -81.32 -56.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.743 1.629 . . . . 0.0 111.558 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.5 m -124.53 120.24 31.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.222 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 120' ' ' GLU . 1.3 pt -60.93 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 124' ' ' MET . 24.0 ptt? -57.45 14.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.327 0.251 . . . . 0.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 118' ' ' ILE . 80.6 tt0 -128.06 -53.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.285 0.565 . . . . 0.0 109.944 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -78.01 -36.76 48.38 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.074 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -116.74 3.93 13.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.618 0.247 . . . . 0.0 111.125 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 119' ' ' MET . 0.6 OUTLIER -132.13 141.17 49.05 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -106.01 6.2 31.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.822 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -156.93 162.03 39.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.3 mt -141.42 133.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.771 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -99.14 -22.24 15.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.722 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.04 139.05 21.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.855 0.359 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.634 ' SG ' ' CZ3' ' A' ' 163' ' ' TRP . 6.8 m -113.31 -17.49 12.28 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.604 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' CYS . 35.7 tttp 52.07 171.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.476 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -59.47 150.22 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.38 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.09 162.49 35.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -75.28 135.07 40.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.468 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.59 -142.63 48.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.57 134.92 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 110.304 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.797 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -122.07 166.01 15.18 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 75.8 mt -114.7 134.55 57.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.633 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.656 ' CD2' HG21 ' A' ' 170' ' ' VAL . 1.8 m-85 -105.71 126.92 52.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.695 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 145' ' ' TYR . 89.2 m-85 -109.49 141.05 42.49 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.629 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.13 -35.35 49.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.92 149.65 39.32 Favored Pre-proline 0 N--CA 1.467 0.424 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.463 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 74.1 Cg_endo -68.35 158.88 55.72 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.024 1.816 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.494 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 8.4 m-80 84.11 10.12 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.761 0.663 . . . . 0.0 110.498 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.7 m-85 76.9 40.76 0.18 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -124.37 -172.41 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.421 . . . . 0.0 110.746 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 148' ' ' ARG . . . 61.94 123.86 0.01 OUTLIER Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 147' ' ' GLY . 54.1 ttp180 -4.49 119.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -91.54 163.91 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.138 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.49 ' OH ' ' NH2' ' A' ' 148' ' ' ARG . 78.7 m-85 -131.2 136.02 47.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.372 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' MET . 43.1 tp -88.62 127.02 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.201 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 152' ' ' LEU . 11.0 mp -90.91 136.09 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.49 156.03 36.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -71.23 66.82 0.44 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.66 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -139.64 24.41 2.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 55.04 176.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -147.92 84.42 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -66.47 -37.69 85.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -124.19 156.52 66.41 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.402 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' CH2' ' A' ' 163' ' ' TRP . 12.5 Cg_endo -56.2 -41.46 76.42 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.342 2.028 . . . . 0.0 113.01 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 165' ' ' ALA . 7.6 pt -77.73 3.67 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.467 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -63.35 -33.07 74.73 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.601 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.906 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 25.8 p90 -95.34 30.92 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.702 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.99 22.37 71.7 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.887 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.906 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.83 123.57 33.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 111.668 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.29 73.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.709 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.98 155.66 35.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.434 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.82 5.27 1.1 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.154 2.569 . . . . 0.0 111.933 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.13 48.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.656 HG21 ' CD2' ' A' ' 139' ' ' PHE . 8.2 p -88.86 151.36 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.083 0.468 . . . . 0.0 110.131 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 172' ' ' SER . 76.6 mm-40 -101.35 -146.5 0.35 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.15 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 118' ' ' ILE . 10.3 p -80.25 -142.56 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.313 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.496 ' N ' ' OG ' ' A' ' 172' ' ' SER . 12.0 p90 178.93 178.76 0.43 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.299 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.797 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.3 ptt180 -159.9 143.1 13.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.923 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.637 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -60.06 144.0 50.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.286 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 176' ' ' ILE . 8.6 mt -79.42 134.79 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.051 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -133.07 134.67 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 110.366 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.442 179.462 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.7 p -157.35 -15.61 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.336 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' GLY . 13.3 tptp 71.12 -32.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 31.74 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.349 0.406 . . . . 0.0 111.318 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 138.44 44.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.48 ' OG1' ' NE1' ' A' ' 47' ' ' TRP . 8.9 t -80.79 135.48 35.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.496 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -138.39 136.81 36.67 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.54 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.58 140.95 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.539 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -135.26 126.2 27.62 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.218 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 123.15 46.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.379 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.31 141.99 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 0.0 110.021 -179.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 95.9 mt-10 -66.26 -28.81 69.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 14' ' ' LYS . 74.4 m-20 -128.76 124.73 36.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 13' ' ' ASP . 9.5 pttm -40.76 177.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.506 0.67 . . . . 0.0 112.205 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.595 HD22 ' NE2' ' A' ' 17' ' ' GLN . 2.0 m-80 76.6 7.66 3.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.293 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.7 OUTLIER 58.26 48.54 12.47 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.406 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 15' ' ' ASN . 8.6 pt20 -117.26 -163.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 19' ' ' ARG . 5.3 t 87.83 -137.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.095 0.558 . . . . 0.0 110.555 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 18' ' ' VAL . 9.6 ptp85 -114.33 29.04 8.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.059 0.457 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 16' ' ' PHE . 9.5 ptt-85 -72.13 159.66 33.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.372 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 23' ' ' CYS . 11.1 p90 -149.95 84.01 1.39 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.362 0.601 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.33 83.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.311 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' TYR . 47.6 t -134.8 131.68 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.227 179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 2.8 p30 -85.71 135.08 33.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' ASP . 1.6 m -170.76 177.33 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.993 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -134.19 127.9 32.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.008 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -151.75 172.41 16.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.38 91.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' OD2' ' OG ' ' A' ' 81' ' ' SER . 44.5 t0 -172.92 122.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -74.81 15.39 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' ASP . 1.9 p80 -57.53 -15.54 7.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.9 p -63.7 -38.91 92.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -78.8 -36.97 41.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.276 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.75 131.29 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.249 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 p -63.0 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.314 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 84.6 mtt85 -73.47 164.01 27.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 110.363 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -148.09 148.19 30.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 -179.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -115.06 -143.64 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -35.58 171.38 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.1 0.476 . . . . 0.0 111.096 -179.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 41' ' ' LYS . 73.9 mt -147.36 166.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.867 0.365 . . . . 0.0 110.549 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 40' ' ' ILE . 13.8 tttt -128.87 120.57 26.46 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.21 125.06 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.122 0.487 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -121.87 87.86 2.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.494 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 90.24 135.49 6.05 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.18 166.68 4.83 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.7 p -97.47 169.85 9.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.795 0.331 . . . . 0.0 110.132 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.48 ' NE1' ' OG1' ' A' ' 6' ' ' THR . 47.3 m95 -143.83 138.53 28.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.67 123.56 50.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 80' ' ' LEU . 1.8 t -121.01 136.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 58' ' ' TYR . 39.9 m-85 -106.83 175.57 5.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.532 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' C ' ' HE ' ' A' ' 52' ' ' ARG . 22.1 mt-10 -98.35 -28.66 13.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.066 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.585 ' HE ' ' C ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -119.34 149.25 47.14 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 32.2 Cg_exo -53.92 148.86 36.38 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.466 1.444 . . . . 0.0 111.893 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 t-20 89.46 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' CB ' ' A' ' 82' ' ' SER . 1.0 OUTLIER 44.78 53.22 7.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.55 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.79 136.23 26.96 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.77 -45.93 1.12 Allowed Glycine 0 N--CA 1.47 0.958 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.593 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 2.6 m-85 -143.92 159.75 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.268 0.556 . . . . 0.0 110.65 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 58' ' ' TYR . 3.3 mmt -131.22 88.74 2.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.598 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.8 m-85 -94.94 114.62 26.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.054 0.454 . . . . 0.0 110.113 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 61' ' ' ILE . 1.8 mp -96.86 119.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.709 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.84 95.47 48.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.644 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.07 166.57 26.41 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.692 1.595 . . . . 0.0 111.243 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HG2' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -41.14 104.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.786 -178.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.28 159.1 24.32 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.082 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -102.61 135.59 43.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.192 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -131.05 99.07 18.21 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.322 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.01 -24.85 7.96 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.694 1.596 . . . . 0.0 111.398 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.485 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 89.0 mt-10 -129.95 158.46 39.5 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.286 0.565 . . . . 0.0 111.091 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -75.0 12.15 0.94 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.446 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.485 ' NE2' ' OE1' ' A' ' 69' ' ' GLU . 44.6 mt-30 -100.54 -12.28 19.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.44 -10.18 24.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.604 0.24 . . . . 0.0 111.638 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -114.43 10.48 17.0 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 74' ' ' MET . 3.3 mpp? 50.09 58.55 5.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.94 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' HA3' ' NE1' ' A' ' 73' ' ' TRP . . . -76.92 -179.86 48.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.46 -72.04 0.7 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 110.547 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.85 ' H ' HD22 ' A' ' 77' ' ' ASN . 0.0 OUTLIER -134.45 46.07 2.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.115 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 41.27 16.93 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.584 0.231 . . . . 0.0 111.368 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 77' ' ' ASN . 11.4 tpp180 -78.79 117.81 20.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.986 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 73' ' ' TRP . 65.1 mt -152.92 130.17 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.25 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' OD2' ' A' ' 29' ' ' ASP . 47.5 t -127.54 -123.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.702 ' CB ' ' H ' ' A' ' 55' ' ' PHE . 1.1 m -36.38 147.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.996 0.427 . . . . 0.0 111.05 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.5 p -144.13 138.04 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.925 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 55' ' ' PHE . 60.6 ttm-85 -141.37 146.67 36.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.266 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -79.69 142.08 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 48' ' ' ALA . 49.3 t -130.13 135.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.673 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -102.76 160.6 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.7 132.66 32.6 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.091 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' CG ' HG12 ' A' ' 136' ' ' VAL . 92.6 Cg_endo -76.47 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.395 2.063 . . . . 0.0 111.697 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.0 p -65.64 146.11 55.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.477 179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.46 -97.85 0.16 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.75 -69.49 3.2 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -172.67 106.41 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.721 0.296 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.404 ' O ' ' CH2' ' A' ' 137' ' ' TRP . 74.4 m-85 -73.23 90.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -104.83 136.34 44.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.92 137.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.423 HE22 HG21 ' A' ' 132' ' ' VAL . 26.0 mt-30 -120.37 110.56 16.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.158 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 98' ' ' ILE . 21.0 pt -107.49 135.19 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.79 135.13 51.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.241 0.543 . . . . 0.0 110.118 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.07 -34.67 70.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 129' ' ' SER . 67.1 mttm -103.92 161.54 13.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.29 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 104' ' ' PHE . . . -76.18 -41.93 25.29 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.763 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -76.97 29.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.801 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 102' ' ' GLY . 78.4 m-85 53.44 70.83 0.55 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -156.3 163.98 38.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.21 -135.94 13.18 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -92.45 136.11 33.48 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.334 0.588 . . . . 0.0 110.913 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 108' ' ' MET . 7.5 tmm? -129.75 142.59 50.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.818 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 107' ' ' GLN . 65.4 m-85 -116.09 133.56 55.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.74 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 111' ' ' THR . 82.8 tt0 -133.2 144.05 49.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.15 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' GLU . 7.6 m 140.21 155.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.789 1.306 . . . . 0.0 110.687 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 3.6 t -94.31 156.57 16.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 112' ' ' THR . 2.4 mm-40 154.92 171.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -89.16 122.82 32.83 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.0 m -117.8 110.1 40.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.063 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' OG ' ' A' ' 172' ' ' SER . 84.9 Cg_endo -80.75 -56.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.689 1.593 . . . . 0.0 111.468 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 m -125.66 118.95 26.75 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.104 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 120' ' ' GLU . 2.1 pt -59.41 -50.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.632 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.402 ' H ' HG13 ' A' ' 118' ' ' ILE . 22.0 ptt? -59.22 15.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 118' ' ' ILE . 28.4 tp10 -127.79 -53.37 1.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -78.75 -36.82 42.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.061 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.67 2.04 12.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.561 0.22 . . . . 0.0 111.371 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 60.22 27.53 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.34 140.63 50.62 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -105.3 6.9 33.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.023 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -156.96 161.25 39.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.92 0.39 . . . . 0.0 110.771 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.403 HG21 ' SG ' ' A' ' 130' ' ' CYS . 24.0 mt -139.66 131.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -98.25 -23.64 15.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.46 ' C ' ' SG ' ' A' ' 130' ' ' CYS . 16.5 p -155.4 147.29 23.36 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.647 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 129' ' ' SER . 1.7 m -148.57 90.31 1.78 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.541 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -93.55 178.41 5.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.811 0.339 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.423 HG21 HE22 ' A' ' 97' ' ' GLN . 94.0 t 50.59 88.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.79 105.82 9.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -72.27 132.39 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.57 -116.79 9.74 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG12 ' CG ' ' A' ' 89' ' ' PRO . 13.6 p -156.07 139.24 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE1' ' C ' ' A' ' 174' ' ' ARG . 0.1 OUTLIER -124.78 170.85 10.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' H ' ' HD1' ' A' ' 137' ' ' TRP . 71.4 mt -119.36 134.85 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.19 133.6 53.06 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -113.63 138.87 49.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.859 -179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.386 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.37 148.05 38.32 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.715 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 60.1 Cg_endo -67.09 163.84 32.49 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.325 2.016 . . . . 0.0 111.51 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.3 m-80 79.39 8.54 1.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.449 -179.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.8 m-85 77.43 32.19 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -112.11 178.3 4.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.08 -161.66 39.84 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 59.3 ttp180 -75.82 140.5 42.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.616 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.37 150.85 24.86 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.446 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 56.4 m-85 -126.76 132.45 51.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.603 ' C ' HD23 ' A' ' 151' ' ' LEU . 6.6 tt -100.95 123.54 45.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 152' ' ' LEU . 3.6 mp -84.44 111.47 19.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.421 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.27 -37.32 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' CE1' ' A' ' 157' ' ' TYR . 69.2 mmtt -65.8 141.56 58.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.056 0.455 . . . . 0.0 110.365 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.5 -40.25 96.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.407 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.02 160.12 26.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.698 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CE1' ' O ' ' A' ' 154' ' ' LYS . 76.4 m-85 -138.93 93.07 2.66 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.854 0.359 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.29 -41.38 76.88 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.637 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -122.74 159.07 54.93 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.526 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.7 -43.72 52.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.373 2.049 . . . . 0.0 112.508 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.5 pt -73.28 1.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.544 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.42 -30.13 70.9 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.352 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.871 ' NE1' ' HB2' ' A' ' 165' ' ' ALA . 9.7 p90 -96.6 27.73 3.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.08 20.38 67.66 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.778 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.871 ' HB2' ' NE1' ' A' ' 163' ' ' TRP . . . -89.58 123.1 33.35 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.948 0.404 . . . . 0.0 111.65 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -27.7 68.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.88 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 p -154.19 154.58 29.96 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.33 5.44 1.53 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.995 2.463 . . . . 0.0 112.054 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 51.48 0.13 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.47 ' O ' HD11 ' A' ' 118' ' ' ILE . 2.3 p -90.81 153.12 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -105.23 -140.95 0.37 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 118' ' ' ILE . 5.6 p -83.4 -144.98 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' N ' ' OG ' ' A' ' 172' ' ' SER . 34.4 p90 -178.8 176.57 0.94 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 -179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.755 ' C ' ' HE1' ' A' ' 137' ' ' TRP . 26.6 ptt180 -161.08 144.11 12.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.602 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.64 ' N ' ' HE1' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -54.48 149.95 9.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 110.842 -178.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.68 66.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.285 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.66 127.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.269 0.557 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.545 -179.607 . . . . . . . . 0 0 . 1 stop_ save_